













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given. 
 
An exploratory trial for examining effects of 
Self-Management Education Programme on patients with 
Chronic Obstructive Pulmonary Disease  
in Macau 
Wai I NG 
PhD 




I hereby declare that this thesis is my own work and has not been submitted for any 
other degree or professional qualification. 




I have my greatest gratitude to many people for their support during this study. 
Firstly, I would like to thank the patients and families who participated in this study 
and patiently shared their views and experiences in the interviews. Their taking part 
in this research made it an enjoyable experience to me and will hopefully lead to 
improvements in support for COPD patients and their families. 
Secondly, I would like to thank the respiratory team, the administrative department 
and the nursing department of Kiang Wu hospital for providing access for the study. 
A special thank has to go to the clinical nurses in Kiang Wu, my lovely students, 
Sarah Lau and Joanne Tam for their support in the data collection and intervention 
throughout the process.     
I would also like to thank my supervisors, Prof. Graeme D. Smith, Dr. Peter T. Reid 
and Dr. John Simpson for their guidance, encouragement and support during this 
thesis. A big thank you is also reserved for Dr. Susanne Kean, Dr. Sue Yeung, Prof. 
Shenning and Stanley Ko for their generous and conscientious advice. A heartfelt 
thank you goes to Jeff Bagnall and Ann Bagnall who kindly helped in proof-reading 
the thesis.  
My thanks also go to Prof. Van Iat Kio and KWNC for providing administrative 
support and my colleagues for providing words of encouragement and useful 
comments on my work.     
Last but not least, important thank you is for my family and friends who took good 
care of my living and helped to release my stress respectively in the due course. 
Simon, my boyfriend deserves my very last gratitude as a listener, ‘debater’ and 
supporter who understood and shared my joy and sorrow. This thesis would not exist 
without all of these people.  
3
Abstract 
Background: Respiratory disease has been one of the top three causes of deaths in 
Macau in the past decade. As one of the chronic respiratory diseases, chronic 
obstructive pulmonary disease (COPD) is incurable, but is preventable and treatable. 
COPD patients suffer from recurrent and progressive respiratory symptoms, and this 
impacts the health and well-being of patients. Self-management education 
programmes (SMEP) provide teaching and learning guidance for understanding 
COPD, emotional support and behaviour change needed to carry out disease-specific 
care in chronic patients. Evidence has demonstrated that SMEP can mediate a change 
in health-related behaviours, improve symptom control and the quality of life of 
COPD patients, with an associated reduction in health care utilization. However, 
SMEP has never been conducted in Macau, and experiences of providing any form 
of chronic care for COPD patients in this place is lacking.  
Aims: This study aimed to explore the effects of a specifically designed 
self-management education programme on Stage II to IV COPD patients in Macau.  
Design: The study was conducted as an exploratory randomized controlled trial in a 
mixed methods approach. Both illness perception and self-efficacy beliefs were 
adopted to formulate the theoretical framework. In the quantitative strand, the 
assessment of primary outcomes included illness perception, self-efficacy and inhaler 
technique. The secondary outcomes included pulmonary function, healthcare 
utilization and health-related quality of life. In the qualitative strand, focus groups 
were conducted to explore the subjective perception and experiences of 
self-management of COPD patients. Fifty one eligible COPD patients were recruited 
and allocated to experimental (26 patients) and control group (25 patients) by block 
randomization. A SMEP for COPD patients was developed and validated according 
to Medical Research Council (MRC) framework.  
Results: Quantitative results indicated that the primary outcomes (illness perception, 
self-efficacy and inhaler technique) improved in the experimental group after the 
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SMEP. In relating to the secondary outcomes, days of hospitalization were reduced 
and symptom dimension of disease-specific health related quality of life (St. George 
Respiratory Questionnaire) improved. Qualitative findings identified the emergence 
of a core theme ‘Essentiality’ and five sub-themes ‘Helplessness’, ‘Mutual 
involvement’, ‘Support’, ‘Control’ and ‘Beneficial’, indicating perception and 
experiences of participants for self-management. These findings indicate a potential 
relationship of illness perception and self-efficacy in guiding COPD patients to adapt 
to health-related behaviour. 
Discussion and Conclusion: This study has obtained evidence for supporting the 
proposed theoretical framework and expected experimental effect through employing 
the MRC guidelines. The study also confirms the estimates of recruitment for a 
definitive RCT, demonstrated readiness and positive impact in Macau COPD patients 
to receive self-management intervention, and SMEP as an acceptable and preferable 
mode of chronic care for COPD for the healthcare system of Macau. 
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Chapter One  Introduction 
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1.1  Introduction 
Respiratory disease has been one of the top three causes of deaths in Macau in the 
past decade. Chronic obstructive pulmonary disease (COPD) contributed to one of 
the top ten causes of mortalities (SSM, 2008a, SSM, 2011). As a chronic lung 
ailment, COPD is incurable, but is preventable and treatable (GOLD, 2013, ATS, 
2004, NICE, 2011). It is believed that exposure to tobacco smoke is the major risk 
factor for COPD, while others include genetic factor or environmental exposures 
(NHLBI, 2009, NICE, 2011). Intriguingly, recent report indicated that 
gastro-oesophageal reflux may be associated with COPD, although such claim 
remains controversial (Pacheco-Galván et al., 2011, NHLBI, 2009b, NICE, 2011). 
Due to the marked increase in tobacco usage in developing countries and aging of the 
population, it is predicted that there will be an increased prevalence of COPD with 
associated morbidity and mortality in the coming decades (Boon and Davidson, 2006, 
Lopez et al., 2006, GOLD, 2008, GOLD, 2013, WHO, 2008). As a nursing 
professional with research interests in respiratory illnesses in Macau, I was interested 
to explore and develop an effective mode of care to prevent COPD patients in Macau 
from disease deterioration and to improve their overall quality of life.   
1.2  Background of the study 
1.2.1 COPD as a Research Target 
Patients having COPD suffer from recurrent and progressive symptoms of coughing, 
sputum production, exertional dyspnoea and eventually respiratory failure. The 
progressive nature of the disease erodes the health and well-being of patients and 
imposes adverse effects, for instance, disability in their daily living. With COPD, 
individuals need to cope not only with the symptoms of their disease, but also with 
the multiple psychological, social, and physical problems associated with their 
condition. Preventing medical crises, managing crises that do occur, handling the 
prescribed treatment, controlling symptoms, and overcoming disabilities, stigma, 
social isolation and economic issues are all related to coping with COPD (Bourbeau, 
11
2003). Some patients may cope very well and adapt to living with it, but for others, 
the chronicity of COPD can adversely affect their coping outcomes (Hwa and Lin, 
2005), resulting in poorer quality of life and/or social dependency. 
For the individual and the healthcare system to confront and relieve this burden, 
patients with COPD are increasingly being encouraged to be actively involved with 
the management of their own illness (Blackstock and Webster, 2007, Bourbeau and 
van der Palen, 2009, Bourbeau et al., 2004, Watson et al., 1997). Active participation 
is a strategy for formulating health behaviour which could buffer the chronicity 
impact of the illness on the patients, it thus helps the chronically ill patients to adapt 
more easily to this chronic condition and cope with the chronicity impact (Hwa and 
Lin, 2005). This health behaviour could be enhanced, for instance by a 
self-management programme that provides teaching and learning, guidance for 
health behaviour change, emotional support, and the skills needed to carry out 
medical regimens specific to the disease (Bourbeau, 2003). Self-management 
programmes were developed and implemented in the healthcare system in the West 
in the 1990’s (Kaptein et al., 2009). Evidence has demonstrated that 
self-management interventions mediate a change in health-related behaviour, 
improve symptom control and the quality of life of COPD patients, with an 
associated reduction in health care utilization (Kaptein et al., 2009, Horne and 
Weinman, 2002, Kohler et al., 2002, Lau-Walker, 2006, Lorig et al., 2001).    
1.2.2 COPD nursing in Macau  
In Macau, the emphasis of healthcare service provision to COPD patients is mainly 
focused on acute management based on the stated mission of “Adequate treatment 
Prioritizing prevention” of the Health Bureau (SSM, 2012a) (Refer to Appendix 1). 
The COPD patients are provided adequate medical treatment and promotion for 
smoking cessation is the main prevention strategy for COPD (SSM, 2008b). The 
chronic care provision for COPD patients is limited in Macau and no COPD 
nursing-related studies or experiences have been reported in any papers or 
publications (SSM, 2002-2010, KWNC, 2002-2011). In the modern era of evidence 
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based medicine, there is room to explore the impact in this population. On the 
contrary, the management of these patients probably relies on the hospital’s acute 
care service and this will burden the already stretched healthcare service; and this 
burden is an avoidable use of this service (AMN, 2009). Therefore, self-management 
intervention is identified as a potential approach for promoting the nursing care for 
Macau COPD patients as well as improving the overall quality of healthcare of 
Macau. 
However, active self-management with the disease appears challenging to Macau 
patients who are mostly Chinese. It is because the Chinese patients were often found 
to exhibit poor health knowledge and skills in relation to their chronic disease and 
self-medication (Tian et al., 2011a, Yin et al., 2013). Evidence demonstrates that 
more Chinese patient choose to acquire knowledge on self-medication from TV 
advertisement than from physicians (Li, 2008). Thus, Chinese tend to undertake a 
passive engagement with healthcare. Instead of directly importing the Western mode 
of nursing care to local COPD patients in Macau, it is necessary to explore the 
feasibility, appropriateness and effectiveness of this approach before application. As 
an initiative study in Macau, I have adopted the Medical Research Council (MRC) 
guidelines (2008) and cognitive-behavioural theories for developing complex 
intervention, and employed a mixed methods approach for the design of the study. It 
aims to explore the impact of self-management education programme on patients 
with COPD in Macau, in relation to patients’ subjective experiences, biomedical, 
behavioural and psychosocial aspects. The study placed particular emphasis on the 
facilitating effects of self-management intervention towards enhancing illness 
perception and self-efficacy beliefs of COPD patients, to initiate health behaviour 
changes and to improve the overall quality of life of these patients. 
1.3  Importance of the study 
Given the predicted impact of self-management education programme on COPD 
patients, this study informs the concrete benefits and weaknesses of this 
self-management intervention applying to the Macau population who are from a 
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different health system and of different culture. It will provide preliminary evidence 
that engaging patients with COPD in self-management has a mediating effect on 
self-beliefs. The study has also identified components for constructing a more 
effective and appropriate local care delivery mode for COPD patients in Macau and 
this can potentially be applicable to patients with other chronic illness. The findings 
and experiences derived from the study have also served as a very good foundation 
for a full randomized controlled trial (RCT). In the long run, it provides practical 
information for initiating a framework for developing a nursing care model for the 
chronically ill of the Chinese population in Macau.  
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1.4  Summary 
COPD patients in Macau lack the supportive care for living effectively with their 
chronic condition, and self-management intervention has the potential to fill this 
health delivery gap. Therefore, this study aims to examine the effectiveness of this 
intervention on COPD patients in Macau with an integration of MRC guidelines and 
mixed methods design. These will be covered in eight chapters of this dissertation. 
Chapter one provides an introduction to the background and importance of the study. 
Chapter two will provide an overview of COPD in terms of its definition, diagnosis 
and clinical management. Chapter three will present a critical literature review of the 
background of self-management and its impact on COPD patients, followed by 
rationale for the development of the research questions. Chapter four will address the 
theoretical framework that combines illness perception and self-efficacy beliefs 
employed in the study. Chapter five will be divided into five sections to address the 
design of the study. Quantitative results and qualitative findings will be presented in 
chapters six and seven respectively. Chapter eight will provide an in-depth discussion 
of the findings and conclude with the implications and limitations of the study.     
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Chapter Two  Overview of COPD 
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2.1  Introduction 
This chapter gives an overview of COPD which is the condition of the target 
population in this study. Since COPD is a combined disease state, it does not have a 
unified definition, clinical diagnosis and classification. This issue will be addressed 
in this chapter. The prevalence of COPD and its associated problems in various 
populations will be followed. Lastly, patients with COPD require a comprehensive 
approach in clinical management and this will be covered with a special attention to 
self-management intervention in the last section of this chapter. The understanding of 
the background of COPD will help to identify the knowledge or care gap for 
enhancing the health status of these patients in Macau.      
2.2  Background of COPD 
2.2.1  Definition of COPD 
According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and 
the American Thoracic Society (ATS), two professional respiratory medicine groups, 
COPD is defined as a preventable and treatable disease state characterized by 
persistent airflow limitation that is usually progressive and is associated with an 
abnormal or advanced chronic inflammatory response to noxious particles or gases in 
the airways and the lung (GOLD, 2013, ATS, 2004). Medical Research Council (MRC) 
refers COPD to:  
“a group of long-term lung disease that includes chronic bronchitis and 
emphysema. It involves a narrowing of the airways that makes it harder for 
air to get in and out of the lungs” (MRC, 2013).  
Hence, COPD has also been called chronic obstructive airway disease (COAD) and 
chronic airway limitation (CAL). The airflow obstruction or limitation characteristic 
in COPD patients does not change markedly over several months (NICE, 2011). The 
chronic airflow limitation is caused by a mixture of pathophysiological alterations in 
the lung, such as small airway disease (Chronic bronchitis) and parenchymal 
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destruction (Emphysema) (GOLD, 2013). The clinical definition of chronic 
bronchitis is: 
 “chronic productive cough for 3 months in each of 2 successive years in a 
patient in whom other causes of productive chronic cough have been 
excluded “ (ATS, 2004).  
Emphysema is  
  “defined pathologically as the presence of permanent enlargement of the 
airspaces distal to the terminal bronchioles, accompanied by destruction of 
their walls and without obvious fibrosis” (NHLBI, 1985) 
These two definitions reflect pathological alteration in the trachea and 
alverolar-capillary unit respectively. These pathophysiological alterations are caused 
by chronic inflammation of the airways which leads to membrane swelling and mucus 
secretion resulting in narrowing and changes in the airway structures. Destruction of 
the lung parenchyma, also by inflammatory processes, leads to the loss of alveolar 
attachments to the small airways and decreases lung elastic recoil. Consequently, the 
combined effect of these pathophysiological changes diminishes the ability of the 
airways to remain open during expiration and leads to progressive hyperinflation and 
decreased pulmonary compliance. This may result in respiratory failure and other 
complications such as cor pulmonale (Reid and Innes, 2010). The degree and pace of 
progression of airflow limitation and development of complication in COPD patients 
varies from person to person (GOLD, 2013, Reid and Innes, 2010).   
In addition, COPD is expounded as a disease state that is accompanied by airway 
hyperactivity and may be partially reversible (Tierney et al., 2002). Thus, despite 
predominantly comprising of chronic obstructive bronchitis and emphysema, a small 
proportion of chronic asthma patients whose airway obstruction has become 
progressively less reversible over time coexist with COPD and chronic asthma was 
suggested to be included in COPD (Williams, 1993). Apart from pulmonary 
component, COPD also demonstrates systematic impact on an individual (Decramer 
et al., 2005). Cachexia is commonly found in severe cases of COPD. This is 
characterized by impaired nutrition, unexplained weight loss and loss of skeletal 
muscle mass and weakness. Evidence demonstrated a meaningful correlation 
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between low body weight and reduced survival rates in patients with COPD, 
regardless of lung function impairment (Decramer et al., 2005). In addition, COPD 
patients are more likely to have osteoporosis, depression, chronic anaemia and 
cardiovascular diseases (Boon and Davidson, 2006). 
In summary, COPD is a heterogeneous disease state which bears the features of airway 
inflammation, airway hyperactivity, progressively and largely irreversibly destruction 
of airway structure and airway blockage. It includes emphysema, chronic bronchitis 
and chronic asthma. In addition, COPD patients may also suffer from systematic and 
extrapulmonary disorders. Therefore, we need to understand and keep updating the 
prevalence and stages of the disease so as to provide timely and adequate intervention 
and this will come next. 
2.2.2  Epidemiology of COPD 
COPD is a life-limiting lung disease of which the primary cause is tobacco smoke 
whether through direct use or second-hand exposure. A report from United States 
stated that COPD affects one out of five persons over the age of 45 (NHLBI, 2009a). 
Moreover, the number of people with COPD who do not know about it accounts for 
the same number formally diagnosed with COPD. In UK, It is estimated that more 
than two thirds of the three million people with COPD in the UK remain 
undiagnosed. They are probably left untreated and could potentially suffer from 
severe restriction in their lives (BLF, 2012). In China, the overall prevalence of 
COPD was 8.2% (of which 12.4% were male and 5.1% female) and approximately 
65% of them were under-recognized or underdiagnosed (Zhong et al., 2007). It has 
caused more than three million deaths in 2005, equating to 5% of all deaths globally 
that year (WHO, 2012). It is also estimated to contribute to more to the global burden 
of disease in terms of disability-adjusted life years (DALYs) than other respiratory 
diseases such as asthma and tuberculosis (Aït-Khaled et al., 2001). Overall, COPD is 
currently the fourth leading cause of death in the world (WHO, 2008). In Macau, 
respiratory disease is the third top cause of all deaths in recent years, coming after 
neoplasms and diseases of the circulatory system (SSM, 2008a). Obstructive airway 
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disease, not including chronic bronchitis, ranged between the sixth to eighth top cause 
among all disease causes of death from 2004 to 2011 (SSM, 2009, SSM, 2011). 
However, World health statistics estimated that total deaths linked to COPD are 
projected to increase by more than 30% in the next 10 years if there is no effective 
intervention to cut risks. Then, COPD may become the third leading cause of death in 
2030 while deaths are predicted to decline in other communicable diseases (WHO, 
2008).  
2.2.3  Clinical Diagnosis 
Emphysema and chronic bronchitis are the two main diseases comprising COPD. 
COPD patients usually demonstrate signs and symptoms caused by airway 
hypersensitivity, inflammation and narrowing, and eventually as the disease 
progresses they may develop problems with gas exchange and finally developing 
respiratory failure. A clinical diagnosis of COPD should be considered in any patient 
aged over 40 who presents with progressive or exertional dyspnoea, chronic cough or 
sputum production, and/or a history of exposure to risk factors for the disease. 
Spirometry serves as the gold standard and objective approach to make the diagnosis. 
The presence of a postbronchodilator FEV1/FVC (Forced Expiratory Volume in the 
first second / Forced Vital Capacity) < 0.70 confirms the presence of airflow limitation 
that is not fully reversible (ATS, 2004, GOLD, 2013, Reid and Innes, 2010). In some 
patients with chronic asthma, it is impossible to completely distinguish COPD from 
asthma using current testing techniques, and both conditions are assumed to be 
coexistent in some patients (GOLD, 2013). In the aspect of differential diagnosis, 
patients with asthma, congestive heart failure, lung carcinoma, bronchiectasis, 
pulmonary tuberculosis, bronchiolitis obliterans and interstitial lung diseases may also 
present with shortness of breath or symptoms similar to COPD, but they should not 
address poorly irreversible airflow.   
2.2.4  Clinical Classification  
The spirometric classification of COPD launched by GOLD provides a referencing 
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clinical criterion for classifying the severity of COPD. GOLD launched the first 
spirometric classification of COPD in 2001 and classified the spirometric severity of 
COPD into 5 categories - From Stage 0 (At Risk) to Stage IV (Very Severe) (GOLD, 
2004). In 2008, GOLD updated the classification criteria by leaving out the first 
category (Stage 0) and keeping Stages I - IV (Mild to Very Severe). Details are shown 
in Table 1. It claimed that there was incomplete evidence for individuals who met the 
definition of 'At Risk' necessarily progress on to Stage I (Mild COPD) and this 2008 
version has been used since then (GOLD, 2008, GOLD, 2013). However, ATS who 
worked with the European Respiratory Society (ERS), keeps the five stages of 
spirometric classification and has not been updated since 2004 (ATS, 2004).  
In reality, there are diverse preferences among physicians about the use of external 
criteria in making a diagnosis. For instance, in Macau, some clinicians prefer to 
diagnose COPD based on their clinical expertise and spirometry is not routinely used. 
Nevertheless, the GOLD classification is popular and widely used in classifying 
participants in surveys and comparing results in experimental researches (Lemmens et 
al., 2010, Rootmensen et al., 2008, Chen et al., 2008a). GOLD (2013) reminded that 
there is a weak correlation between pulmonary function, symptoms and impairment of 
a patient’s health-related quality of life (HRQoL). 
The severity of COPD can be identified in terms of both spirometry findings and 
clinical presentations of the patients as illustrated below. 
Stage I : Mild COPD – Symptoms of chronic cough and sputum production may be 
present, but not always. At this stage, the individual is usually unaware that his 
or her lung function is abnormal. 
Stage II : Moderate COPD – Shortness of breath typically developing on exertion and 
cough and sputum production sometimes also present. Patients at this stage 
typically seek medical attention because of chronic respiratory symptoms or an 
exacerbation of their disease.  
Stage III : Severe COPD – Greater shortness of breath, reduced exercise capacity, 
fatigue, and repeated exacerbations that almost always impacts on patients’ 
quality of life. 
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Stage IV : Very Severe COPD – The presence of respiratory failure may also lead to 
effects on the heart such as cor pulmonale. At this stage, quality of life of the 
patients is very appreciably impaired and exacerbations may be life 
threatening.  
Table 1. Comparison of the Spirometric Classification of COPD severity based on 
Post-Bronchodilator FEV1 by GOLD between versions in 2001 and 2008. 
Spirometric results based on Post-Bronchodilator FEV1 Stage 
2001 2008 
Stage 0 : At Risk Chronic cough and sputum 
production; lung function is still 
normal 
--- 
 In patients with FEV1 /FVC < 0.70 
Stage I : Mild  FEV1 ≥ 80% predicted FEV1 ≥ 80% predicted 
Stage II : Moderate 50% ≤ FEV1 < 80% predicted 50% ≤FEV1  < 80% predicted 
Stage III : Severe 30% ≤FEV1 < 50% predicted 30% ≤ FEV1 < 50% predicted 
Stage IV : Very severe FEV1 < 30% predicted or  
FEV1 < 50% predicted plus 
chronic respiratory failure 
FEV1 < 30% predicted or  
FEV1 < 50% predicted plus 
chronic respiratory failure 
Source: 1) (GOLD, 2004) ; 2) (GOLD, 2008)
2.3  Clinical Management of COPD 
Presently, there is no cure for COPD, however, it is preventable and treatable (GOLD, 
2013, ATS, 2004, Reid and Innes, 2010). Patients should be identified as early in the 
course of the disease as possible and definitely before the late stage of the illness when 
exertional dyspnoea or disability is substantial. Therefore, management of patients 
with COPD is focused on two components: (1) prevention - assessing and monitoring 
disease and reducing risk factors, (2) treatment – managing stable COPD and 
exacerbations (GOLD, 2008, ATS, 2004, GOLD, 2013). Prevention involves public 
health strategy in combating tobacco use, improving air quality, vaccination and 
detection of early cases. Conventional treatment for COPD usually includes 
pharmacotherapies, non-pharmacotherapies and surgery (Reid and Innes, 2010, 
NHLBI, 2006). Advances in therapies have improved survival for COPD patients 
(NIH, 2009). Pharmacologic therapy for COPD includes prescribing bronchodilators, 
corticosteroids and antibiotics in accordance to individualized assessment with the 
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goal of reducing symptoms, the frequency and severity of exacerbations, and 
improving health status and exercise tolerance. The treatment is usually given by oral 
tablets or by inhaled route. Common inhaler devices are metered-dose inhaler (MDI), 
dry powder inhaler (DPI) and nebulizer. MDI usage requires patients to coordinate 
with the dose initiation of the device. It can be used alone or combined with a spacer 
device or aerochamber to overcome coordination problems and improve lower 
airway deposition. DPI includes turbuhaler, accuhaler and handihaler, and they are 
breath-induced in usage. Nebulized therapy is usually given to patients of severely 
overinflated and very low inspiratory flow rate.  
Non-pharmacologic therapies includes pulmonary rehabilitation, oxygen therapy and 
ventilator support. The principal goals of pulmonary rehabilitation are to reduce 
symptoms, improve quality of life, and increase physical and emotional participation 
in everyday activities (GOLD, 2013). Pulmonary rehabilitation generally refers to a 
comprehensive programme which consists of exercise training, smoking cessation, 
nutrition counseling and education. Exercise training ranges from inspiratory muscle 
training to endurance training (for instances, the former being pursed-lips breathing, 
maximum sustained voluntary ventilation, inspiratory resistive breathing, and 
threshold loading, and the latter being treadmill exercise, bicycle ergometry) with the 
aims to regulate the breathing pattern of the patients and to improve their exercise 
tolerance (Grassino, 1989, Reid and Samrai, 1995, GOLD, 2013). In the practical 
implementation of pulmonary rehabilitation, it is ideally run by a multidisciplinary 
team which comprises respiratory doctor, respiratory nurse, respiratory 
physiotherapist, occupational therapist, dietician, smoking cessation adviser, social 
worker, and pharmacist (Man et al., 2004). However in reality, it depends on the local 
availability, cost and administrative policies. In general, nurse or/and physiotherapist 
are two main professionals who provide it, yet in their health education the nurses’ 
role is often limited to delivering smoking cessation, nutrition counseling, education 
and light exercise training (for instances, pursed-lips breathing and upper limb 
exercises) (Watson et al., 1997, Littlejohns et al., 1991, Lacasse et al., 1996). When 
both pharmacological and non-pharmacological approaches are unsatisfactory and 
the patients fulfill the indication for undergoing surgery, bullectomy or lung volume 
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reduction surgery or lung transplantation can be alternative options (GOLD, 2013).   
In this case, corresponding nursing management of patients with COPD has thus 
been evolving from simply one-way patient education to dynamic patient 
self-management education and lately with a collaborative chronic care model to 
respond to the comprehensive needs of COPD patients (Kaptein et al., 2009). 
Providing patient education to improve patients’ knowledge is necessary, although 
knowledge improvement about the disease provides no guarantee of improvements in 
illness behaviour or self-care, or most importantly in well-being (Bourbeau et al., 
2004, Bourbeau and van der Palen, 2009, Kaptein et al., 2009). To improve the health 
of chronically ill patients, improving knowledge by patient education alone was 
demonstrated to be rarely successful and together with behavioural modification 
formulating behavioural-oriented interventions (i.e. self-management education) 
have been found to be consistently more successful at enhancing the clinical course 
of chronic disease (Blackstock and Webster, 2007, Bourbeau et al., 2004, Adams et 
al., 2007). Furthermore, development of a more advanced care delivery mode, called 
chronic care model has been proposed in the past decade. It incorporates health care 
delivery system design, decision support, and clinical information systems in 
additional to nurse-led self-management education or multidisciplinary pulmonary 
rehabilitation, resulting in a desirable patient care environment (Adams et al., 2007).
However, chronic care model is not justified to be introduced to Macau. It is because 
this model demands multi-disciplinary and systematic effort. Its requirement for 
setting up is likely beyond the local preparedness and the pace of healthcare 
development of Macau where respiratory specialized nursing has not yet been 
developed for managing COPD patients. Also, introduction of chronic care model 
goes beyond the scope of a nursing study. Therefore, to be practical, 
self-management education is more feasible to be introduced to the COPD patients in 
Macau. 
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2.4  Summary 
COPD is an incurable obstructive airway disease state which broadly includes 
emphysema, chronic bronchitis and chronic asthma. It is one of the top causes of 
death regionally, nationally and worldwide, and global health prediction is claimed to 
cause more deaths. It can place a tremendous burden for the individual, family, 
society as well as the country; this is due to the progressive disability and healthcare 
dependence associated with the development of the disease. Importantly, COPD is 
preventable and treatable. There is standard reference and spirometric classification 
for clinical diagnosis and disease severity determination respectively. Clinical 
management of COPD patients comprises components of prevention and treatment 
with an integration of pharmacotherapies and non-pharmacotherapies. Much 
evidence indicates that nurses could play a significant role in equipping the patients 
to live with their chronic condition by self-managing their disease, in terms of 
self-management education programme (SMEP). As a comparatively new approach, 
the effect of SMEP on COPD patients in Macau is yet to be studied and remains 
unknown to this population. Therefore, a critical literature review of the background 
of self-management intervention and relevant experiences in Macau will be 
presented in the following chapter. 
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Chapter Three  Literature Review  
- Self-management and COPD patients 
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3.1  Introduction 
Self-management education or self-management education programme is an 
approach that evolved throughout the 1990s in the West (Kaptein et al., 2009). It is 
an advancement of the healthcare for the chronically ill whose conditions are 
multiply determined, and the traditional acute care mode could no more have 
satisfied the health needs of these patients (Kaptein et al., 2009, Oleary, 1985). To 
implement and evaluate a self-management intervention for COPD patients in Macau 
demands a thorough assessment of corresponding theories and experiences so as to 
get a full picture of the research subjects and context. The aims of this chapter, 
therefore, are to define self-management and self-management intervention, to 
review the impact of self-management intervention on COPD patients and the 
common outcome evaluations for this intervention. This critical review of literatures 
will be concluded at the end of the chapter outlining the potential for eliciting a 
theoretical framework within this study. 
3.2  Literature searching strategy 
Literature has been identified from searches on Medline, CINAHL, the Cochrane 
library, PsycINFO, EMBASE, Google scholar, hand searched local health-related 
journals, websites of professional group and authorities, and doctoral dissertation for 
the years 1970 to 2013 (March). Keywords used in literature searching included 
COPD, chronic obstructive pulmonary disease, chronic obstructive airway disease, 
patient education, patient self-management, self-management, self-care, chronic care, 
self-management education, self-management programme, disease-management. 
From these search results articles written in English or Chinese are selected. 
Bibliographies of the retrieved articles were also reviewed for additional papers. 
3.3  Definition of Self-management  
Self-management is defined as:  
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“the active participation of the patient in the treatment of the disease based 
on sufficient coping behaviour, compliance with inhaled medication, 
attention to changes in the severity of the disease, and adequate inhalation 
technique” (Worth and Dhein, 2004, P. 267).  
Self-management is also described as:  
“a set of skilled behaviours and refers to the various tasks that a person 
carries out for management of their condition” (Bourbeau et al., 2004, P. 
271).  
It is obvious that self-management comprises much more than patient education or 
just aiming at making patients more knowledgeable. Self-management actually 
involves patients participating actively in their care by integrating skills to manage 
their daily life and acute exacerbation by means of engaging health behaviour or 
carrying out medical regimens. To actualize self-management in the patient, a 
relevant education programme has to be present in the process of care. Such an 
education programme is usually called self-management education, self-management 
programme or self-management education programme, and these names are usually 
used interchangeably. As defined by Bourbeau (2003), self-management education 
programme applies to: 
 “training that integrated specific skills for patients to control their disease 
and live functional lives. The programme could include education about 
recognition of an acute exacerbation and action to be taken, as well as 
periodic home visits and telephone calls provided by a health professional” 
(Bourbeau, 2003, P. 313).  
In this dissertation, the term ‘self-management education programme (SMEP)’ is 
used. Each of the above approaches incorporates cognitive elements such as 
promoting positive self-talk with an attempt to challenge irrational beliefs about the 
adverse effects of treatment, and also includes managing skills and behavioural 
elements such as goal-setting, a behavioural contract and training in contingency 
management (Kaplan et al., 1984).  
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3.4  Self-management Education Programme (SMEP) 
3.4.1  Components of SMEP  
SMEP aims at health behaviour changes, and the relevant behaviour modification 
implies the appropriate use of many disease-related skills (Bourbeau et al., 2004). 
SMEP usually involves two categories: COPD education and self-treatment 
guidelines (i.e. an action plan) (Effing et al 2009). The COPD education includes 
knowledge of COPD and disease-specific health behaviours. The action plan which 
is self-treatment guidelines is a written plan which helps an individual recognize a 
deterioration in their symptoms and to initiate changes to treatment early and reduce 
the impact of the exacerbation (Walters et al., 2010). Evidence indicated that a 
multi-component self-management education programme can have an impact on the 
health status of patients with COPD (Bourbeau, 2003). Referring to GOLD 
guidelines (2013), the combination of the components in an education programme 
for COPD varies according to different stages of the disease. Information and advice 
about reducing risk factors is regarded as essential at all stages. In addition to that:   
Stage I Mild COPD to Stage III Severe COPD  
- Information about the nature of COPD 
- Instruction on how to use inhalers and other treatments 
- Recognition and treatment of exacerbations  
- Strategies for minimizing dyspnoea 
For Stage IV Very Severe COPD 
- All of the above topics 
- Information about complications 
- Instruction on using oxygen treatment 
- Discussion of advance directives and end-of-life decisions.  
Systematic reviews by Bourbeau (2003), Monninkhof et al. (2003) and Effing et al. 
(2007) revealed that SMEP empirically includes interventions such as teaching about 
the basic anatomy and physiology of the lungs and in relation to COPD, smoking 
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cessation, improving exercise, nutrition, self-treatment of COPD exacerbations or 
action plan, inhalation technique, stress relaxation technique, controlling breathing, 
energy conservation, education on coping with activities of daily living or 
community services, or a combination of these various elements. A patient who 
incorporates these self-management elements should integrate them in their everyday 
lives by considering their interrelationship and implementing appropriate changes in 
a variety of circumstances (Bandura, 1989, Searle et al., 2007).  
3.4.2  SMEP in Clinical Practice 
SMEP was provided in group or individual sessions by allied professionals from the 
forms: written, verbal, visual and audio (Effing et al., 2007). Programme material 
such as booklets was provided to the patients for reading (Bourbeau, 2003). In the 
group sessions, four to six participants were advised, as a small group arouses more 
interaction and involvement of the participants (Worth and Dhein, 2004, Kara and 
Aşti, 2004). Effing et al.(2007) and Monninkhof et al. ’s (2003) systematic reviews 
revealed that the follow-up time of COPD SMEP studies ranged from two months to 
twelve, with one study also evaluating hospital admission after 24 months. It was 
also viewed that six monthly follow-up might be too short a duration to assess 
significant effects of self-management interventions on HRQOL of COPD patients 
(Rootmensen et al., 2008). However, the majority of studies took a six-month 
follow-up period (Coultas et al., 2005, Effing et al., 2007, Monninkhof et al., 2003).
A wide variety of outcome measures were used to evaluate the effectiveness of 
SMEP. The next section deals with the impact of self-management and will review 
the potential measurements for assessment.  
3.5  Impact of Self-management intervention on COPD patients 
and relevant Assessment 
Various meta-analyses, review articles, randomised trials and observational studies 
provide substantial evidence that programmes providing self-management education 
are associated with improved outcomes ranging from the mastery of a particular skill 
30
to various dimensions of the well-being of the COPD patients. (Lemmens et al., 2009, 
Effing et al., 2007). These outcomes include biomedical aspects (symptom control, 
frequency of exacerbations), health-related behaviour formation or behaviour change 
(proper inhalation skills or inhaler usage, appropriate medication use), self-belief 
(illness perception and self-efficacy), health-related quality of life (disease-specific 
health related quality of life) and healthcare utilization (hospital admission, hospital 
stay, outpatient visits, emergency room visits, general practitioner visits). However, 
SMEP is ineffective and does not show improvement in some indicators, for instance 
pulmonary function namely FEV1, FEV1/FVC and generic HRQoL (Effing et al., 
2007, Watson et al., 1997, Lemmens et al., 2009). Exploration of empirical studies 
and relevant measures for assessing the outcomes in COPD follows in the next 
section.    
3.5.1  Biomedical outcomes  
The most important goal of self-management in COPD patients is to manage 
symptoms such as dyspnoea and exacerbations, anticipating that an approach from 
the patient may reduce the need to engage emergency consultation from healthcare 
services. In terms of symptom control, a significant reduction in dyspnoea measured 
with the BORG-scale or MRC was observed in COPD patients after receiving SMEP 
(Effing et al., 2007, Lemmens et al., 2010). Moreover, SMEP can significantly 
reduce exacerbations in COPD patients compared with the control group 
(Rootmensen et al., 2008, Worth and Dhein, 2004). In Rootmensen et al.’s (2008) 
study, patients in the group engaging in self-management eventually suffered from 
1.5 exacerbations per 1,000 observation days while the incidence rate in the control 
group was 3.6 per 1,000 observation days. In that study, exacerbation was defined as 
worsening of respiratory symptoms that required treatment with oral steroids as 
judged and prescribed by general practitioner or pulmonary physician (Rootmensen 
et al., 2008). 
The benefits of SMEP are independent of any effect on pulmonary function (at least 
in terms of FEV1 or VC). The majority of studies have shown that the beneficial 
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effects of SMEP are not accompanied by any apparent improvement in pulmonary 
function in terms of bettering FEV1 and FEV1/FVC (Lemmens et al., 2009, Watson et 
al., 1997, Effing et al., 2007); but this may be due to the irreversible and progressive 
nature of COPD. Moreover, a considerable number of studies have found that 
pulmonary function test results neither show any strong correlation with 
health-related quality of life nor predict reduced quality of life of COPD patients 
(Yohannes et al., 1998, Kaptein et al., 2009, Stallberg et al., 2009). Thus, 
measurements of FEV1 and FEV1/FVC can reliably monitor any deterioration in 
respiratory function occurring during the course of the SMEP, but they may not be 
suitable to be the primary outcome of SMEP study. 
3.5.2  Health-related behaviour formation or behaviour change 
The inhaler is the main device for COPD patients to receive bronchodilators and 
corticosteroids and these medications form the major treatment regimen of these 
population. However, not all patients could have received an introduction into correct 
usage of their inhalation medication (Hämmerlein et al., 2011). A substantial 
proportion of inhaler users made at least one essential error in their inhalation 
technique when inhaling medication (Hesselink et al., 2001, Hämmerlein et al., 2011), 
this happened more on those using MDI than DPI (Molimard et al., 2003, Hardwell 
et al., 2011). Patient using MDI had the highest rate of incorrect handling among all 
inhalers, indicating that the majority of patients using MDI were unable to use it 
correctly (Khassawneh et al., 2008, Hilton, 1990). On the other hand, some studies 
demonstrated no significant dependencies on inhaler devices in the handling of 
inhalation technique (Hämmerlein et al., 2011, Roy et al., 2011). However, evidence 
shows that an improvement in inhalation technique and a reduction of more than 
50% in the need of rescue medication in COPD patients when they are taught proper 
medication use (Gallefoss, 2004, Lemmens et al., 2009, Roy et al., 2011). In addition, 
DPI use remained significantly associated with higher rates of adherence (Roy et al., 
2011). Proper inhaler technique and adherence may consequently improve control of 
COPD but also allow dose reduction in the long run (Hesselink et al., 2001). 
Moreover, repeated instruction on inhalation techniques was found to contribute to 
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adherence to inhalation therapy through decreasing intentional non-adherence 
(Takemura et al., 2010). Watson et al. (1997) found that SMEP also produced 
behaviour change in the interventional group in terms of more antibiotics usage when 
they had respiratory infections. 
3.5.3  Self-belief 
Theoretically, adherence to self managing and disease managing was associated with 
the specific illness and treatment beliefs of the patients (Horne and Weinman, 2002). 
Converging evidence demonstrated that SMEP can impact positively on either illness 
perception or self-efficacy which influences and mediates the change in 
health-related behaviours, symptom control, quality of life and health care utilization. 
(Horne and Weinman, 2002, Kaptein et al., 2009, Kohler et al., 2002, Lau-Walker, 
2006, Lorig et al., 2001). When SMEP was introduced to the Chinese population 
with chronic illness in Siu and colleagues’ (2007) study in Hong Kong, the team 
demonstrated significantly higher self-efficacy in the participants in managing their 
illness by means of more cognitive methods used to manage pain and symptoms, and 
felt more energetic than the non-educated patients.   
Patients in self-management schemes also expressed feeling “much safer” or “safer” 
and higher satisfaction in living with their illness (Gallefoss, 2004, Lemmens et al., 
2009). Findings echoed that the stronger the patients’ feelings of capability to 
manage functional activities, the less functional impairment they feel (Kohler et al., 
2002). Self-belief outcomes can directly reflect the ‘product’ of the education in 
terms of cognition and behaviour change. 
3.5.4  Health-related quality of life 
Health-related quality of life (HRQoL) refers to a multi-dimensional construct which 
contains different health state items that relate to symptoms, impairments, functional 
status, and emotional domains affected by an illness and its consequent therapy as 
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perceived by the patient (Chatterji et al., 2002, Smith, 2008). It has become, in chronic 
care, a welcome measure of health outcomes in addition to survival rates, duration or 
severity of disease, mortality rate and others. In regard of HRQoL of COPD patients, 
both young and old COPD patients were found to have significant impairment of 
HRQoL in comparison to normative population values (Alonso et al., 1998, Desikan et 
al., 2002, Stallberg et al., 2009).  
Tam et al. (2007) also found that the HRQoL of COPD patients in Macau was lower 
than the norm of the population in Shanghai (Tam et al., 2007). These findings reflect a 
significant impact of COPD on patients' lives and that they are living with a lower 
quality of life than the general population. Nonetheless, there is controversy regarding 
whether or not SMEP can improve quality of life in COPD patients. Some posit that 
self-management by COPD patients is essential to achieve optimal quality of life 
(Bourbeau and van der Palen, 2009, Warwick et al., 2010). On the contrary, 
inconclusive results were observed in systematic reviews and randomized trials for 
improvements in health-related quality of life of COPD patients who either had 
self-care education or self-management plans when compared with patients without 
either (Coultas et al., 2005, Rootmensen et al., 2008, Watson et al., 1997, Effing et al., 
2007, Adams et al., 2007, Monninkhof et al., 2003, Bucknall et al., 2012, Lemmens 
et al., 2010). Alternatively, a two-year longitudinal follow up of the effects of SMEP 
in Lorig’s (2001) study found that participants did not show deterioration in any 
other health state as one would otherwise expect during that period of time (Lorig et 
al., 2001). Self-management may thus in some way promote the maintenance of 
health in COPD patients. Blackstock and Webster (2007) specifically emphasized 
that there was a tendency towards HRQoL improvement if patients were assigned to 
disease-specific self-management interventions. Hence, health-related quality of life 
improvement should be the ultimate goal of self-management coming after the 
establishment of self-management skills and self-belief (Bourbeau and van der Palen, 
2009). 
There are three main types of HRQoL measures used for assessing HRQoL of patients 
in healthcare setting, namely global QoL, generic QoL and disease-specific QoL 
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questionnaires (Smith, 2008). In regard to COPD, generic and disease-specific 
measures appear to be amongst the most widely used in clinical and research activities 
(Lemmens et al., 2009, Doll and Miravitlles, 2005). The generic health-related 
instruments include the EurolQol five-dimension questionnaire (EQ-5D), the Medical 
outcomes study 36-item short form health survey (SF-36), the Sickness impact Profile 
(SIP), the measure your medical outcome profile (MYMOP), the Medical outcomes 
study 6-item general health survey (MOS-6A), the Nottingham health profile (NHP), 
etc. (Doll and Miravitlles, 2005). Among them, SF-36 is one of the most commonly 
used generic instrument for comparing the measuring properties of the disease-related 
QoL measurement tool (Alonso et al., 1998, Stallberg et al., 2009).  
The well-established respiratory specific disease-related QoL measurements are the St 
George Respiratory Questionnaire (SGRQ), the Clinical COPD Questionnaire (CCQ), 
the Chronic Respiratory Disease Questionnaire (CRQ), the Breathing Problems 
Questionnaire (BPQ), and the Airway Questionnaire (AQ 20/30). SGRQ is the most 
popular scale used in studies in Europe and America and occasionally in Asia (Alonso 
et al., 1998, Alemayehu et al., 2002, Desikan et al., 2002, Doll and Miravitlles, 2005, 
Lemmens et al., 2009, Stallberg et al., 2009, Lei et al., 2007, Lu et al., 2007, Mölken et 
al., 1999, Jones et al., 1991). In these studies, it is used as a standard tool to compare 
newly proposed questionnaires, to compare measurements of health between patient 
populations and as a strategy to monitor the outcomes of clinical interventions.  
3.5.5  Healthcare utilization
COPD patients who have participated in SMEP appear to reduce visits to their 
general practitioner, number of outpatient visits as well as hospital admissions. In a 
twelve-month follow-up after patient education and self-management plan, educated 
COPD patients paid approximately five times less visits to their general practitioners 
than non-educated COPD patients (73% versus 15%, P<0.001). The reduction of the 
need for short-acting B2-agonist inhalations as rescue medication may keep a greater 
proportion of patients independent of their GPs (Gallefoss, 2004, Gallefoss and 
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Bakke, 1999). Moreover, SMEP was also associated with significant reduction in 
hospital admission or hospital days (Lorig et al., 2001, Worth and Dhein, 2004, 
Effing et al., 2007). The reduction equated to at least one hospital admission less 
among patients receiving SMEP compared to those receiving usual care (Effing et al., 
2007, Lorig et al., 2001, Worth and Dhein, 2004). In contrast, another review 
demonstrated that SMEP itself did not improve hospitalizations or emergency visits, 
in patients with COPD (Adams et al., 2007) Thus, the impact of SMEP on the 
reduction of healthcare utilization is clearly possible, however, it may not always be 
the case. 
3.6  Self-management Intervention in Macau  
To explore the experiences of self-management or nursing care for COPD patients in 
Macau, literature searching on Medline, CINAH and two major health-related 
journals of Macau for the years 2001 to 2012 (December) was conducted by using
key words including Macau, COPD, COAD, chronic obstructive pulmonary disease, 
chronic obstructive airway disease, chronic bronchitis, emphysema, 
disease-management, self-management, chronic illness (SSM, 2002-2010, KWNC, 
2002-2011). Of the nine COPD-related papers found, however, none was related to 
nursing care for these patients. This implies either a lack of follow up care or 
inconclusive effects of self-management interventions for COPD patients in Macau. 
There is an absence of experience for both nurses and the COPD patients in Macau in 
participating in any continuous care promoting activity.  
In Macau, over 90% of the residents are Chinese (DSEC, 2011). Chinese patients 
generally demonstrate inadequate health knowledge and behaviour regardless of their 
education (Tian et al., 2011a, Yin et al., 2013, Tian et al., 2011b). They preferably 
adopt a ‘convenient’ approach in promoting their own health as TV advertisement 
and health history of family members and friends were found to be their main source 
of the knowledge on disease control or treatment management (Tian et al., 2011a, Li, 
2008). Therefore, Macau Chinese may probably be accustomed to passive 
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engagement with their disease management. However, SMEP requires them to shift 
their role to cooperating with health professionals and to being active participants in 
disease management, thus presenting challenges to the success of the intervention. 
Therefore, I initiated this study to fill this knowledge gap. Instead of directly 
importing the Western mode of nursing care into local COPD patient care in Macau, 
it is necessary to explore the feasibility, appropriateness and effectiveness of SMEP 
to a different population of different culture. 
3.7  Research Questions  
1) Could self-management interventions developed in the West have positive 
effects on COPD patients in Macau?  
2) How do COPD patients in Macau perceive and adapt to a self-management 
approach? 
37
3.8  Summary 
This critical review of the literatures has demonstrated the development of SMEP in 
COPD care from an international perspective. A knowledge gap of the feasibility and 
effectiveness of SMEP for COPD patients in Macau is identified and relevant 
research questions are raised. On the other hand, pulmonary function, health 
utilization and quality of life are common measurements targeted to reflect the 
effectiveness of SMEP on patients with COPD or on other chronic illnesses. 
However, due to their inconsistency and time-consuming nature for achieving 
significant improvement in an individual’s well-being, these outcomes are more 
likely to be the ultimate goals rather than primary goals of SMEP. In this case, the 
core goals of SMEP should anticipate converting the taught knowledge and skills 
into permanent beliefs and behaviour among the COPD patients before attaining the 
ultimate goals. Then the questions arise: what are the driving forces for the 
knowledge and skills of establishing health behaviour, how can one accept, utilise 
and integrate the COPD knowledge and self-treatment guidelines into daily living? 
Illness perception and self-efficacy are identified in bridging the 
cognitive-behavioural dynamic since they are two important conceptual determinants 
in constructing and maintaining behaviour through the understanding of one’s 
thinking (Baum et al., 1984, Leventhal et al., 2008, Bandura, 1986, Bandura, 2004). 
The focus and the interrelationship in developing self-management behaviour in 
COPD patients are addressed in the theoretical framework which will be delivered in 
the following chapter.  
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Chapter Four  Theoretical Framework 
of the Study 
40
4.1  Introduction 
There are many theories that try to bridge the divide between knowledge and action 
and the beliefs of self-perception and self-efficacy are two of them. Intriguingly, 
these two theories may potentially be effective in different but inter-related ways in 
enabling and sustaining an individual’s control and influence over a long-term 
condition, (for example, in chronic disease management). Engaging in 
self-management necessarily requires the receiver (patient) to both understand and 
put into practice what has been explained (Bourbeau et al., 2004). The actualization 
of self-management is thus influenced by the patient’s degree of understanding and 
of the capability to engage in self-management (Bourbeau et al., 2004, Bourbeau and 
van der Palen, 2009). Both theories of self perception and self-efficacy argue that 
when patients confront change, (for instance, in adaption to self-management), their 
existing beliefs on representation and perception of illness, cost and benefits of the 
change, and capability of behavioural change are being confronted (Bandura, 2004, 
Leventhal et al., 2008). So, although theories drive one’s cognitive processing to seek 
an appropriate response, illness perception however is more likely to serve the 
cognitive belief of patients, while self-efficacy serves their efficacy-belief, they are 
different in scopes but share a mutual pathway to behavioural change (Lau-Walker, 
2006). Here, the concepts of illness perception and self-efficacy are taken into 
account as the mediational influences of SMEP in achieving cognitive and 
behavioural change in patients with COPD. In this section, both concepts of illness 
perception and self-efficacy are examined critically to delineate their underlying 
theories and to explain their interrelationship in contributing to SMEP and 
formulating self-management behaviours in COPD patients.  
4.2  Illness Perception 
Illness perception refers to how patients create their own models or representations 
of their illness (Weinman et al., 1996). It is the core idea stemming from the 
self-regulation model of Leventhal and colleagues, who proposed that patients 
construct a representation of their experience with their illness and this, in turn, 
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determines their coping responses (Baum et al., 1984). The illness representation is 
derived from the patient’s ‘lay’ beliefs and cumulative understanding about their 
illness and previous experiences, but when they are integrated with external 
information and existing schemata (the normative guidelines that people hold), they 
are interpreted into new representations. These interpretations are used to plan coping 
procedures or behaviour and to select action plans and outcomes (Hale et al., 2007, 
Weinman and Petrie, 1997). This can explain why people posit their condition and 
display differing emotional responses despite sharing the same diagnosis or 
equivalent severity of illness. The representation bears five components. These are: 
1) Identity - labelling of the symptoms;  
2) Cause - beliefs about the etiology of the illness;  
3) Timeline - beliefs about how long the illness may last;  
4) Consequences - beliefs about its consequences; 
5) Curability / Controlability - belief about whether the illness can be cured or 
controlled.  
These components can interact with each other, for instance, if a patient conceives 
his condition as genetically born (Identity), he is more likely to create a 
representation of his condition as long-lasting (timeline) or incurable (curability/ 
controllability). These representations develop as soon as patients become aware of 
their initial symptoms and are subjected to change with disease progression, 
emergent symptoms and treatment response (Weinman et al., 1996). These 
representations hence reflect the cognitive and emotional response of patients to their 
symptoms and illness. However, these representations are possibly affected by 
systematic cognitive and emotional biases employed by patients who may positively 
appraise an incurable condition, resulting in various patterns of health behaviour and 
variation in compliance with treatment (Weinman and Petrie, 1997). Due to the effect 
of patients’ self representation of their illness on their coping, an understanding of 
patients’ illness perceptions and intervention influencing patients’ interpretations are 
essential for effective patient management.  
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4.3  Self-Efficacy  
Self-efficacy is conceptualized as the cognitive processing of diverse sources of 
information conveyed by the direct and mediated experiences of an individual. It was 
first introduced by Albert Bandura in 1977, who proposed that personal efficacy is a 
self-referent thought in psychosocial functioning that mediates the relationship 
between acquisition of knowledge and performance of response patterns, meaning 
that it bridges the gap between knowledge and behaviour (Bandura, 1986, Bandura, 
1977). Self-efficacy plays a central and explanatory role for analyzing and predicting 
the behavioural change of an individual (Bandura, 1977, Bandura, 2004, Warwick et 
al., 2010, Wong et al., 2005). In a self-efficacy approach, outcome expectations and 
efficacy expectations are the main constructs of the theory (as shown in Figure 1).  
PERSON                  BEHAVIOUR                  OUTCOME 
Figure 1. Diagrammatic representation of the difference between efficacy 
expectations and outcome expectations (as cited in Bandura 1977) 
In outcome expectation, cognitive processes play a prominent role in the acquisition 
and retention of new behaviour patterns through learning from previously response 
consequences. Through self-corrective adjustments based on informative feedback 
from performance, previously response consequences serve as an inarticulated way 
of informing performers what they must do to gain beneficial outcomes and to avoid 
unfavourable ones. Another construct, efficacy expectation, is either the conviction 
that one can successfully execute the behaviour required to produce the outcomes or 
one’s judgement of his/her capabilities to execute given levels of performances 
(Bandura, 1977, Bandura, 1986, Bandura, 2004). Thus, how one acts or behaves 
depends largely on one’s self-appraisal of efficacy. Positive appraisal of personal 
efficacy influences the choice of behavioral settings, and when combined with 






behaviour (Bandura, 1977, Bandura, 1986, Bandura, 2004). To illustrate this, if 
COPD patients presume that they are capable of mastering self-management 
(efficacy expectation) and that adopting self-management strategies are good for 
their health (outcome expectation), they would be more likely to initiate and persist 
with self-management strategies. Conversely, if they judge self-management exceeds 
their capabilities (for instance, to implement an action plan) even if they know it is 
good, they may also avoid putting a self-management plan into practice. Previous 
findings have shown that behaviour is mediated by expectations and so were found to 
be consistent with Bandura’s proposition (Kaplan et al., 1984, Kohler et al., 2002). In 
short, the stronger the perceived personal efficacy and positive outcome expectations, 
the more active engagement and persisting effort will apply.  
Whether one’s expectation of self-efficacy is optimistic or pessimistic, it is based on 
four principal sources of information: 1) performance accomplishments; 2) vicarious 
experience; 3) verbal persuasion; 4) physiological states (Bandura, 1977, Bandura, 
1986). Performance accomplishments are the most influential source of information 
because it originates from authentic mastery experiences, whereby successes boost 
efficacy expectations and repeated failures weaken them, especially early in the 
course of events. The literature supports the view that performance mastery 
establishes and enhances self-percepts of efficacy with regards to health (Bourbeau et 
al., 2004, Kaplan et al., 1984, Oleary, 1985). And providing experiences of 
performance mastery is an effective strategy to establish and strengthen self-efficacy 
and enhance efficacious expectations for success in managing similar health 
threatening conditions in the future. To sum up, the effectiveness of building up one’s 
self-efficacy depends on the mode of delivering information. Also, to enhance 
patients’ perceived self-efficacy in self-management of illness, the key step is to 
cognitively instil beneficial outcomes of self-management and provide learned 
experiences to promote positive efficacy expectations of self-managing. Then, this 
may assure the likelihood of COPD patients’ participation and persistence in 
self-management. 
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4.4  Interrelationship of Illness perception and Self-efficacy with 
Behavioural Change 
Instead of treating illness perception and self-efficacy beliefs as two separate schools, 
there is a potential to integrate them when pursuing self-management behaviours. 
Firstly, both theories provide health care professionals with a basis from which to 
understand the behaviour formulation of patients and how patients interpret the 
events or experiences that affect them and construct responses from cognitive 
processing. Similarly, illness perception involves the cognitive processing of illness 
belief and self-efficacy involves the cognitive processing of efficacy belief. Using 
one or other of these two approaches may capture patients’ beliefs at the expense of 
overlooking their expectations of ability or vice versa. Secondly, adopting 
self-managed may appear to be a threatening event to the traditional dependent role 
of COPD patients, that possibly hinders the illness belief and efficacy belief of the 
patients. Both beliefs therefore play an important role in guiding the coping response 
and efforts in self-management. Behavioural response and subsequent appraisal are 
driven by the perceptions of illness in the patients, whose behaviour represents a 
‘common sense’ response to their cognitive and emotional interpretation of 
symptoms and health information in the process of belief formulation. This belief of 
illness, in turn, guides the appraisal of the personal efficacy (Horne and Weinman, 
2002). Hence, self-perception and self-efficacy are unlikely to be separate strands in 
inducing self-managing behaviours in the patients, while they interrelate and 
supplement closely with each other in bridging knowledge and action (Refer to 
figure 2).  
In reviewing the literature, each approach is found inadequately explaining the cause 
of a particular health-related behaviour or response. Leventhal et al. (2008) suggested 
that both motivation elements (attitudes, intentions) and action elements (action plan 
and personal efficacy) are essential for healthy or risk-reducing behaviours. Having 
only one or the other may be insufficient to generate behaviour. For example, To 
enable the COPD patients in Macau to adopt the self-treatment guidelines (action 
plan) which requires them to identify the signs and symptoms of an exacerbation and 
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then take different medications, it may be inadequate to build confidence in them in 
managing the treatment plan by merely equipping them with a motivation element 
(favourable illness perceptions). Moreover, one’s illness representation can affect 
one’s perceived effectiveness of behavioral strategies and perceived competence to 
manage their illness, especially in cases of chronic illness. Representation of specific 
self-vulnerabilities or depressing moods that hinders patient’s participation in 
health-relevant behaviours are considered to be affected by personal traits, but how it 
relates to and mediates these specific behaviours or biological vulnerabilities remains 
unclear (Leventhal et al., 2008). However, a self-efficacy approach tries to fill the 
theoretical gap by explaining that perceiving physical infirmities and an inability to 
attain previously achievable valued performances can be highly depressing. 
Depressive modality can be more influential than physical incompetency in 
impairing personal efficacy to initiate and persist with adaptive activities. Perceived 
self-efficacy and depressive mood, in this case, affect each other bidirectionlly 
(Bandura, 1989). The impact of induced mood may well lead one to deduce the 
correlation between the representation of depressing mood and shrinking behaviours. 
Although there are not many studies relating both beliefs, it is clear in a series of 
publications of Lau-Walker both that there is significant relationship between illness 
perceptions and self-efficacy, and that illness perception components predict 
self-efficacy. She found that the greater one perceives the consequences of the 
condition resulting (consequence component of illness perception), the lower general 
self-efficacy appears to be available to cope with the condition (Lau-Walker, 2006, 
Lau-Walker, 2004). The resulting belief will intervenes over time forming a 
long-time lifestyle if no intervention interferes at the early stage (Lau-Walker, 2007). 
Both theoretical and empirical claims enlist the need to integrate both stances of 
illness representation and personal efficacy in assessments aimed to gain a more 
comprehensive understanding of patients’ reactions to their conditions and treatment. 
Furthermore, Johnson (1999) illustrated that a combination of self-regulatory 
intervention (instruction in coping) and self-efficacy promoting intervention 
(self-care activities) is more effective than adopting either approach singly for 
reducing negative response and enhancing general coping in patients (Johnson, 1999). 
46
This suggests that there is more to the responding behaviour than increasing 
confidence of self-efficacy or vice versa. Therefore, both theories supplement each 
other to induce health-related behaviours. On the other hand, illness perception 
serves as a threshold of self-efficacy and both approaches eventually influence 
self-management behaviours. Accordingly, cognitive information and 
self-management skills aiming at enhancing both the illness representation and 
personal efficacy should be incorporated in the design of self-management education 























4.5  Summary 
Two cognitive-behavioral theories, namely illness perception and self-efficacy 
beliefs are employed as the main structure of the theoretical framework of this study.   
These two beliefs have demonstrated an association in mediating a change in health 
behaviour in cardiac patients and that may then enhance the potential for the 
improvement of ultimate goal, for instance, pulmonary function, HRQoL and 
healthcare utilization in COPD patients. However, the impact of these two beliefs has 
not been examined in COPD patients with an integration of SMEP. Under these 
circumstances, the following chapter will identify the research hypothesis and aims 
and will then expound the overall design of the study with particularly consideration 
of the discussion in the literature review.         
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Chapter Five  Study Design 
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5.0  Introduction 
Since there has been a lack of experiences and studies of the effectiveness of 
self-management intervention to COPD patients in Macau, as an initiative study, my 
research questions included two aspects: (1) the effects of self-management 
interventions developed in the West on COPD patients in Macau, (2) the subjective 
perception of the patients on this newly approach. These research questions led to the 
study design of using a mixed methods approach which was embedded within an 
experimental design.  
In this chapter, focus is given on the philosophical assumptions of this study design 
and sampling issues. These are related to four main concepts: embedded design, 
experimental design, complex intervention and mixed methods. The whole chapter is 
divided into five sections. Section one: The research hypothesis and research aims 
will be addressed followed by the rationale for accommodating an embedded design 
in a traditional experimental design and the methodology in relation to how and what 
methods were mixed. Section two: The rationale and implementation of sampling 
strategies adopted will be presented together with the methods used for data 
collection for the quantitative strand. Section three: The qualitative approach used for 
sampling and data collection in the mixed method design will be given. Section four: 
The development of the intervention of this study, SMEP, will be addressed with 
respect to MRC’s (2008) framework for complex intervention development. Section 
five: The data analysis strategies for both quantitative and qualitative strands will be 
presented and a special focus will be given to the approach of connecting quantitative 
and qualitative data. These five sections form the fundamental basis for the rigor 
process and findings of the study.   
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5.1  Section One  Research Aims and Methodology 
5.1.1  Research Hypothesis 
5.1.1.1  Null Hypothesis  
Self-management education does not have positive effects on the biomedical 
condition, health-related behaviour, psychosocial belief and overall well-being in 
COPD patients in Macau. 
5.1.1.2  Alternative Hypothesis  
Self-management education has positive effects on the biomedical condition, 
health-related behaviour, psychosocial belief and overall well-being in COPD 
patients in Macau. 
5.1.2  Research Aims  
 To compare the illness perception, self-efficacy, inhaler technique, 
pulmonary function, healthcare utilization and health-related quality of 
life of Macau COPD patients before and after implementation of 
self-management education.  
 To compare the illness perception, self-efficacy, inhaler technique, 
pulmonary function, healthcare utilization and health-related quality of 
life of Macau COPD patients who have undergone self-management 
interventions and who have received conventional therapy.  
 To explore the mediating effect of illness perception on self-efficacy of 
COPD patients 
 To identify the factors which positively affect Macau COPD patients’ 
illness perception, self-efficacy and health-related quality of life. 
 To explore the perception and experiences of Macau COPD patients 
towards self-management.  
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5.1.3  Rationale for the Study Design 
5.1.3.1  Philosophical Assumption 
The study was based on an embedded design where a mixed methods approach was 
employed within a traditional experimental design. Embedded design was initially 
named ‘dominant-less dominant study design’ and previously ‘nested design’, these 
similarly referred to the methods and results relating to the dominant paradigm with a 
small component of a less-dominant paradigm residing in it (Creswell, 1994). This 
design enables the collection and analysis of different types of data in order to 
enhance the application of an experimental design to address the primary propose, 
namely the effects of self-management education on COPD patients, of the study 
(Creswell and Plano Clark, 2011). As a qualitative strand was planned within the main 
experimental design, there should be an alternative paradigm in additional to 
post-positivism of which experimental design is typically used. In this way 
pragmatism was the philosophical basis for this study (Teddlie and Tashakkori, 2009). 
Firstly, due to my personal perspective of the world, I believe that there is not at all 
an absolute ‘truth’ or ‘reality’ that we can identify or assert, since truth exists on a 
continuum rather than on either objectivity or subjectivity while reality varies from a 
single fact to a construct of multiple perspectives and meaning as long as the 
methods applied can achieve it. Secondly, it is because the proposed research 
questions are primarily oriented to inform about the use of a mix of quantitative 
(confirmatory) and qualitative (exploratory) approaches. Pragmatism sees the 
compatibility of quantitative and qualitative methods and it is open to a mix of 
methods if the research questions and practicalities of the research context suggest it 
(Brannen, 2005). Pragmatists criticize any distinction between absolute objectivity 
and subjectivity and the epistemological issues existing on opposing poles of 
positivism and constructivism, so it allows any methods to be employed which 
achieve best explanations of the feasibilities and effectiveness of self-management in 
COPD patients in the given study. Moreover, a pragmatist always preconceives 
theoretical accounts of the world with suspicion, I should even be tentative and open 
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to empirical correction (Jarvie and Zamora Bonilla, 2011). In additional to 
identifying the epistemological stance employed in mixed methods study, it was also 
necessary to examine the justifications for using mixed methods in an experimental 
design wherein the quantitative approach is predominantly the methodology.       
5.1.3.2  Mixed methods in Experimental Design 
Mixed methods approach involves incorporating multiple methods in a project and 
needs much reflection on the justification of adopting such a combination (Fielding, 
2008). It is important to start with an examination of the definition of mixed methods. 
After decades of refinement, Creswell and Plano’s (2011) most updated definition for 
mixed methods combines the core characteristics of the approach in relation to 
methods, a philosophy and a research design orientation.  
“In mixed method, the researcher :  
- Collects and analyses persuasively and rigorously both qualitative and 
quantitative data (based on research questions); 
- Mixes (or integrates or links) the two forms of data concurrently by 
combining them (or merging them), sequentially by having one build on the 
other, or embedding one within the other;  
- Gives priority to one or to both forms of data (in terms of what the research 
emphasizes); 
- Uses those procedures in a single study or in multiple phases of a program of 
study; 
- Frames these procedures within philosophical worldviews and theoretical 
lenses; and 
- Combines the procedures into specific research designs that direct the plan 
for conducting the study.” (Creswell and Plano Clark, 2011, P. 5)
In this study, a mixed methods approach was chosen based on research questions. As 
addressed in the previous philosophical inquiry, the given research questions of this 
study bear both confirmatory and explanatory statements where mixed methods are 
compatible. In addition, this study aims to evaluate the effects of a self-management 
education programme on COPD patients. SMEP comprises multiple components and 
is usually regarded as complex intervention (Details see Chapter three, section 3.4). 
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Mixed methods embedded in an experimental design may be particularly useful for 
research studies evaluating complex interventions as such on human beings. Unlike 
pure laboratory experiment, complex interventions involve more than one 
independent variable, and outcomes may be interweaving and due to many different 
reasons. In spite of merely pursuing the objective truth through quantitative methods, 
the qualitative data collection method used in an experimental design can 
additionally better understand qualitative differences between groups, including 
differences in the reactions of subjects to the experimental conditions and 
experiences underlying experimental effects (Polit and Hungler, 1997). In other 
words, qualitative data illuminates the meaning of statistical results by adding a 
narrative understanding to the numeric findings (Hesse-Biber, 2010). However, there 
were claims for the potential technical flaws in regard to methodological interaction 
and prioritization (Fielding, 2008). Special attention is needed to recognize this 
“add-ons” component being in no way as important as the 
hypothetico-deductive-driven approach in an experimental design (Tashakkori and 
Teddlie, 1998). Creswell and colleagues (2008) also acknowledged the qualitative 
approach as supplemental rather than subordinate or unobtrusive simply due to its 
intrinsic nature (Creswell et al., 2008). Thus, the supplemental qualitative approach 
may help explain or augment findings generated from the larger quantitative 
approach and probably enhance the overall experimental design in some way 
(Bryman, 2008, Bryman, 2006).
In other words, the combination of quantitative and qualitative methods helps to 
enhance and clarify the findings from one method with the findings from another, 
providing different aspects and depth of examination on the effects of a complex 
intervention. More importantly, the complexities of social beings are not just treated 
as some figures, but studied directly in order to project the subjective views of the 
world and obscuring insights (Watson, 2008, Polit and Beck, 2010, Keady and 
Watson, 2008). This mixed methods approach in experimental design may lead to 
knowing whether and how the complex interventions are effective and/or ineffective 
for the participants, which eventually helps to streamline the self-management 
programme and make it more efficient and cost-effective. 
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5.1.4  Methodology 
5.1.4.1  Exploratory randomized controlled trial  
A randomized controlled trial (RCT) comprised a random allocation of participants, a 
control and an intervention for testing (Polit and Beck, 2010, Smith, 2008). Here, 
eligible participants were randomly allocated to either an experimental group 
(self-management group, SMG) which received an intervention (SMEP) in addition 
to conventional therapy or a control group (CG) which just received conventional 
therapy. Pre-test and post-test assessments were conducted to examine changes in 
dependent variables (for instances, biomedical, psychosocial, behavioural and 
subjective aspects) after the intervention when the two groups were compared (Polit 
and Beck, 2010). To date, no RCT studies have ever explored the effectiveness of the 
implementation of any nursing care / rehabilitative programme for COPD patients or 
self-management intervention for patients with any chronic disease in Macau. It is 
anticipated an exploratory trial will identify potential relationships between varying 
components and will provide a basis for a definitive RCT in the region. Exploratory 
trial is the second phase of evaluation of RCT for complex interventions to improve 
health and is the crucial stage prior to a main RCT (MRC, 2000, MRC, 2008). All 
evidence gathered in this phase can inform the intervention and be tested on varying 
components to see what effect each has on the intervention as a whole. 
5.1.4.2  Mixed methods 
In this design, I used two methods to address different research questions and 
collected data in three phases: the first phase is for pre-test, second phase is for 
post-test (six months after intervention) and third phase is the follow-up of second 
phase (as shown in diagram 1). A shorthand notation was used to describe the design: 
QUAN(+qual). This notation indicates: 
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“an embedded design in which the research implemented a secondary qualitative 
strand within a larger quantitative experiment, the qualitative methods occurred 
during the conduct of the experiment, and the qualitative strand enhanced the 
conduct and understanding of the experiment.“  (Creswell and Plano Clark, 2011, 
P. 110) 
Diagram 1 Relationship of different concepts in the Embedded design, 
QUAN(+qual)  
 Sampling 
In the quantitative strand, validated questionnaires and scales were used to collect 
quantitative data regarding illness perceptions, self-efficacy, and health-related 
quality of life respectively. In the qualitative strand, focus groups were conducted on 
patients from the experimental group to explore their experiences and perceptions of 
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each other, their relationship and their sequence, rather than simply throwing 
together different methods (Barbour, 2008).  
Regarding the approach of mixing, a concurrent as well as a sequential approach for 
data collection were employed (Creswell and Plano Clark, 2011). Throughout the 
process, quantitative data was the primary focus and was initially collected in the 
first phase to establish a baseline assessment of the subjects. In the second phase, 
both quantitative and qualitative data were concurrently collected to specifically 
answer differing aspects of research questions. Quantitative data was collected to 
evaluate the outcomes of the intervention in terms of statistic description and 
inferences, while the secondary qualitative data was to examine potential meaning of 
self-management to COPD patients in Macau. Then, both sets of data were analyzed 
independently. In the third phase, sequential data collection and analysis took place. 
It was a subsequent collection and analysis of qualitative data that was informed by 
the data collected in the post-test phase. The third, sequential qualitative phase built 
on the second concurrent phase, and data of the two phases were connected and 
compared in the discussion section wherein the conclusion of the study was 
developed. The data collected in the third phase helped to enhance understanding of 
how subjects viewed the results of the trial (Creswell and Plano Clark, 2011). In this 
way, the rationale for this approach was that the quantitative strand of the study 
aimed at identifying factors that statistically associated with participants’ overall 
well-being before and after interventions, whereas the qualitative strand focused on 
explaining the processes whereby this occurred (Bryman, 2006). 
5.1.5  Section Summary 
The testing of self-management intervention, an initiative nursing approach, has led 
to the development of two research questions of this study which were of 
confirmatory and explanatory nature. An embedded design was thus adopted where a 
primary focused quantitative approach combining with a supplemental qualitative 
approach within a traditional experimental design was used to answer these two 
questions. Pragmatism was discerned to be the philosophical foundation of the study 
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as it accommodates different methods and different forms of data rather than adopts 
an either-or stance. Based on this paradigm, I have tried to depict the multiple scopes 
of mixed methods used in exploratory RCT for examining effects of complex 
intervention, namely the SMEP in this study. Also, through stating the rationale of 
using this approach, namely timing, sequence and strategy of mixing the data, the 
findings of this study were anticipated to have demonstrated rigor inferential 
conclusions as well as to have incorporated the insight into perceptions by patients of 
their own situation. The next step of the study design is the sampling and data 
collection issues. Hence, in the next two sections, both issues will be presented with 
regard to the quantitative and qualitative approaches respectively. 
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5.2  Section Two  Sampling and Data Collection Strategy for the 
Quantitative Strand 
5.2.1  Study Population and Sample 
In the quantitative strand, the target population of the research is COPD patients in 
Macau. Sampling was planned to be conducted at one of the two largest hospitals, 
two largest health centers of the Health Bureau and the elderly day care centers of 
Macau. Patients who fulfill the GOLD’s (2008) diagnostic criteria of COPD Stage II 
& IV were selected from medical wards, respiratory out-patient departments of the 
hospital, the health centers and the elderly day care centers suggested.  
 5.2.1.1  Inclusive criteria for sample selection 
 Post-bronchodilator FEV1 of stage II, III and IV COPD stated by GOLD in 
2008, measured by the same validated spirometry. 
 COPD refers to emphysema, chronic bronchitis and the chronic asthmatic 
condition that their airflow limitation is not fully reversible.   
 COPD patients with concomitant diseases and conditions are included as long 
as the patients are not in the acute stage of those diseases/conditions at the time 
of recruitment.  
 Participants should be 40 years old or above.  
 Participants in Macau should understand Cantonese and communicate in 
written Chinese.  
 Participants’ consent is freely given to take part in the research upon fully 
informed about the process and risk of participation and autonomous decision.   
 Participants are in a stable stage of their disease and approved by their 
attending doctor as competent for participating in the study. 
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 5.2.1.2  Exclusive criteria for sample selection  
 Stage I COPD patients according to the GOLD’s (2008) spirometric 
classification of COPD. 
 Patients with reversible asthma, congestive heart failure, lung carcinoma, 
bronchiectasis, pulmonary tuberculosis, bronchiolitis obliterans and interstitial 
lung diseases who may present reversible airflow limitation during respiration.  
 COPD patients who are in the acute condition of concomitant diseases or who 
come for treating their concomitant diseases.  
 Patients who are in acute stage of an exacerbation of COPD, cognition 
impaired, deficit in mobility or unwilling to participate in the research.  
5.2.2  Sampling Procedures 
5.2.2.1  Research ethical review and Participant recruitment  
This study was approved by the subject area research ethics team/coordinator of the 
School of Health in Social Science of the University of Edinburgh (See Appendix 2). 
Formal applications for research sampling were sent to the suggested hospital, the 
Health Bureau and eight elderly day care centers in Macau. The application to the 
suggested hospital was approved [No.(11)001] (See Appendix 3), while the Health 
Bureau and one elderly day care centre rejected the application. The reasons of 
rejection were keeping confidentiality for their patients and unavailability. Potential 
eligible participants were selected from medical wards and respiratory out-patient 
departments of the hospital. The recruitment of participants happened at the end of 
the out-patient visit or about discharge from hospital admission, through either 
referring or approval from the physicians of the respiratory team of the hospital as 
well as referral from the person-in-charge of the elderly day care centres. All patients 
approached were obtained verbal consent before assessing and confirming their 
eligibility for participating in this trial.   
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Figure X  Trial profile 
Figure 3  Trial profile   
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5.2.2.2  Sample Size 
As a phase II exploratory trial, sample size calculated by power analysis for 
achieving minimal clinical significance was unlikely required (MRC 2008). The 
sample size was then planned to reach a minimum of 50 to enable basic statistical 
analysis for informing potential relationship of various concepts in the modelling 
stage. In practice, 89 patients were approached (Refer to Figure 3). They were 
informed about the aims and process of the study and their rights in the due course, 
followed with spirometric tests for verifying the eligibility of the patients. 51 patients 
fulfilled the inclusive criteria. 
The main reasons for exclusion were because the patients (42.7%, 38 out of 89) did 
not fulfill the inclusion criteria by having a history or condition of bronchiectasis, 
pulmonary tuberculosis, congestive heart failure or classifying into stage 0 according 
to the GOLD’s (2008) spirometric classification of COPD. Eight patients (9.0%) 
refused to participate in the study, of which most of them regarded useless to 
attending the SMEP and one previously had received pulmonary rehabilitative 
training in Hong Kong. Three patients were unable to complete the assessment and 
were therefore excluded. 
5.2.2.3  Randomization 
All 51 eligible subjects were randomly allocated to either SMG or CG. SMG 
underwent the SMEP in additional to conventional treatment and CG received only 
conventional treatment. Subject allocation was based on block randomization (MRC, 
2000), in which each subject was assigned to a block in accord with his/her stage of 
COPD and he/she randomly picked a card stating either SMG or CG. To balance the 
number of subjects of each stage of disease in each group, there were an equal 
number of cards of both groups in each block (stage of disease). I performed 
randomized consent by obtaining the written informed consent in terms of the 
assigned group of the subjects (Information sheet and consent form see appendix 4, 5, 
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6, 7). This approach may be ethically preferable to a conventional design where it 
would be intolerable for those in the CG to know that a potentially beneficial 
intervention was being denied through randomization (MRC, 2008). Then, the 
consented subjects were scheduled baseline assessments (Tier 0 assessment or T0). 
However, one subject from the control group withdrew consent with a reason of 
being unavailable for the trial before the baseline assessment took place. Therefore, a 
total of 50 subjects (26 subjects in SMG and 24 subjects in CG) participated in the 
trial (Figure 3). 
5.2.2.4  Blinding and Bias minimization 
In group allocation, single-blind technique was applied to the subjects, so they were 
unaware of which group they were in (Smith, 2008). Moreover, persons who 
delivered the intervention were not responsible for conducting the post-intervention 
assessment. Also, the investigators who performed post-intervention assessment were 
blinded to group assignments so as to minimize bias on outcome data (Smith, 2008).  
5.2.2.5  Dropout of participation 
During the study, one subject in SMG did not complete the SMEP as she was 
repeatedly absent from the scheduled educational workshops. All subjects in the 
SMG received an assessment of their inhalation technique of the inhalers at the 
completion of the self-management workshop (Tier one assessment or T1). During 
the six-month follow-up, one subject in SMG and two subjects in CG withdrew 
participation from the T2 assessment. Two subjects from SMG and two subjects 
from CG were unable to be contacted, and one subject from CG had died. At the end 
of the study, the number of subjects who completed T2 assessment was 23 for SMG 
and 19 subjects for CG. The dropout rate was 17.6%. 
5.2.3  Method of Data Collection  
Both quantitative and qualitative data were collected to assess effects of 
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self-management interventions on Macau COPD patients in this embedded mixed 
methods design. This section only describes the method of quantitative data 
collection while the qualitative part will be presented in the next section. All aspects 
of outcome assessment are displayed in figure 4 in relation to the theoretical 
framework. In the quantitative strand, assessment of the demographic, biomedical, 
psychosocial and behavioral aspects of the subjects was done through questionnaire 
investigation and pulmonary function testing and behavioural checking. 
(Questionnaire sample see appendix 8; demographic data see Appendix 8 section 1). 
It is unwise to put focus on all measurements, so I posited primary outcomes and 
secondary outcomes of the trial based on the proposed theoretical framework and 
literature review. In the following, I will address all measures selected and utilized 
for assessing both the primary outcomes (Illness perception, self-efficacy, inhaler 
technique) and the secondary outcomes (pulmonary function, rescue medication and 
healthcare utilization, health-related quality of life) of this study in terms of their 
characteristics, measurement properties and clinical application.  
5.2.3.1  Primary Outcomes 
Provided that COPD is incurable, but treatable and preventable in nature, lost 
pulmonary function would largely be unable to restore by existing medical and 
nursing interventions (GOLD, 2013, ATS, 2004). Reducing mortality and improving 
pulmonary function were certainly not the aims of the study whereas the 
psychosocial and behavioral outcomes were taken into consideration. In the light of 
the theoretical framework and literature review, the intent of SMEP clearly was to 
enhance the illness perception and self-efficacy and subsequently the health 
behaviour of COPD patients. Illness perception and self-efficacy belong to the 
psychosocial dimension while and health behaviour belongs to the behavioral 
dimension of an individual. Therefore, the primary outcomes were illness perception, 
self-efficacy and inhaler usage technique and relevant measures adopted should 
reflect the dimensions in question and also the research purpose of interest. I will 
first present the Revised Illness Perception Questionnaire (IPQ-R) and COPD 
Self-Efficacy Scale (CSES), followed by the assessment inhaler technique.  
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5.2.3.1.1 Psychosocial data collection 
Measurement scales such as The Revised Illness Perception Questionnaire (IPQ-R), 
COPD Self-Efficacy Scale (CSES), Medical outcomes study 36-item short form 
health survey (SF-36) and St. George Respiratory Questionnaire (SGRQ) are used to 
assess the psychosocial aspects of the participants before and 6 months after the 
self-management intervention. Since Macau population share the same written and 
spoken language of Hong Kongers, traditional or Hong Kong Chinese version of 
these four questionnaires are used (Chen et al., 2008b, Lam et al., 1998, Yu et al., 
2004). Application for purchasing the license of using SF-36 is approved by the 
QualityMetric Incorporated, and other three scales are granted permission by the 
authors to be used for free in this study.  
5.2.3.1.1a  Illness Perception Measurement
The revised version of illness perception questionnaire (IPQ-R) was used in this 
study (Appendix 9). This questionnaire is divided into three sections: Identity 
dimension, illness representation dimension and causal dimension. Identity 
dimension is presented in the first section including 14 commonly experienced 
symptoms and each symptom is rated on a yes or no response format. The sum of the 
yes-rated items on this rating forms the illness identity subscale. In the illness 
representation dimension, seven subscales such as consequences, timeline 
acute/chronic, time cyclical, personal control, treatment control, illness coherence 
and emotional representatives are presented in 38 items rating on a five-point 
Likert-type scale: strongly disagree, disagree, neither agree nor disagree, agree, and 
strongly agree. Mean scores of each item for every subscale were calculated for both 
the identity and illness representation dimensions. The causal dimension is divided 
into two sessions. In the first session, the subjects are required to self-report three 
causal items attributional to their COPD. A percentage on the accumulation of the 
three attributions reported by all patients was presented. In the second section, the 
participants rate on 18 given attributional items in regard to the cause of their disease 
with the same Likert-type scale.  
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The 18 attributional items are categorized into four main attributional factors: 
Psychological attributions, risk factors, immune system factors and chance factors. 
However, it is inappropriate to sum all of the items as each item represents a specific 
causal belief (Weinman et al., 1996). Thus, I provide the sum of each of the four 
attributional factors and an average rating of each item. Regarding the measurement 
properties of IPQ-R, the three sections show an acceptable consistency in 
assessments and good structural validity and all the subscales demonstrate good 
internal reliability with Cronbach alpha’s of 0.75 in the first section, 0.79 to 0.89 in 
the second section and 0.67 to 0.86 in the third section (Moss-Morris et al., 2002). 
The revised illness perception questionnaire (IPQ-R) was translated into traditional 
Chinese version (See appendix 8: Section 5) and is available on the web 
(http://www.uib.no/ipq/pdf/IPQ-R-Chinese.pdf). However, its psychometric 
properties have not been shown. 
5.2.3.1.1b  Self-Efficacy Measurement
The COPD Self-Efficacy Scale (CSES) was chosen and it consists of 34 items which 
explore five dimensions, (for instances, negative effect, intense emotional arousal, 
physical exertion, weather/environment and behavioural risk factors) of COPD 
patients (Appendix 10). The five factors show a good validity and its reported 
internal consistency was satisfactory, having the Pearson product-moment of 
test-retest reliability correlation coefficient of 0.77 (p<0.001) (Wigal et al., 1991). It 
was claimed that the CSES would be useful in measuring increases in self-efficacy 
following an educational or self-management intervention. Nonetheless, caution is 
needed in interpreting results based on individual scores since it was established on a 
group basis (Wigal et al., 1991). In Wong et. al.(2005)’s study, CSES was translated 
into simplified Chinese by an English to simplified Chinese and back translation 
method (Wong et al., 2005). It achieved a content validity index ranging from 0.64 to 
0.85 and three items were removed from the original English version, resulting 31 
items covering five subscales: negative effect (11 items), intense emotional arousal 
(seven items), physical exertion (six items), weather or environment (five items), 
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behavioural risk factors (two items). The final simplied Chinese CSES version 
demonstrates good test-retest reliability of correlation coefficient r=0.88. I have 
contacted Wong and was granted permission to use the scale. However, this 
simplified Chinese CSES has neither validated on a large population nor external 
validity confirmed. As simplified Chinese is usually expressed in Mandarin orally, 
this version is not totally applicable in Macau because Macanese basically reads 
traditional Chinese and speaks Cantonese. In this case, I have converted the 
simplified Chinese version into traditional Chinese version. Three experts in nursing, 
education or clinical respiratory nursing who comprehend both forms of Chinese 
were invited to validate the items of the scale with respect to language expression. 
The content validity index (CVI) was computed and it reached 0.91 (ranged from 
0.67 to 1.00). Refinement in the wordings was performed on four items of the scale 
as recommended by the experts. The final version of traditional Chinese CSES was 
administered to three COPD patients for assuring understanding before data 
collection, no major revision was recommended (See appendix 8: Section 4). 
5.2.3.1.1c  Inhaler technique
When we assess the self-efficacy of an individual on a specific task or action, it was 
advised to assess his or her performances as well (Jiang et al., 2004). To assess 
COPD patient’s self-management behaviour, researchers often examined the mastery 
rate of inhalation skills or inhalation technique of them (Bourbeau et al., 2004, 
Rootmensen et al., 2008). In this study, however, I assessed inhaler technique of the 
subjects. In inhaler technique assessment, both the inhalation technique and proper 
inhaler care were included. A device-specific inhalation checklist which lists the 
proper steps of each type of inhaler was developed according to the instructions 
given by the relevant pharmaceutical companies. The mastery rate of the usage of all 
prescribed inhalers was assessed through the observation of the inhaler technique of 
the participants (Appendix 11). The mastery rate of inhaler technique was presented 
in a percentage which was computed through dividing the sum of correct steps by the 
total steps of the inhaler technique. Total scores range from 0% to 100%, with higher 
scores indicating better performance. 
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5.2.3.2.  Secondary Outcomes 
5.2.3.2.1  Biomedical measurement 
Pulmonary function parameters such as post-BD FEV1, post-BD FEV1% predicted 
were examined to assess the condition of the airway after administrating 
bronchodilator. Pulmonary function is usually assessed by spirometry, and both 
post-BD FEV1 and post-BD FEV1/FVC serve as the clinical criteria for diagnosing 
and monitoring COPD. To obtain these measurements, I followed the pulmonary 
function test instruction advised by GOLD (2008). The subjects were instructed to 
blow at a spirometric device (Model: Spirobank II). Four to five blows were 
generally needed to optimize the readings of both FEV1 and FEV1/FVC. In regard to 
assessing post-BD FEV1 and post-BD FEV1/FVC, standard dose of short-acting β2
agonist (bronchodilator 400 μg) was administrated to the patient either through a 
nebulizer or spacer and spirometry was repeated 10~15 minutes later. The presence 
of a post-BD FEV1< 80% of predicted and post-BD FEV1/FVC < 0.70 confirms the 
presence of airflow limitation which is a typical finding in COPD patient. After 
obtaining the measurements before and after bronchodilator administration, the 
difference was then calculated and divided by the pre-test value and expressing it as a 
percentage. If there is an increase of <12% and 200ml, it indicates a lack of 
bronchodilator reversibility (GOLD, 2008). The above test was carried out on 
condition that the patient had not inhaled short-acting bronchodilators in the previous 
six hours, long-acting bronchodilators in the previous 12 hours, or intaken 
sustained-release theophylline in the previous 24 hours.  
5.2.3.2.2  Rescue medication and Healthcare utilization 
A COPD patient may presumably be in stable condition when he is on regular 
treatment. But if he experiences exacerbation or severe symptoms and regular 
treatment could not relieve the condition, he may need to use rescue medication, for 
instance, short-acting bronchodilator (SABA), prescribed oral corticosteroid, and 
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antibiotics (GOLD 2013). If rescue medication as such could not relieve the 
condition, he may need medical consultation at out-patient department or emergency 
room depending on the perceived severity with the patients. Thus, the consumption 
of rescue medication and demand of healthcare service could reflect the stability of 
the disease of the patients. In this study, the frequency of using SABA, number of 
unplanned out-patient or emergency room visit and number of days of hospitalization 
of the participants were assessed. For the frequency of using SABA, the subjects 
were asked to base on their own practice in six months reporting among choices 
including: Never use, two times/week, two to seven times/week, once per day and 
more than once per day. For healthcare utilization, number of self-reported 
unplanned out-patient or emergency room visit usually refers to the unscheduled 
doctor and nurse visits per patient in a specific period of time (Effing et al., 2007, 
Bourbeau and van der Palen, 2009) (See general section of appendix 8). I took this as 
the definition for assessing this variable by taking into account that unscheduled visit 
was due to respiratory condition and happened in the past six months. Moreover, 
hospital admission and hospital days were defined by counting times of 
hospitalization and total days of hospitalization due to COPD exacerbation 
respectively in a specific period of time (Effing et al., 2007). The participants in this 
study were requested to report the total number of days of hospitalization in relation 
to COPD exacerbation in the past six months.  
5.2.3.2.3  Health-related Quality of Life measurements 
Generic HRQoL measure (SF-36v2) and disease-specific HRQoL measure 
(SGRQ-HK) were used to assess the quality of life status of the participants. Since 
Macau population share the same written and spoken language of Hong Kong 
residents, as such traditional or Hong Kong Chinese version of the two instruments 
are applicable in Macau (Chen et al., 2008b, Lam et al., 1998, Yu et al., 2004). 
License of using SF-36v2 has been purchased from the QualityMetric Incorporated 
which developed the instrument (See appendix 12). For SGRQ-HK, permission was 
granted by the authors for using it for free in this study. 
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5.2.3.2.3a  Generic health-related Quality of Life
For the assessment of generic HRQoL, the Chinese (HK) version of the SF-36 
(SF-36v2) was used in this study (See Appendix 8: Section 2). It was first validated 
against the original U.S.-English SF-36 by Lam and her colleagues in 1998 and the 
two questionnaires were found to be equivalent in concepts and measurements (Lam 
et al., 1998, Lam et al., 2005). The SF-36v2 is a self-administered generic HRQoL 
instrument for the assessment of a general health status in a month period. It has 36 
items covering eight domains including physical function, role-physical, bodily pain, 
general health, vitality, social function, role-emotional and mental health (Ware, 
2005). Physical functioning (PF) consists of 10 items and reflects levels and kinds of 
limitations between the extremes of physical activities ranging from strenuous sport 
to dressing oneself. Role-physical (RP) consists of four items which cover an array 
of physical health-related role limitations. Bodily pain (BP) comprises two items 
which pertain to the intensity of the bodily pain and the extent of its interference with 
normal work activities respectively. General health (GH) comprises five items which 
include a rating of overall health and four items addressing the subject’s view and 
expectations of his or her health. Vitality (VT) has four items which capture 
differences in one’s subjective well-being, for instance, energy level and fatigue. 
Social functioning (SF) has two items which assess health-related effects on quantity 
and quality of social activities. Role-emotional (RE) consists of three items and they 
reveal mental health-related role limitations. Mental health (MH) has five items 
which assess major health dimensions with respect to anxiety, depression, loss of 
behavioral/emotional control and psychological well-being. The eight domains 
indeed reflect two broad components of health: Physical component summary (PCS) 
and mental component summary (MCS). PF, RP and BP contribute most to the 
scoring of PCS while MH, RE and SF contribute most to the scoring of MCS. Two 
domains (VT and GH), however, contribute substantially to both components. There 
is no total scoring for SF-36v2, but measures are reflected on the domain scores. The 
domain scores are calculated through a scoring software (QualityMetric Health 
Outcomes™ Scoring Software 4.0) provided by QualityMetric Incorporated. In 
principle, the higher the score of each of the eight domains, the PCS and MCS, the 
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better the generic HRQoL is indicated (Maruish and Turner-Bowker, 2009).   
SF-36v2 bears the scaling success rate on discriminant validity at 92.5% to 100% for 
all scales. In regard to its internal consistency, the Cronbach’s alpha coefficients of 
internal reliability (RTT) were above the standard of 0.65 for all scales. It is 
suggesting that the SF-36v2 would be able to detect any deterioration in the health 
status of these subjects (Lam et al., 1998). However, changes in SF-36 for assessing 
health status may be underestimated in subjects who show higher baseline scores in 
the scales of the SF-36. As recommended, disease-specific instrument was used as a 
complementary approach to assess the HRQoL (Sato et al., 2004). 
5.2.3.2.3b  Disease-specific health-related Quality of Life
The Hong Kong Chinese version of SGRQ (SGRQ-HK), which is a disease-specific 
assessment tool for COPD patients, was selected to assess the disease-specific 
HRQoL status of the subjects before and 6 months after the intervention in this study 
(See appendix 8: Section 3). SGRQ-HK was translated from original English version 
of SGRQ and validated by Yu et al. in 2004. SGRQ-HK contains of 75 items which 
are divided into three sections: Symptoms, activity and impacts. The symptoms 
section reflects the level of symptomatology in terms of frequency and duration of 
COPD symptoms. The activity section captures physical activities that cause or are 
limited by breathlessness. The impacts section covers aspects associated with 
employment, being in control of health, panic stigmatization, the need for medication 
and its side effects, and expectation for health and disturbance in daily life. There is a 
special weighting system for calculating SGRQ of which all the subscales with a 
positive response were summed. The score was then calculated by dividing the 
summed weightings by the maximum possible weightings for that section, and it 
results in a total score and three subgroup scores. Thus, a high score indicated poor 
quality of life (Yu et al., 2004). In Yu et al.(2004)’s study, SGRQ-HK shows validity 
with a construct of explaining 88% of variance and a high internal consistency with 
the Cronbach’s α of 0.74 averagely across all subscales and total scores. It is stable 
for repeated measurements over time as its short and long-term test-retest reliability 
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ranging from 0.97 to 0.98 and 0.70 to 0.86 respectively. It is claimed to be a reliable 
and valid instrument for assessing QoL in Hong Kong Chinese people with COPD 
(Yu et al., 2004).  
5.2.4  Administration of measures 
Before administrating the four chosen measures (IPQ-R, CSES, SGRQ-HK and 
SF-36v2), I have given to five Macau COPD patients for confirming their 
understanding to the questionnaires prior to real data collection. The possibility of 
misunderstanding may be present among the elder adults in Macau who are relatively 
low educated as 70% of them have received primary education or lower (KWNC, 
2004), questionnaires were conducted on a structured interview basis to avoid 
misinterpretation of the respondents (Bryman, 2008). Six senior undergraduate 
students of nursing programme were recruited as investigators for this study. To 
maximize the inter-rating reliability, all investigators were given a four-hour training 
for learning how to perform pulmonary function testing and for getting familiar and 
maximizing unity in administrating the assessments. All measures were conducted at 
T0 and T2 to examine the effects of the intervention. Exceptionally for inhaler usage 
technique, it was assessed at T0, immediately after the intervention (Tier 1, T1) and 
T2 to assure the sustainability of the behaviour with the participants after the 
intervention.  
5.2.5  Section Summary 
In the final study, two rather than three sectors of proposed sampling venues 
approved sampling for this study. A total of 50 subjects consented and participated in 
the experiment of which 26 subjects and 24 subjects were allocated to SMG and CG 
respectively by block randomization and the study ended up with a total of 42 
subjects, indicating 17.6% of drop out. Various measures were used to assess these 
participants. IPQ-R, CSES and inhaler technique checklist were used to assess the 
primary outcomes (Illness perception, self-efficacy and inhaler technique), while the 
post-FEV1 and post FEV1%, frequency of rescue medication usage and unplanned 
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visits to outpatient and ER, days of hospitalization, SF-36 and SGRQ were used to 
assess the secondary outcomes (pulmonary function, rescue medication usage, 
healthcare utilization, generic and disease-specific HRQoL) of the experiment. These 
measures were delineated with respect to their construct, validity and reliability. 
Moreover, the data collection method and sampling for the qualitative data will be 
presented in the following section. 
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5.3  Section Three  Qualitative Data Collection and Sampling 
Strategy  
5.3.1  Introduction 
Focus groups were conducted on a sub-sample of SMG who received the intervention 
and completed the quantitative assessment. Focus groups were used to explore at 
some length concerning issues evolved from the questionnaire results (Fielding and 
Fielding, 1986). But why focus groups were used rather than one-to-one interview? 
How could these focus groups be carried out in a way that corresponded to its 
supplemental secondary role within an embedded design? In this section, I offer 
rationale for adopting focus groups as method to elicit the views of participants and 
how this fits with the research aims and present the principles employed in conducting 
focus groups. As qualitative sampling usually does not aim to produce a 
representative and ‘identical’ sample, sampling was focused on approach where the 
issue central to the research question was explored (Barbour, 2007). So this will also 
cover the arguments for the determination of the number of focus groups and for 
purposive sampling in the selection of focus group participants. 
5.3.2  Definition of Focus group 
The term, focus group has sometimes been used interchangeably with ‘group 
interview’, ‘focus group discussion’ and ‘focus group interview’ (Barbour, 2007). 
Focus group was found most frequently used and suitable term for expressing hybrid 
characteristic. Barbour (2007) also tended to uphold the definition that she drew with 
Kitzinger in their book published in 1999. Kitzinger and Barbour (1999) defined 
focus groups as follows:  
“Focus groups are group discussions exploring a specific set of issues, 
distinguishing from the broader category of group interviews by the 
explicit use of group interaction to generate data. Instead of asking 
questions of each person in turn, focus group researchers encourage 
participants to talk to one another: asking question, exchanging anecdotes, 
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and commenting on each others’ experiences and points of view.” (Barbour 
and Kitzinger, 1999, P.4)
5.3.3  Rationale for using Focus groups 
Focus group was claimed to be ideal for exploring people’s attitudes, experiences, 
opinions, wishes and concerns and examine people’s different perspectives by 
investigating how points of views are constructed and expressed. Morgan (1998) 
argued that focus groups may suit to understand complex behaviour and motivation 
as the interaction among the participants consist of their efforts to understand each 
other. They are curious to know how people behave and the motivations that underlie 
these behaviours, so focus groups were regarded as avenue to reveal deep 
motivational insights (Morgan, 1998). The main feature of focus group making it 
distinct from one-to-one interview is that researcher can hear new ideas of interest 
arisen from the group in additional to the prepared topics. Through contact and 
observation with the participants of this study during implementing SMEP, they were 
slightly shy and not good at articulating their feelings and opinions. In this case, 
one-to-one interview may not be an appropriate option to collect data due to its 
serious atmosphere and higher demand of ability in verbal expression. On the 
contrary, focus group embraces friendliness and respect in nature and the participants 
could share more easily (Morgan, 1998). To resolve the issue of shyness in the 
participants, I intended to provide a familiar setting for this qualitative interview as 
the participants have already participated in a group intervention and the focus of the 
interview was on how they as a group made sense out of the intervention. The 
interpersonal communication in a group may help to clarify similarities and 
differences in expressed opinions and/or values (Freeman, 2006). Subsequently, by 
contrasting and comparing among the participants, they could become more explicit 
about their views. 
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5.3.4  Conducting Focus Groups 
5.3.4.1  Topic Guide and Focus Group Moderator Preparation 
A semi-structured interview was employed with the main focus on two elements: 
perceptions and experiences of the participants towards self-management. An 
semi-structured interview enabled the participants to throw out their ideas and 
opinions within their flow of conversation and their interaction, and the two foci can 
direct the group from running off the topic (Bryman, 2008). Hence, the focus group 
topic guide was a brief and a focus one (Appendix 13). Since I was the moderator of 
the self-management education workshops, a fairly good patient-nurse relationship 
has been built up with the participants. Due to lack of experienced personnel for 
conducting focus groups, I invited a moderator not involved in the study who had 
experiences of conducting qualitative interviews to conduct the focus groups. To 
ensure reliability, training was given to the moderator by introducing the aims and 
methods of study, the aims of the focus groups and relevant focus group facilitating 
skills, the SMEP and the characteristics of the participants. We have particularly 
rehearsed with the focus group topic guide before doing for real.  
5.3.4.2  Focus groups in practice 
The participants were invited to participate in the focus groups through telephone 
calls. The focus groups were taken place in a meeting room at out-patient department. 
The three focus groups lasted for 60 to 85 minutes. None was stopped due to time 
constraints or fatigue of participant. During the focus group, an observer was within 
the group to help taking notes of the group dynamics and contextual information. A 
debriefing with the moderator and the observer was done following each focus group, 
to review the salient messages and ambiguity captured in the process. The focus 
groups were audio-recorded to keep the full information for analysis (Joyce, 2008). 
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5.3.5  Sampling strategy for Focus Groups 
5.3.5.1  Determining number of Focus Groups 
Among all 50 recruited participants of the study, the 26 participants allocating to the 
SMG were eligible to participating in the focus groups. In this case, the focus groups 
aimed at exploring a narrow category of people, so fewer focus groups could be 
acceptable (Krueger, 1988). Even so, the number of focus group to hold is likely to 
be related to the different characteristics of participants reflected in selection. 
Barbour (2007) argued that even holding two focus groups with similar 
characteristics may gain firmer ground for the patterning of the data as long as they 
make as much comparison as possible. On the other hand, the participants in this 
study might share intense and lengthy experiences with their disease management, 
thus smaller focus group could possibly get more in-depth insights in this specific 
perception and experience (Krueger, 1988). In the perspective of a researcher, 
smaller group is more likely to pay closer attention to the type and content of 
interaction (Barbour, 2008). Therefore, three focus groups with each having four 
patients were conducted at T2 in this study. It is because when the third focus group 
was conducted, there were not many new codes appeared and data saturation was 
considered to have reached. After determining the number of focus groups, further 
concern here relates to the strategy for selecting participants who can give rise to 
data of relevance to the research aims. 
5.3.5.2  Selecting participants for Focus Group 
Given that this study was an embedded design, the focus group paid a less dominant 
and a supplementary part in the overall data collection. Hence, it was considerably 
adequate to drive the participant selection by the purpose and practical concerns of 
the study. In this case, purposive sampling was adopted and sampling strategies as 
such reflects diversity and provides the maximum possibilities for comparisons 
(Barbour, 2008). In terms of implementation, I purposively selected among the SMG 
participants by matching characteristics, for examples, age, gender, stage of severity 
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of the disease and family conditions, which are found to have some bearing on their 
experiences of living with COPD (Guthrie et al., 2001, Leung et al., 2002, Punekar et 
al., 2007). In this study, the education level of the participants was also taken into 
account as it can possibly affect his/her ability of receiving information from the 
SMEP. This approach to sampling formed a structure composing both male and 
female COPD patients at extreme age, from mild to severe stage of disease and 
encountering the disease independently or with family support. Therefore, 18 
participants were selected from 23 participants of the experimental group who have 
completed the trial. The remaining five participants were not selected because they 
either bear the same background characteristics of the selected participants or have 
deficiency in hearing. 10 participants as well as one family member (wife of a 
participant) consented to participate in the three focus groups. Eight invited 
participants were lost due to three feeling sick, two were out of town, two were 
hospitalized and one was unavailable when the focus groups took place. The 
characteristics of the participants selected by purposive sampling are shown in table 
2.  
Table 2   Characteristics of participants of the focus groups 
 Sex 
 Male Female 
Age  < 60 
         61 to 70 
         71 to 80 
-- 
5  (3 NA) 
2  (3 NA) 
2 +1* 
1 (1 NA) 
(1 NA) 
COPD classification 
         Stage II 
         Stage III 
         Stage IV         
1  (3 NA) 
4  (1 NA) 
2  (2 NA) 




         Illiteracy 
         Primary 
         Secondary 
         Tertiary or above 
-- 
5  (5 NA) 






         Live alone 
         With partner or children 
         With partner and children 
-- 
   (2 NA) 
7  (4 NA) 
1 (1 NA) 
1(1 NA) 
1 
Total  7  (6 NA) 3 = 1* (2 NA) 
NA : non attendance 
* Family member 
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5.3.6  Characteristics of Focus Group Participants 
The participants ranged from 47 to 74 of age and were at stage II to IV of COPD. 
Due to failure of recruiting an illiterate and tertiary educated participant, the focus 
group participants had primary to secondary level of education. The participants were 
either living alone, with a partner, or with both partner and children. They may share 
similar diverse concerns and issues in relation to family support in encountering 
disease management. In addition, a third party, a family member, has joined one 
focus group and she may potentially provide views on disease management from an 
informal caregiver’s perspective. 
5.3.7  Section Summary  
In the qualitative strand, I argued for the use of focus groups to understand 
self-management, such a complex behaviour, and motivation in the interaction 
among the participants. Focus group topic guides were prepared with special 
attention of ensuring open discussion and group dynamic. I intentionally avoided 
myself to facilitate the focus groups so as to minimize bias and the invited moderator 
was given relevant training of running focus groups. Three focus groups were 
conducted. They consisted of 11 participants who were of diverse characteristics 
were purposively selected from experimental group to explore their experiences and 
perceptions of self-management. 
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5.4  Section Four  Complex Intervention of the Experiment  
-- Self-management Education Programme 
5.4.1  Introduction 
The intervention of this study, namely SMEP, is a complex intervention and there is no 
‘standard’ programme developed or run with well and widely recognition in any 
reported studies (Effing et al., 2007, Adams et al., 2007). The development of the 
protocol of SMEP has followed the MRC (2008) framework which rigorously 
provides guidance for developing and evaluating a complex intervention. This 
framework advised a sequential series of phases: ‘Pre-Clinical’ – initial theory 
exploration; Phase I - modelling; Phase II - exploratory trial; Phase III - definitive 
RCT or main trial; Phase IV - or long term surveillance. As mentioned earlier in 
methodology chapters, this study has undertaken the phase II of the complex 
intervention evaluation process where I can experiment with the intervention and 
evidence derived can support the theoretically expected treatment effect (MRC, 2000). 
The next section will present the process of developing and conducting the SMEP in 
this study. 
5.4.2  Development of Self-management Education Programme 
The SMEP consists of three components: 1) Self-management education workshop, 2) 
Patient handbook and 3) Telephone follow-up. The steps for establishing these 
components are addressed in four different stages as followed.   
5.4.2.1  Preparation Stage – Programme development 
5.4.2.1.1  Self-management Education Workshop 
A protocol for the SMEP was developed based on the GOLD (2013) advice on 
education programme for COPD patients at different stage of severity and systematic 
review reporting about the structure of SMEPs (Effing et al., 2007, Monninkhof et al., 
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2003). The protocol of the self-management education workshop was initiated and it 
comprised two main components: 1) COPD education and 2) self-treatment guidelines 
(or an action plan) (Refer to Figure 5). This figure demonstrated the structure and 
relationship of the topics of the workshop in accordance to the MRC framework for 
identifying the key relations among topics. 
Main  
components
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Use of different inhalers 
Monitoring and identifying 
exacerbation 
Adjustments of dosage use 
Response to exacerbations 
at night 
Figure 5.  Interrelationship among the intervention components. 
The sequence and method for the delivery of the topics were designed under the 
consideration of the theories of illness perception and self-efficacy beliefs. In regard 
of improving illness perception belief, the workshop has been designed to clearly 
identify the symptoms and aetiology of COPD (Identity and Cause), to stress its 
chronicity and possible reverse consequences (Timeline and consequences), and 
encourage the patients about the controllability of the disease (Control). To 
incorporate the self-efficacy belief in enhancing self-management, I planned the 
simple but essential mastery topics at the beginning session in order to bring success 





accomplishment); participant’s successful experiences were shared among the group 
(vicarious experience); I shared scientific reports on positive impact of 
self-management of COPD patients (verbal persuasion); any improvement in 
oximetry parameters during pursed lips breathing was feedback to the participants to 
boost confidence in the intervention (physiological status) (Roberts et al., 2009, 
Bandura, 1989). These activities attempted to promote and strengthen the 
participants’ outcome expectations and efficacy expectations for engaging in 
self-management.  
5.4.2.1.2  Patient handbook 
The patient handbook was developed according to the information included in the 
workshop (Appendix 14). Considering that the targeted participants were 
comparatively senior in age, the handbook was written in characters with large font, 
with lay expression and the support of instructive pictures and photographs in order to 
achieve a better understanding among the participants. 
5.4.2.1.3  Telephone Follow-up 
I collected the personal telephone number of all participants under their consent and 
informed them about the telephone follow-up during the six months observation 
period. Telephone calls were made to participants in SMG every other month to 
reinforce the teaching content and clarify queries of them. However, the participants 
of CG were given a courtesy phone call which is of no educational advice. They were 
only asked about some updates of their healthcare utilization and were not provided 
with any health education information in the call. Another aim of making placebo 
telephone follow-up was to get in touch with the control group participants to 
minimize drop out. Each telephone call lasts five to 15 minutes. 
5.4.2.2  Pilot Stage – Programme Validation 
5.4.2.2.1  Content Validity 
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Before the real implementation of the complex intervention in the experiment, content 
validity and pilot exercise were conducted on the initial protocol of the SMEP. In 
content validity, I invited two locally based respiratory physicians, one respiratory 
nurse, one nurse specialist in respiratory rehabilitation, one physical therapist, one 
dietician and one Traditional Chinese Medical physician to review the relevancy and 
the feasibility of the programme protocol. The experts were briefed about the 
definition of self-management and aims of the study, and they rated on the components 
against three choices : they are 1) relevant/feasible; 2) relevant but revision 
necessary/feasible but revision necessary; 3) irrelevant/infeasible. The content validity 
index (CVI) for the COPD education component was 0.99 (0.67~1.00) in 
appropriateness and 0.98 (0.67~1.00) in feasibility. For assessing the content validaity 
of action plan, although it is essential in SMEP by definition, the experts showed 
controversial opinions. Thus, an independent content validity has further been carried 
out by inviting all seven respiratory doctors of the study venue to review the 
appropriateness and feasibility of the action plan. Their response demonstrated a CVI 
of 0.77 (0.43~1.00) in appropriateness and 0.74 (0.29~1.00) in feasibility. Topics rated 
low content validity (0.29 and 0.43) include self-management of steriod and 
antibiotics usage respectively. The final action plan excluded these two content and 
only included the directive for adjusting short-acting bronchodilator (See appendix 
15), then the overall CVI for the SMEP shows a high validity both in appropriateness 
(0.95, ranges from 0.67 to 1.00) and in feasibility (0.93, ranges from 0.67 to 1.00). In 
addition, alteration to the SMEP has been made according to the recommendation 
given by the experts, for instance, including recipe of Chinese home-made soup which 
is specifically for people with respiratory conditions and introduction of 
supplementary nutritious products (See Table 3).  
5.4.2.2.2  Pilot testing 
In the pilot exercise, four COPD patients were invited to attend the revised 
self-management education workshop. They commented that four 1.5-hour 
workshops running every other week were quite time-consuming. The paticipants 
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expressed no apparent difficulty in comprehending the teaching content and 
particularly appreciated the content of inhaler usage, breathing exercise and recipe of 
the Chinese home-made soup. In overall, the participants appreciated the workshop 
and the protocol of the workshop was finalized to be three 1.5-hour workshops 
running once every week so as to save the time of participants and enhance the 
smoothness of the progress. 
Table 3. The combination and distribution of the topics of the self-management 
education programme pre- and post-validity testing 






1 (1.5 hrs) Topic 1–6 Information about 
nature of COPD 
Topic 7-11 Use of difference 
inhalers 
Topic 12  Monitoring and 
identifying exacerbations 
Topic 13  Recording of 
exacerbations 
 1 (1.5 hrs) Topic 1–6 Information about nature 
of COPD 
Topic 7-11 Use of difference inhalers
Topic 18  Action plan (short-acting 
bronchodilators administration only)
Topic 27  Response to exacerbations 
at night 
Topic 12  Monitoring and identifying 
exacerbations 
Topic 13  Recording of exacerbations
2 (1.5 hrs) Topic 14-17 Breathing 
exercises 
Topic 18   Action plan  
2 (1.5 hrs) Topic 14-17 Breathing exercises 
Topic 19-23 Coughing techniques 
Topic 24   Relaxing exercise 
Topic 25-26 Energy saving technique
3 (1.5 hrs) Topic 19-23 Coughing 
techniques 
Topic 24   Relaxing exercise
Topic 25-26 Energy saving 
technique 
Topic 27   Response to 
exacerbations at night  
3 (1.5 hrs) Topic 28-30 Diet and pulmonary 
health (including Chinese home-made 
soup) 
Topic 31  Smoking Cessation 
Topic 32  Vaccination 
Topic 33-35 Managing stable 
condition and preventing 
complications 
4 (1.5 hrs) Topic 28-30 Diet and 
pulmonary health 
Topic 31  Smoking Cessation
Topic 32  Vaccination 
Topic 33-35 Managing stable 
condition and preventing 
complications 
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5.4.2.3  Pre-implementation Stage - Facilitator Training 
I, as a registered nurse and nursing educator in Macau, was the principle instructor of 
the workshop and two other nurses who have been experienced in respiratory care 
(eight years of experiences) participated as intervention agents in some sections of the 
workshops. An eight-hour training was carried out among the researcher and the 
intervention agents by rehearsing the programme protocol to assure inter-instructor 
reliability in the experiment. 
5.4.2.4  Implementation Stage – Programme running  
All participants in the SMG were invited to complete the SMEP by attending three 
self-management education workshops, getting a patient handbook and being 
arranged a telephone follow-up after the workshop. The workshops were taken place 
in an out-patient chronic illness center of the hospital where most participants were 
recruited. This center was about 100m2 and was particularly designed for health 
education purpose as it has been equipped with multimedia and projectors. The 
teaching content of the workshop was delivered in verbal and visual forms by means 
of lecturing, demonstration, re-demonstration and video watching. Each workshop 
was run in a group-based with four to six participants interacting with each other. Two 
participants were taught on an individual basis as they could not join the scheduled 
workshop due to personal reasons. For those who dropped some sections owing to 
unforeseen commitments, holidays, sickness and other reasons, they have been 
arranged to join in other groups and attend the missing section(s). The study did not 
interfere with participants’ regular out-patient visit pattern. Participants who requested 
for assistance from their caregiver or family member in the workshop were allowed to 
be accompanied by appointed significant other(s). Oxygen, quick-relief medications 
and Ambu-bag were ready in the room for safety considerations. (Worth and Dhein, 
2004, Kara and Aşti, 2004). Every participant was given a patient handbook which 
was referred to from time to time during the workshop.  
87 
5.4.3  Conventional Therapy 
Participants allocated to the CG followed their routine visit to the physicians and 
received medicinal therapy which uses to relieve airway construction, suppress 
inflammation, coughing and sputum production. Prescribed medications used in 
Macau for relieving airway construction include short-acting β2 agonists, 
short-acting anticholinergics, combined relievers, preventers (inhaled corticosteroids), 
long-actingβ2 agonists and combined preventers. In addition, oral theophylline for 
relieving wheezing and corticosteroids for relieving cough and sputum production and 
suppressing airway inflammation would have administrated if needed. For patients 
suffering from dyspnoea or hypoxia, oxygen therapy was given. 
5.4.4  Section Summary 
A SMEP was developed under the MRC (2008) framework for developing and 
evaluating complex intervention. As in a theoretical and modeling phase, both illness 
perception and self-efficacy beliefs were incorporated in the education programme 
development in order to enhance these two aspects when engaging in 
self-management. The SMEP comprises self-management education workshop, a 
patient handbook and telephone follow-up for six months after the workshop. The 
protocol of the self-management education workshop has high content validity in 
COPD education component, whereas only bronchodilators management showed 
high validity and was included in the action plan component of the workshop. The 
workshop has been piloting on four COPD patients and it was in overall 
understandable and acceptable among them. The finalized SMEP was performed on 
the SMG participants while the control group received conventional therapy which 
included routine medical treatment for COPD. After conducting the intervention, 
relevant assessments were done to evaluate its impact on the participants. The next 
section will present the methods for analyzing and interpreting data collected from 
the quantitative and qualitative strands, and the approach for mixing these data. 
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5.5  Section Five  Data Analysis 
5.5.1  Introduction 
This section covers the technical aspects of analyzing and interpreting the data 
collected. To analyzing quantitative data, SPSS 13.0 software was used to produce 
descriptive and inferential statistics. On the other hand, the qualitative data was 
viewed as subjects’ expression of unique experiences which embedded with 
meanings. Thematic analysis based on a constructionist approach was adopted to 
analyze the focus groups and interpret the emerging themes (Silverman, 2011). Thus, 
in this section, the quantitative data analysis will be addressed first, followed by 
qualitative data analysis and the mixing of quantitative and qualitative data will be 
covered in the last part of this section. 
5.5.2  Quantitative Data Analysis 
All numeric data was assessed for pattern of distribution using the skewness and 
kurtosis statistics or Kolmogorov-Smirnov Z test (De Vaus, 2002). When distribution 
of the data measurement was normal, parametric methods were used where meeting 
the assumption for execution including independent t-test (F) and Pearson’s product 
moment correlation coefficient (Pearson’s correlation, r). When distribution was not 
normally distributed, non-parametric methods were used accordingly including 
Mann-Whitney U-test (U), Wilcoxon signed rank test (Z) and Spearman’s rank-order 
correlation coefficients (spearman’s correlation, rho). For analyzing categorical data, 
I used chi-square (χ2) to examine the relationship between variables by assessing the 
statistical significance of a contingency table (Argyrous, 2005). Statistical 
significance was set at the level of p < 0.05. The following paragraphs will give a 
detailed presentation of the specific statistical methods used in relation to three 
aspects namely the demographic data, primary and secondary outcomes. 
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5.5.2.1  Demographic data analysis 
Descriptive analysis demonstrated the demographic conditions as well as the 
comparable properties of the participants. Mean, standard deviation (SD), frequency 
as well as percentage were computed to demonstrate the participants’ demographic 
characteristics and clinical characteristics. To compute the baseline comparison of 
both SMG and CG, I did independent t-test on normally distributed clinical variables, 
for instances, ‘age’, ‘post-BD FEV1‘, ‘post-BD FEV1% predicted’ and ‘number of 
concomitant diagnosis’, while I did Mann-Whitney U-test on non-normally 
distributed variables, for instances, ‘sex’, ‘years of diagnosis’, ‘amount of smoking in 
pack years’, ‘mastery rate of all inhalers’, ‘amount of smoking in pack year’, 
‘number of unplanned visit to MD or ER’ and ‘days of hospitalized’. Nominal or 
ordinal variables such as ‘sex’, ‘education level’, ‘smoking habit’, ‘working 
condition’, ‘marital status’, ‘living condition’, ‘medical expenses’, ‘long-term 
treatment’, ‘frequency of using SABA’ and ‘flu vaccination’ were analyzed with 
chi-square to compare between SMG and CG, of which Yates’ continuity correlation 
was particularly used in comparing variables with cells having five to nine cases and 
Fisher’s exact test used in comparing variables with cells having less than five cases 
(Plichta and Garzon, 2009).    
5.5.2.2  Primary and secondary end outcomes analysis 
This paragraph presents statistical methods which possibly provide findings 
capturing research aim one and two covering the primary and secondary outcomes of 
this study. Firstly, to compare the scores of self-efficacy, illness perceptions, mastery 
rate of inhalation skills, pulmonary function, and health-related quality of life 
between SMG and CG, independent t-test or Mann-Whitney U-test was utilized. Both 
tests can be used when the grouping variable is dichotomous, the measures of each 
value of the variable constitute an independent random sample and the variable is an 
interval or ratio, while Mann-Whitney U-test can also be used when the variable is 
ordinal and the total sample size is at least eight (Plichta and Garzon, 2009). These 
comparisons were performed at T0 and T2 to examine for statistical difference in 
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post-test outcomes between the two groups in compared with their baseline 
assessment. Secondly, paired t-test or Wilcoxon signed rank test was utilized to 
compare the above scales between T0 and T2 or T1 and T2 within groups. The paired 
t-test can be used with confidence, and there is a lower risk of error if just a few 
assumptions are violated, the sample size is large, the data are not too skewed, and 
there is a fairly large range of values. The Wilcoxon matched-pairs test has fewer 
assumptions and can be used with ordinal-, interval-, or ratio-level data. It assumes 
that there are at least five paired measures to compare (Plichta and Garzon, 2009). 
Although these tests involve multiple testing that may lead to accuracy problems, the 
testing variable can be measured on the same person at two different points in time. 
Therefore, they can examine the effects of the intervention on SMG in compared 
with CG. Thirdly, Pearson’s correlation can identify factors positively or negatively 
associated with the participants’ outcomes. Provided that the total and all subscales 
scores of IPQ and CSES were normally distributed, Pearson’s correlation was run to 
assert relationship between the illness perception and self-efficacy of the participants. 
Moreover, to further examine factors associating with the illness perception, 
self-efficacy and health-related quality of life of the participants, Pearson’s 
correlation or spearman’s correlation was computed. This examined their association 
with the demographic characteristics of the participants. In summary, these tests 
possibly revealed the effects of the SMEP if statistical significances were found 
between groups or within groups in time, given that homogenous features were 
identified in both groups and all external factors were held constant.  
5.5.3  Qualitative Data Analysis 
Focus group, as a qualitative method of data collection, is not intended to infer, 
generalize or make statement about the population, but to understand and provide 
insights about how people perceive a situation (Krueger, 1988). In particular, it 
anticipates to making significant meaning construction among participants on the 
focused topic. In the following, I discuss the data analysis of focus groups in the view 
of the choice of approach for analysis and how did I conduct the analysis.  
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5.5.3.1  Understanding Data Analysis for Focus Groups  
Conventional approaches utilized for analyzing focus group were content analysis and 
thematic analysis. Although many claimed the homogenous nature of both approaches, 
qualitative research experts tried to categorize them under the name of quantitative 
content analysis and qualitative thematic analysis (Silverman, 2011). Morgan (1997) 
upheld that descriptive counting in content analysis is especially useful to make 
comparisons within and across focus groups, with Frankland and Bloor (1988) added 
more weight to content analysis by stating that systematic counting prevents 
impressionistic assumptions (Frankland and Bloor, 1988). On the contrary, others 
argued that content analysis simply gives access to how people talk about their 
experiences or view of the world while thematic analysis aims to ground interpretation 
of meaning from how people lived in the social world (Braun and Clarke, 2006, 
Silverman, 2011). In contrast, Silverman (2011) tried to infer the lost sight of the 
whole with thematic analysis and assert the superiority of constructionist approach 
over thematic analysis by grasping the process as well as content within the focus. 
Nonetheless, I found that this attempt of making distinct differentiation between 
thematic analysis and constructionist analysis has overlooked the constructionist 
stance bearing in the thematic approach. Thematic analysis is, in essence, sharing the 
stance of the constructionist paradigm which views how events, realities, meanings, 
experiences, and it also explores the product of a range of discourses and interaction 
operating within society or between individuals (Braun and Clarke, 2006). Group 
dynamic demonstrates how accounts are articulated, censured, opposed and changed 
through social interaction (Barbour and Kitzinger, 1999). It was persuasive to think 
that thematic analysis conducted within a constructionist stance is not merely 
dependent on quantifiable measures or patterning response or meaning within the 
data set, it also focuses on the socio-cultural contexts and structural conditions by 
taking both salient and latent themes into consideration.  
In this line of reasoning, I adopted thematic analysis in this study to analyze the 
focus group data. Focus group data, in this sense, was seen to tap into the process of 
social knowledge formation. I, as a researcher, utilized thematic analysis to examine 
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how such knowledge emerged in group interactions within a specific context. Group 
interactions in the focus groups present a social environment, so conducting focus 
group data analysis should avoid lifting comments out of context and out of sequence 
and should capture when and how participants modify or even reverse their positions 
in the interacting process (Krueger, 1988). Knowledge developed this way in regard 
of SMEP should largely be the constructs of negotiation and interpretation of 
meaning between the participants and me, as the researcher. After determination of 
employing thematic analysis for analyzing the focus groups I will look into the 
concrete steps of implementation in the next paragraph. 
5.5.3.2  Conducting Focus group data analysis 
5.5.3.2.1  Transcribing and Coding 
Analyzing focus groups, resembling other qualitative approaches, has to transcribe 
the focus group recordings, and then proceed to coding, categorizing and theme 
development. As thematic analysis captures not only what people talk about things, 
but also how people talk through it and their interaction in that specific context, I 
decided to transcribe the three focus groups in the discourse level which detains the 
pitch and volume of the participants’ speech and the dynamic of the group (Gibbs, 
2007) (Transcript symbols and sample of transcript refer to appendix 17 and 18 
respectively). This formed the foundation for further constructionist thematic 
analysis. Since the focus groups were conducted in Cantonese, they have been 
translated into English by independent translator who can comprehend both 
Cantonese and English fluently. Then, analysis started with in-vivo coding which is a 
process of attuning myself to the participants’ language, perspectives, and 
worldviews through reading the transcripts and the tapes (Saldana, 2009). After 
finishing the initial coding, the coding scheme has been examined; evaluated for 
meaning, trends, and relationships; and refined by clarifying the terminology and 
definitions to ensure dependability (Bryman, 2008). 
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5.5.3.2.2  Developing Categories and Theme  
Coding further enables the organization and grouping of similar coded data into 
categories and thus identifies a pattern (Saldana, 2009). I compared the various 
categories with each other and some consolidated in a way that I felt the “meaning” 
of the data was transcended and I progress to a more general and more abstract 
construct, namely a theme. A theme is a phrase or sentence that distinguishes what a 
unit of data tells and/ or means (Saldana, 2009). Theme and categories were 
re-examined by repeatedly comparable reflection on participants’ meanings and the 
patterned codes. Reflection was done by drawing the context in the analysis in order 
to grasp a full view of the phenomenon. Barbour depicted this concept as follows:   
“Rather than simply seeking to identify the views of the various participants, 
attention to the context in which comments are made and the exchanges 
between group members allows us to develop an analysis that takes account 
of the complexities involved, including the explanations, justifications and 
tentative hypotheses advanced by people taking part in our research.” 
(Barbour, 2007) (Barbour, 2007, P. 136) 
As I am the only researcher in the study, inter-coder agreement was not the main issue 
in the study. An academician who is expert of qualitative research has helped to 
review a sample of transcribed data, the coding scheme and themes identified. This 
process assured the confirmability and trustworthiness of the findings (Bryman, 2008). 
5.5.3.2.3  Reflexivity in Analyzing Process 
Group is the main unit of analysis where captures the group interaction combining 
both observation of interaction and access to the verbal expression of the participants 
(Krueger, 1988, Barbour, 2007). After then, I interpreted the findings by stepping back 
from the detailed results and advancing their larger meaning in view of the research 
problems, questions in a study, the existing literature and personal experiences 
(Creswell and Plano Clark, 2011). On the contrary, the relationship between the 
researcher and the researched may be challenged by accused of affecting the practical 
adequacy of knowledge claims. However, there was argument that thinking is never 
emotion-free. Emotion should not or could never be partitioned from reasoning, but 
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should be understood and reflected on during research process (Bondi, 2005). 
Reflexivity is identified as an anchor of a researcher in self-sensations and 
self-knowledge and is defined by Gray as follows :   
“Research reflexivity, predominantly understood as the researcher’s engagement 
with her own positioning in relation to the world she is researching, and/or the 
self-conscious writing up of research as itself an act of representation, is currently 
invoked as a way of addressing the presence of the knower in the known and vice 
versa  (Gray, 2008).
.
In this case, by applying reflexivity in data interpreting process, here I demonstrate an 
inquiry on the formative conditions all along the process by self-consciously 
addressing my biographical relationship to the topic and the instability between the 
research text and the object of the study in terms of divergent voices or contradiction to 
potential readings. This enables me to have access to opportunities to discuss 
emotional experiences of research in confidence and non-prescriptively (Liz Bondi 
2005). I believe reflecting on my own emotional experiences as such serves to develop 
rich understandings of what it is. According to Reinharz (1997), the researcher should 
examine the various aspects of ‘selves’ in that specific research situation (Reinharz, 
1997).   
My biographical relationship to the topic: 
 Research-based selves – being a PhD student, executor of the intervention, 
being the contact person of the participants throughout the process, being a 
registered nurse with respiratory nursing experience. 
 Brought selves – being Macanese, being a daughter of a man who has no 
COPD but has smoked for 40 years, being a nurse with 10 years experiences in 
teaching and practicing respiratory nursing in Macau. 
 Situationally created selves – being a nurse not attached to the hospital, being a 
listener, being a researcher, being an instructor. 
Being the researcher as well as intervention executor of this study, I acknowledge that 
I had the advantage of better understanding the background and contextual 
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characteristics of the participants. However, my personal affection for the success of 
the intervention might have biased the interpretation on the participants’ responses. 
The participants might accept to be interviewed with the motivation of anticipating for 
more health information or to help the researcher by showing appreciation for the free 
‘service’ (workshop). 
To conclude, I have considerably discussed the deliberation of the choice for the 
approach of focus group data analysis. Also, I have delineated the naturally social 
interactive form of focus group and how does this element integrate into the analyzing 
process. It is apparent that data analysis of focus group is by no means separated from 
the design of the study and the epistemological stance employed in the study. 
Therefore, I employed thematic analysis which bore an underlying constructionist 
ground to analysis the focus groups. After then, it is critical to appropriately combine 
the qualitative findings with the quantitative results. The approach of data mixing will 
be provided in the following section. 
5.5.4  Mixing of Quantitative and Qualitative data 
As an embedded design with a combination of concurrent and sequential approaches, 
data analysis was accordingly conducted with different avenues in different phases. 
Integration of two sets of different forms of data and their results in a meaningful 
way can be challenging, it is important to articulate the strategies employed (Bryman, 
2007). In the concurrent phase, the quantitative and qualitative data were analyzed 
separately as they answered different research questions (Creswell and Plano Clark, 
2011). In the sequential phase, the secondary qualitative data was collected after the 
acquiring the quantitative results in the concurrent phase. Connected mixed methods 
data analysis was considered as a specific strategy for interpreting sequential results. 
In this strategy, the analysis of the first data set was connected to data collection in 
the second data set. Analysis was focus on how the second data set could build on 
what was learned in the quantitative data set (Creswell and Plano Clark, 2011). This 
involved mixed methods interpretation which looked across the quantitative results 
and the qualitative findings and made an assessment of how the information 
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addressed the mixed methods question in the study. This mixed methods 
interpretation is called “meta-inferences” and its definition is:   
“Inferences in mixed methods research are conclusions or interpretations drawn 
from the separate quantitative and qualitative strands of a study as well as across 
the quantitative and qualitative strands, called meta-inferences.” (Creswell and 
Plano Clark, 2011, P. 212) 
Applying the definition to the present study design, meta-inferences referred to the 
notion that the follow-up qualitative data would provide a better understanding of the 
problem than merely using the quantitative results. Meta-inference should be drawn 
at the end of the study and included in the larger interpretation in the discussion and 
conclusion of the study (Creswell and Plano Clark, 2011). Moreover, regarding 
addressing the mixed methods question, meta-inferences needed to be responsive to 
answering a question such as: To what extent do the qualitative follow-up findings 
explain the participants’ reactions to self-management intervention? It was to connect 
the primary and secondary results in a way to give an interpretation for responding to 
the question. 
5.5.5  Section Summary 
This section has addressed the approaches for analyzing the quantitative and 
qualitative data collected in this study. Distribution of data was carefully examined to 
identify the use of parametric or non-parametric statistical methods. The quantitative 
data was analyzed with SPSS software to examine the baseline assessment with 
descriptive statistics and to differentiate the impact of the intervention between SMG 
and CG with inferential statistics. In terms of qualitative data analysis, thematic 
analysis based on a constructionist approach was employed to analyze and interpret 
the focus groups. The quantitative and qualitative findings were connected to 
produce meta-inferences that responded to answering the proposed mixed methods 
questions.    
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5.6  Summary 
This chapter is divided into five sections which provide a detailed account of 
embedded design associated with experimental design, complex intervention and 
mixed methods. In section one, a pragmatic foundation was embraced to 
accommodate mixed methods in this study as pragmatism was flexible enough to 
respond to both confirmatory and exploratory research questions of the practical 
context suggested. An exploratory RCT with mixed methods (quantitative method 
and qualitative method) was employed with reference to MRC (2008) framework for 
developing and evaluating complex intervention. These methods were mixed in 
concurrent and sequential approaches during the process data collection. In section 
two, randomized sampling in block randomization approach was proposed for the 
RCT and purposive sampling was adopted for the qualitative strand. In section three, 
the methods of data collection were presented in terms of primary outcomes (illness 
perception, self-efficacy and inhaler usage technique) and secondary outcomes 
(post-BD FEV1, post-BD FEV1% predicted, frequency of using rescue medication 
and healthcare utilization, generic and disease-specific HRQoL) and supplemental 
data (focus groups). Measures used for assessing primary and secondary outcomes 
were delineated with respect to the construct, validity and reliability of each measure. 
On the contrary, focus group is defended for exploring the subjective experiences of 
self-management of the participants. In section four, the process of the development 
of the intervention, SMEP, was introduced in accordance with the MRC guideline, 
and its expert validity and pilot exercise were addressed. The validated SMEP was 
allocated to SMG while conventional therapy was given to the CG. In section five, 
the rationale for the application of descriptive and inferential statistics for the 
quantitative data was given, while thematic analysis with a constructionist ground for 
analyzing focus groups was explained. Subsequently, meta-inferences could be 
produced from the connection and interpretation of both sets of findings. In the next 
chapter, the quantitative results will be presented in respect of primary outcomes and 
secondary outcomes of this study.
99 
Chapter Six  Quantitative Results 
100 
6.0  Introduction 
The study examined the SMEP for COPD patients in Macau. The results are 
presented in four parts in this chapter. Part one presents the basic characteristics of 
the samples in terms of demographic data and clinical data to give an overview of the 
sample recruited. This part also includes the comparison of these basic characteristics 
between the SMG and CG. Part two presents results of the primary end outcomes 
including illness perception, self-efficacy and inhaler technique, and secondary end 
outcomes including pulmonary function, healthcare utilization, generic HRQoL and 
disease-specific HRQoL. Significant differences between the SMG and CG and 
within groups at pre- and post-test are displayed in relevant tables to indicate the 
effects of SMEP on these measures. Part three presents the bivariate correlation 
statistics of illness perception and self-efficacy to examine the relationship among 
concepts in these two beliefs adopted in the theoretical framework of the study. Part 
four presents the inter-relationship of basic characteristic variables and significant 
variables of the above two beliefs by using a correlation matrix. This demonstrates 
factors which are positively or negatively associated with the illness perception and 
self-efficacy of participants.     
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6.1  Part One  Sample characteristics 
6.1.1  Demographic characteristics 
The overall characteristics of the recruited 50 participants are showed in table 4. The 
mean age of the participants was 67.9 (SD 10.2) and it ranged from 44 to 87 years. 
74% (37 participants) were male, 68% (34 participants) were either ex-smoker or 
current smoker whose amount of smoking made up a mean of 13.2 pack years (SD 
25.7). In relation to educational level, the majority of the participants was either in 
primary level (52%, 26 participants) or illiterate (14%, 7 participants). 78% (39 
participants) of them had no working experiences at all, were retired, unemployed or 
lost working ability due to disease(s). Most of the participants (74%, 37 participants) 
were married or were having a stable partner and 84% (42 participants) were living 
with partner and children or either side. Regarding the medical expenses, most 
participants adopted a mix of public medical coverage (72%, 36 participants) and 
self-payment (72%, 36 participants).   
6.1.2  Clinical characteristics 
Among all participants, 52% (26 participants) were diagnosed COPD while the 
others were either diagnosed of chronic bronchitis (32%, 16 participants) or 
emphysema (10%, 5 participants), of which 6% (3 participants) previously diagnosed 
asthma in their medical record were found to be fulfilling the diagnosis of COPD 
according to the GOLD’s (2008) spirometric classification of COPD in this study. 
Based on the GOLD’s classification of severity of COPD, 42% (21 participants), 
42% (21 participants) and 16% (8 participants) of the participants belonged to stage 
II, III and IV respectively. The average year of being diagnosed of COPD was 8.4 
(SD 8.6) (range 1.0-30.0). Their post-bronchodilator FEV1 % predicted was 
averagely 47.9% (SD 16.5) (range 15.0-79.0) with an associated mean 
post-bronchodilator FEV1/FVC at 49.1 (SD 11.0) (range 27.7-69.8). 72% (36 
participants) had at least one concomitant disease and the mean number of concomit- 
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Table 4  Basic characteristics of the sample
Mean 
(n = 50) SD Frequency %
Demographic  characteristics
Sex 
Male       37 74
    Female       13 26
Age     67.9 10.2
Education level (n = 42) 
Illiteracy (Non-educated)     7 14.0
    Primary level      26 52.0
    Secondary level       15 30.0
    Tertiary level or above     2 4.0
Smoking habit 
Non-smoker      16 32.0
    Current smoker      12 24.0
    Ex-smoker      22 44.0
Amount of smoking in pack year  (SD)  13.2 25.7
Working condition 
Retired or Never work     24 48.0
    Currently working     11 22.0
    Unemployed       5 10.0
    Lost working ability due to  disease     10 20.0
Marital status 
Single       3 6.0
    Married       37 74.0
    Divorced or widow     10 20.0
Living condition 
Live alone      5 10.0
    Living with partner or children    18 36.0
    Living with partner and children    24 48.0
    Living with relatives or friends    3 6.0
Medical expense 
Public medical coverage     36 72.0
    Self-payment      36 72.0
    Paid by patients’ families     14 28.0
    Medical insurance     2 4.0
    Charity support      9 18.0
    Others       1 2.0
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Table 4  Basic characteristics of the sample (Continued)
Mean 
(n = 50) SD Frequency %
Clinical characteristics
Diagnosis 
    Emphysema      5 10.0
    Chronic Bronchitis     16 32.0
    COPD       26 52.0
    Others       3 6.0
COPD Classification  
Stage II       21 42.0
    Stage III      21 42.0
    Stage IV      8 16.0
No. of years of being diagnosed 8.39 8.62
Long-term treatment for respiratory condition  40 80.0
Pulmonary function 
  Post BD FEV1    1.10 0.51
  Post BD FEV1% predicted   47.9 16.5
Number of concomitant diagnosis 1.18 0.98
-tant disease was 1.18 (SD 0.98) (range 0 – 4), and from the most common one to the 
least one, they were cardiovascular disease, skeletal-muscular disease, endocrine 
disease, urinal disease, gastroenterological disease, ophthalmological and 
otorhinolaryngological disease respectively. 20% (10 participants) was not treated for 
their respiratory conditions.
6.1.3  Baseline characteristics of experimental group and control 
group 
Baseline characteristics of the participants (26 participants in SMG and 24 in CG) are 
presented in Table 5. Although the SMG showed a higher percentage of females 
(76.9%, 10 participants) than CG (23.1%, 3 participants), Fisher’s test did not show 
significant difference (p=0.054). Another potential factor influencing the effects of 
the intervention could be the treatment received by the participants, here in table 6 
indicates the participants’ treatment in terms of the severity of the disease for 
reference. For all the other variables, both groups did not show statistical difference          
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Table 5 Baseline characteristics of the participants in SMG and CG 
 SMG 
(n = 26) (%) 
CG 




Number of patients 
Before intervention (T0)




    Female 
Age Ϫ (SD) 
Education level (n = 42) 
Illiteracy (Non-educated)
    Primary level
    Secondary level 
    Tertiary level or above
Smoking habit
Non-smoking
    Current smoker
    Ex-smoker
Amount of smoking in pack year(SD)
Working condition 
Retired or Never work 
    Currently working 
    Unemployed  




    Married  
    Divorced or widow 
Living condition 
Live alone 
    Living with partner or children 
    Living with partner & children 

































































Table 5 Baseline characteristics of the participants in SMG and CG (Continued)
SMG 
(n = 26) (%) 
CG 





Public medical coverage 
    Self-payment
    Paid by patients’ families 
    Medical insurance 
    Charity support 
    Others 
Clinical characteristics
Diagnosis 
    Emphysema
    Chronic Bronchitis
    COPD
    Others 
COPD Classification  
Stage II  
    Stage III
    Stage IV
No. of years of being diagnosed 
Pulmonary function 
    Post BD FEV1
    Post BD FEV1% predicted
Number of concomitant diagnosis 
Under long-term treatment for 
respiratory condition 
Inhalers used  
    MDI
    MDI + Spacer 
    Turbuhaler 
    Accuhaler 





























































Table 5 Baseline characteristics of the participants in SMG and CG (Continued)
 SMG 
(n = 26) (%) 
CG 




Rescue medication and Health care 
utilization in past 6 months: 
Frequency of using SABD 
    -    Never use 
    -    1-2 times/week 
    -    2-7 times/week 
    -    Once/ day 
    -    > once/ day 
No. of unplanned visit to MD or ER  
(SD) 

























* Median (95% Confidence interval) 
Table 6  The treatment that participants received at pre-intervention assessment  
Stage II Stage III Stage IV Treatment received 































































































































in terms of age, diagnosis, pulmonary function, staging of disease, number of 
concomitant disease, smoking habit, education, rescue medication and health care 
utilization and flu vaccination received in past 6 months before the trial. I could 
assume that both groups were well matched and the participants of the two groups 
probably came from the same population and were randomly allocated into two 
groups. This minimized the risk of committing type II error and the two groups could 
be presumed as comparable in the trial. 
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6.2  Part Two  Primary outcomes and Secondary outcomes 
6.2.1  Primary outcomes 
6.2.1.1  Illness Perception  
6.2.1.1.1  Identity Dimension 
The illness perception outcomes are demonstrated in three sections which include 
identity dimension, illness representation dimension and causal dimensions 
respectively. Firstly, the mean score for the illness identity dimension was 4.69 
(SD=2.63) with the maximum of 11.0 (Table 7). Among the given 13 symptoms, the 
most often identified symptom was breathlessness (98%, 48 participants), followed 
by sleeping difficulties, fatigue and loss of strength, etc. In the meantime, the 
participants also identified pain (16.3%, 8 participants) and stiff joints (14.3%, 7 
participants) as the identity of their COPD condition. 
Table 7  Identity dimensions perceived by COPD patients 
Range
Mean (SD) Min Max 
Believed to be 
related to COPD 
(n = 49) %
Identity subscale 0-13 4.69 (2.63) 0.0 11.0  
Symptoms
  Pain 8 16.3
  Sore throat 14 29.6
  Nausea 9 18.4
  Breathlessness 48 98.0
  Weight loss 22 44.9
  Fatigue 30 61.2
  Stiff joints 7 14.3
  Sore eyes 2 4.1
  Headache 8 16.3
  Upset stomach 5 10.2
  Sleeping difficulties 31 63.3
  Dizziness     9 18.4
  Loss of strength 25 51.0
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6.2.1.1.2  Illness Representations 
Table 8    Comparison between experimental and control group on illness  
            representations dimension at T0 and T2. 










SMG CG SMG CG 
 (n = 26) (n = 24)  (n = 23) (n = 19)
Identity(range1-14) 4.36 (2.61) 5.09 (2.67) 0.05(0.83) 5.00 (3.66) 6.11 (3.23) 1.07(0.31)
Timeline 3.49 (0.84) 3.43 (0.91) 0.02(0.89) 3.90 (0.93) 3.81 (0.79) 0.07(0.79)
Consequences 3.43 (0.68) 3.12 (0.76) 1.17(0.29) 3.40 (0.96) 2.94 (0.69) 2.77(0.10)
Personal control 3.27 (0.62) 3.40 (0.76) 1.04(0.31) 3.28 (0.72) 3.06 (0.77) 0.15(0.70)
Treatment control 3.34 (0.51) 3.21 (0.69) 1.45(0.24) 3.12 (0.75) 3.38 (0.74) 0.03(0.87)
Illness coherence 2.87 (0.74) 2.85 (0.79) 0.00(0.98) 2.73 (0.96) 2.76 (0.84) 0.36(0.55)
Timeline cyclical 3.42 (0.70) 3.45 (0.96) 2.14(0.15) 3.60 (0.86) 3.36 (0.74) 0.58(0.45)
Emotional 
representations 
3.27 (0.85) 3.19 (0.94) 0.69(0.41) 3.18 (0.99) 2.89 (0.98) 0.37(0.55)
Table 9   Comparison of median differences in illness representations between T0 
and T2. 
Subgroup SMG   Median Z CG  Median  Z 
(range 1-5) (range#) p-value (range#) p-value
T0 (n=25) T2 (n=23)   T0 (n= 23) T2 (n=18)
Identity  4.00 4.50 -0.88 5.00 5.00 -1.86 
(range1-14) (2.00-6.00) (1.00-8.50) 0.38 (3.00-7.00) (4.75-7.25) 0.06 
Timeline  3.67 4.00 -2.47 3.50 4.08 -1.84 
(2.67-4.17) (3.50-4.71) 0.013* (2.67-4.17) (2.96-4.54) 0.06 
Consequences 3.67 3.58 -0.29 3.00 2.67 -0.22 
(3.00-3.83) (2.29-4.07) 0.78 (2.50-3.83) (2.50-3.67) 0.83 
Personal control 3.33 3.33 -0.14 3.67 3.00 -2.43 
(2.67-3.75) (2.67-3.71) 0.89 (2.83-3.83) (2.33-3.75) 0.015*
Treatment  3.20 3.20 -1.11 3.20 3.50 -0.24 
 control (3.00-3.90) (2.80-3.60) 0.27 (2.80-3.80) (2.70-4.00) 0.81 
Illness  3.00 2.90 -0.94 2.80 2.40 -0.52 
 coherence (2.40-3.50) (2.00-3.45) 0.35 (2.40-3.60) (2.15-3.60) 0.60 
Timeline cyclical 3.50 3.50 -0.90 3.50 3.50 -1.03 
(3.00-3.75) (3.00-4.25) 0.37 (3.00-4.25) (2.69-4.06) 0.30 
Emotional  3.33 3.25 -0.09 3.17 2.50 -0.69 
 representations (2.58-4.00) (2.33-3.88) 0.93 (2.33-3.83) (2.00-3.83) 0.49 
# Interquartile range;  * p-value < 0.05    
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According to Weinman and colleauges (1996), the mean scores for each subscale can 
be assessed with the neutral point of 3. Hence, the sample of this study had six 
subscales (‘Timeline acute/chronic’, ‘consequences’, ‘personal control’, ‘treatment 
control’, ‘timeline cyclical’ and ‘emotional representations’) with mean scores 
greater than 3 and one subscale (‘illness coherence’) lower than 3. Independent t-test 
showed that there was no significant difference at T0 and at T2 between the SMG 
and the CG (Table 8). On condition that the total number of paired cases is less than 
30, Wilcoxon signed ranks tests rather than paired t-tests are appropriate to determine 
whether there were any differences between the median scores at T0 and T2 for each 
group (Plichta and Garzon, 2009). Results revealed that scores on most of the eight 
IPQ-R subscales had remained unchanged, however, there was a significant increase 
in the median score in ‘timeline acute/chronic’ for the SMG (Z = -2.47, P = 0.013) 
(Table 9). A significant decrease in the median score from 3.67 to 3.00 (Z = -2.43, P = 
0.015) was found in the CG in ‘personal control’.  
6.2.1.1.3  Causal Dimension 
In the causal dimension, the results of self-report causal items and degree of causal 
attribution are presented. Among all self-report causal items, the highest reported 
item was ‘don’t know or never thought of’ (52%) in the participants, implying that 
they have no idea of or they have never thought of the causes of their disease. It was 
followed by ‘smoking’ (44%) and ‘pollution’ (38%) (Table 10). Overwork (24%) 
was the fourth highest reported factor considered influential in COPD and there was 
a vast report of causal agents (40%) identified beyond the given 18 causal items, for 
instances, recurrent flu, malnutrition, cold weather, poor living condition, exposure 
to chemicals, and others. In addition, there was a more obvious drop in reporting 
‘don’t know or never thought of’ in the SMG at T2 (24%) from T0 (5%) than that 
was in CG (from 28% to 12%). The SMG also had a higher increase in reporting 
‘smoking’ and ‘environment pollution’ to be causal agents at T2 from T0 than CG 
did. Nonetheless, ‘overwork’ and ‘others’ remained highly mentioned at the two time 
points. 
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Table 10  Self-report causal attributions for COPD 
Causal agent   Percentage of patients reporting causal agent (%) 
 Total SMG CG 
    T0 (n=50) T0 (n=26) T2 (n=23) T0 (n=24) T2 (n=19)
Don't know or never thought of 52 24 5 28 12 
Smoking  44 24 29 20 10 
Pollution in the environment 38 14 24 24 20 
Overwork  24 18 24 6 12 
Altered immunity  20 14 15 6 12 
Ageing  18 12 15 6 24 
Alcohol  12 6 7 6 7 
Poor medical care in my past 12 8 2 4 12 
Hereditary  10 4 10 6 7 
Stress or worry  10 6 5 4 0 
A germ or virus  8 0 2 8 7 
Diet or eating habits  6 2 2 4 5 
Accident or injury  2 0 0 2 0 
Family problems or worries 2 2 0 0 0 
My emotional status  2 2 0 0 0 
My own behaviour  0 0 5 0 0 
Others   40 20 15 20 12 
With regard to the degree of causal attribution (See Table 11), no attempt was made 
to compute comparison within groups in the causal dimension as there is a too 
diverse or sparse distribution in each item to perform an adequate statistical analysis. 
To examine the average score of overall items, the SMG was more inclined to 
attribute their illness to their immune status and risk factors than to psychological 
status and to chance/accident. Items most strongly agreed by the participants as 
causal attribution to COPD were ‘altered immunity’ (T0 : 3.98, T2 : 4.00), 
‘environmental pollution’ (T0 : 3.57, T2 : 3.68)  and ‘ageing’ (T0 : 3.70, T2 : 3.68) 
respectively. Wilcoxon signed ranks test was performed to compare the subscales 
between groups and the results showed that the participants held their illness 
attributive beliefs consistently in prior to and after the trial as no significant difference 
was found for both the SMG and CG at the two time intervals.
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Table 11 Comparisons of the IPQ – causal items perceived by patients in SMG at T0  
and T2.   
SMG     Causal dimensions 
  Subscale items T0 (n = 26)  T2  (n = 23) Z P-value
 (range 1-5) range Median (range#)/
 Mean (SD) 
Median (range#)/
 Mean (SD) 
Psychological attributions 6 - 30 17.0 (12.0-18.5) 15.0 (11.8-18.3) -1.20 0.23
  Stress or worry 2.76 (1.29) 2.35 (1.29)
  My mental attitude 2.37 (0.97) 2.08 (1.10)
  Family problems or  
    worries 2.29 (0.98) 2.10 (1.19)
  Overwork 3.32 (1.27) 3.23 (1.35)
  My emotional status 2.53 (1.19) 2.15 (1.12)
  My personality 2.29 (0.79) 2.05 (1.04)
Risk factor attributions 7 - 35 21.0 (18.0-23.5) 20.0 (17.8-24.0) -1.29 0.20
  Hereditary 2.60 (1.13) 2.45 (1.38)
  Diet or eating habits 2.71 (1.00) 2.55 (1.30)
Poor medical care in  
my past 
 3.22 (1.25) 3.00 (1.41)
  My own behaviour 3.21 (1.17) 2.98 (1.44)
  Ageing 3.70 (1.04) 3.68 (1.21)
  Alcohol 2.34 (1.14) 2.33 (1.31)
  Smoking 3.50 (1.53) 3.40 (1.60)
Immune attributions 3 - 15 10.5 (9.0-12.0) 11.5 (10.0-12.0) -1.03 0.30
  A germ or virus 3.08 (1.04) 3.25 (1.28)
  Pollution in the  
    environment 
 3.57 (1.16) 3.68 (1.07)
  Altered immunity 3.98 (0.92) 4.00 (0.78)
Chance attributions 2 - 10 5.5 (4.0-6.0) 4.0 (3.8-6.0) -0.26 0.80
  Chance or bad luck 2.53 (1.21) 2.45 (1.30
  Accident or injury 2.12 (0.75) 1.93 (0.92)
# Interquartile range.
6.2.1.2  Self-efficacy  
Table 12 shows the means and Z scores of the CSES by groups and overall sample in 
baseline analysis. For the mean scores of all samples, ‘physical exertion’ is the only 
subscale which scored below the mid-point of 3.0 (Mean 2.64, SD 0.66) and ‘intense 
emotional arousal’ had the highest score (Mean 3.30, SD 0.61). Due to skewed 
distribution in the measures of ‘weather/environment’ subgroup, Mann-Whitney 
U-Test was conducted to determine whether there were any significant differences 
between the scores for each group. There was no significant difference in all 
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subgroups and total score of CSES between the SMG and CG at both T0 and T2 
assessments.   
Wilcoxon signed ranks tests were done to identify whether there were any significant 
differences between T0 and T2 assessments for each group. As shown in Table 13, 
there were no significant differences found in all subgroups and total scores of CSES 
in the CG. In SMG, there was a significant increase from T0 to T2 in the total scale 
(Z = -2.44, P = 0.015) and three subgroups: ‘intense emotional arousal’ (Z = -2.54, P
= 0.01), ‘physical exertion’ (Z = -2.57, P = 0.01) and ‘weather/environment (Z = 
-2.63, P < 0.001).  
Table 12  The scores of total CSES and its subgroups and baseline comparison of 
SMG and CG 





  Mean (SD) SMG (n=25) CG (n=23)     
Negative affect 3.23 (0.63) 3.10 3.40 -0.73 0.47 
 (2.90-3.60) (2.60-3.90)
Intense emotional  3.30 (0.61) 3.10 3.40 -1.04 0.30 
  arousal  (2.95-3.65) (3.00-4.00)
Physical exertion 2.64 (0.66) 2.80 2.60 -0.35 0.72 
  (2.20-3.00) (2.20-3.00)
Weather/  3.17 (2.51) 2.80 3.00 -1.13 0.26 
  Environment   (2.20-3.10) (2.30-3.50)
Behavorial risk factors 3.25 (0.76) 3.00 3.00 -0.72 0.47 
  (3.00-3.50) (2.50-4.00)
Total CSES score   3.14 (0.79) 3.00 3.30 -0.86 0.39 
  (2.70-3.35) (2.60-3.60)
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Table 13   Comparison of mean differences in self-efficacy scores between T0 and 
T2 
Subgroup SMG   Median(range#) Z 
CG  
Median (range#) Z 
T0 (n=25) T2 (n=23) (P-value) T0 (n= 23) T2 (n=18) (P-value)
Negative affect 3.10 3.55 -1.81 3.40 3.60 -1.60 
(2.90-3.60) 3.10-4.00) (0.07) (2.60-3.90) (3.23-4.00) (0.11)
Intense emotional 3.10 3.70 -2.54 3.40 3.75 -0.71 
arousal (2.95-3.65) (3.10-4.10) (0.01)* (3.00-4.00) (3.00-4.03) (0.48)
Physical  2.80 3.00 -2.57 2.60 2.80 -0.83 
exertion (2.20-3.00) (2.20-4.00) (0.01)* (2.20-3.00) (2.55-3.40) (0.41)
Weather/ 2.80 3.50 -2.63 3.00 3.10 -0.36 
Environment (2.20-3.10) (2.70-4.0) (0.008)** (2.30-3.50) (2.45-3.55) (0.72)
Behavorial  3.00 3.50 -1.18 3.00 4.00 -0.63 
risk factors (3.00-3.50) (2.88-4.00) (0.24) (2.50-4.00) (3.00-4.00) (0.53)
Total CSES  3.00 3.50 -2.44 3.30 3.40 -1.00 
 score (2.70-3.35) (3.00-4.00)  (0.015)* (2.60-3.60) (2.90-3.73)  (0.32)
# Interquartile range 
* P-value <0.05; ** P-value < 0.01 
6.2.1.3  Accuracy of Inhaler technique 
The average accuracy of inhaler technique for the participants was 56.6% (SD = 21.2) 
in which there was no significant difference in both SMG and CG at baseline (F = 
3.2, P = 0.08) (Table 14). Among all inhalers, the mastery rate of MDI was the 
lowest (41.7%, range 33.3-58.3), followed by MDI using together with spacer 
(61.9%, range 47.5-69.2), handihaler (62.5%, range 56.3-64.1), turbuhaler (64.3%, 
range 55.3-78.6) and accuhaler (69.2, range 65.4-80.8). In Mann-Whitney U-test, no 
significant differences were found at T0 with the mastery rate of MDI (U = 109.5, P
= 0.71), MDI using together spacer (U=7.5, P = 0.54), Accuhaler (U = 0.5, P = 0.02) 
and handihaler (U = 10.0, P = 0.58) between SMG and CG. However, considering 
that the total number of samples using turbuhaler was less than eight (n = 6), related 
samples test had not performed on comparing the mastery rate of turbuhaler between 
groups (Plichta and Garzon, 2009). 
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Table 14  Mastery rate of inhaler usage and comparison of SMG and CG at T0. 
Types of inhalers Total  
























Turbuhaler   (n=6) 64.3 
(55.3-78.6) 














# Interquartile range 
* P-value <0.05      
Due to the small number of users of various inhalers, two combined groups of 
inhalers, namely ‘all inhalers’ and ‘dry powder inhalers’ are formed for computing 
comparisons between T0 and T1 and T2 (as showed in Table 15). Wilcoxon signed 
ranks tests showed that the mastery rates in SMG were significantly higher at T1 and 
T2 than T0 in terms of usage of all inhalers (T1 84.6% > T0 58.3, Z = 3.92, P = 
0.000); (T2 83.3% > T0 58.3%, Z = -3.92, P = 0.000), MDI (T1 75.0% > T0 50.0, Z
= -3.18, P = 0.001); (T2 83.3% > T0 50.0, Z = -3.30, P = 0.001), and dry powder 
inhalers (T1 87.5 > T0 62.5, Z = -2.37, P = 0.02); (T2 85.7 > T0 62.5, Z = -2.20, P = 
0.03). In the comparison between T1 and T2 in SMG, no significant differences were 
found on groups of all inhalers, MDI and dry powder inhalers. On the other hand, 
there was a significant difference in the median mastery rate of all inhalers group 
between T0 and T2 in CG (Z = -2.20, P = 0.04), but no significant differences in 
MDI (Z = -1.69, P = 0.09) and dry powder inhalers (Z = -1.27, P = 0.20). In 
Mann-Whitney U-tests, no significant differences were found between SMG and CG 
at T0 in mastery rate of all inhalers, MDI and dry powder inhalers, however, the 
median mastery rates of all inhalers at T2 were found significantly higher for SMG 
than CG (83.3% > 71.4%, U = 208.0, P = 0.045).   
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Table 15  Comparison of mastery rate of inhalers at different time points within and 
between groups 
6.2.2  Secondary outcomes 
6.2.2.1  Pulmonary function 
Comparisons of the post-BD FEV1 and post-BD FEV1 % predicted between T0 and 
T2 were computed by Wilcoxon signed ranks test and results were showed in Table 
16. There was significant increase in the post-BD FEV1 in both SMG (Z =  -2.27, P 
= 0.023) and CG (Z = -2.22, P = 0.027) between the two time points while no 
significant differences were found in the post-BD FEV1 % predicted accordingly. On 
condition that the measures of post-BD FEV1 and post-BD FEV1 % predicted were 
normally distributed and the total sample size was 42 at T2, independent t-tests were 
conducted to compare the two groups at T2 and there was no significant difference in 
the means of SMG and CG (See Table 17).  
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Table 16  Comparison of pulmonary functions between T0 and T2 for SMG and CG . 
     SMG (n = 23†)  Z  CG (n = 19†)  Z
  Median (range#) (P-value) Median (range#) (P-value)
    Tier 0 Tier 2   Tier 0 Tier 2   
Post-BD FEV1 0.99 1.12 -2.27 1.01 1.03 -2.22 
(0.70-1.51) (0.76-1.60) (0.023)* (0.61-1.54) (0.87-1.58) (0.027)*
Post-BD FEV1 % 48.0 49.0 -0.86 46.0 47.5 -1.87 
  predicted (38.3-64.5) (40.0-69.0) (0.39) (32.3-57.8) (38.0-68.0) (0.06) 
# Interquartile range 
* P-value <0.05 
 † refers to number of pairs for tesng
Table 17  Comparison of pulmonary functions between SMG and CG at T2. 
SMG (n = 26) CG (n = 24) F P-value 
Mean SD Mean SD     
Post-BD FEV1 1.19 0.49 1.23 0.54 0.02 0.81 
Post-BD FEV1%   
predicted 52.8 22.1 54.1 21.0 0.00 0.85 
6.2.2.2  Rescue medication and Healthcare utilization 
Wilcoxon signed ranks tests were conducted to compare the median of the above 
variables between T0 and T2 for the SMG and CG. As shown in Table 18, the 
participants of both groups adopted similar frequency in using the rescue medication 
and in paying visit to the MD and ER at T0 and T2. However, the SMG had less days 
of hospitalization at T2 than at T0 while the CG remained unchanged and this 
difference was statistically significant (T2 0.0 < T0 2.0, Z = -2.24, P = 0.025). In 
regard to the comparison between groups at T2, the Mann-Whitney U-test did not 
show any significant difference in the three variables (See Table 19).    
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Table 18  Comparison of rescue medication and health care utilization at T0 and T2 
between SMG and CG 
   SMG (n = 23†) Z  CG (n = 19†)  Z
 Median (range#) (P-value) Median (range#) (P-value)
  Tier 0 Tier 2   Tier 0 Tier 2   
Frequency of using    
SABD 
0.0       
(0.0-4.0) 




0.0    
(0.0-2.8)




  Never use f (%) 14 (53.8) 11 (47.8)  14 (58.3) 8 (42.1)
  1-2 times/week 2 (7.7) 2 (8.7)  2 (8.3) 2 (10.5)
  2-7 times/week 3 (11.5) 5 (21.7)  2 (8.3) 5 (26.3)
  Once per day 0 (0.0) 0 (0.0)  2 (8.3) 0 (0.0)
  > once per day 7 (26.9) 5 (21.7)  4 (16.7) 4 (21.1)
No. of unplanned  1.5 0.0 -1.17 1.0 1.0 -0.68 
  visit to MD or ER (0.0-4.0) (0.0-2.0) (0.24) (0.0-3.5) (0.0-3.0) (0.50) 
Days of hospitalized 2.0 0.0 -2.24 0.0 0.0 -0.66 
  (0.0-10.3) (0.0-0.0) (0.025)* (0.0-8.0) (0.0-0.0) (0.51) 
# Interquartile range 
* P-value <0.05 
 † refers to number of pairs for tesng.
Table 19  Comparison of medical utilization in past 6 months between SMG and CG 
at T2. 
    SMG (n = 23) CG (n = 19) U-test P-value
    Median Range# Median Range#
Frequency of using  
short-acting 
bronchodilator 
1.0 0.0-1.0 1.0 0.0-2.0 209.5 0.81 
No. of unplanned visit  0.0 0.0-2.0 1.0 0.0-3.0 179.5 0.29 
  to out-patient or  
  Emergency room 
Days of hospital admission 0.0 0.0-0.0 0.0 0.0-0.0 192.5 0.28 
# Interquartile range             
6.2.2.3  Generic health-related quality of life 
The mean SF-36 scores of all participants were shown in table 20. In general, their 
mean score for mental health summary (50.1, SD=9.1) was higher than that of 
physical health summary (39.6, SD=8.9). Among all subgroups, the mean bodily 
pain score was the highest (50.0, SD=12.8), followed by mental health (49.1, 
SD=8.6), vitality (48.6, SD-=12.1), role-emotional (45.8, SD=10.0), social 
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functioning (45.3, SD=12.7), role-physical (42.9, SD=10.3), physical functioning 
(40.3, SD=11.0), general health (32.2, SD=10.1). Provided that the ‘bodily pain’ 
measures were not normally distributed, Mann-Whitney U-test was done to compare 
the median of each SF-36 subgroups between SMG and CG at T0 and T2, however, 
no significant difference was identified in the U-statistics at both time points.  
Table 20  The scores of SF-36 and baseline comparison of SMG and CG  
Subgroup   Total  T0   Median (range#) U-test P-value
 Mean (SD)
  T0 (n=50) SMG (n=26) CG (n=24)     
Physical  40.3 (11.0) 41.3 (31.8-50.7) 40.2 (28.6-52.3) 305.0 0.89 
Functioning 
Role-Physical  42.9 (10.3) 43.4 (32.4-52.6) 44.6 (37.3-52.0) 260.0 0.43 
Bodily pain 50.0 (12.8) 48.4 (37.2-62.1) 62.1 (37.6-62.1) 272.0 0.57 
General Health 32.2 (10.1) 31.5 (23.4-38.2) 28.2 (23.4-41.6) 264.5 0.82 
Vitality 48.6 (12.1) 47.4 (39.6-56.0) 49.0 (45.9-55.2) 265.5 0.50 
Social Functioning 45.3 (12.7) 45.9 (37.8-55.9) 51.4 (35.0-56.9) 257.0 0.51 
Role-Emotional 45.8 (10.0) 44.2 (36.4-55.9) 48.1 (44.2-55.9) 236.0 0.20 
Mental Health 49.1 (8.6) 47.2 (43.0-54.2) 50.0 (44.4-55.6) 221.5 0.17 
Perception 
Physical health 39.6 (8.9) 39.9 (33.9-47.1)  40.7 (32.0-46.7) 263.0 0.80 
  summary 
Mental health 50.1 (9.1) 49.9 (42.7-55.2) 53.5 (46.4-60.6) 209.0 0.16 
  summary  
# Interquartile range     
In Table 21, the Wilcoxon signed ranks tests revealed that there was no significant 
difference in the median of each SF-36 subgroup between T0 and T2 for both SMG 
and CG. Among all subgroups, the participants of both groups scored their general 
health the lowest (median 26.7 – 35.3) throughout the two time points and they were 
much lower than the Hong Kong norm of 55.98 (95% CI : 55.17 – 56.78) (Lam, 
1999).  
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Table 21   Comparison of medians in SF-36 between T0 and T2 
Subgroup SMG   Median (range#) Z CG Median (range#) Z 
(n = 23†) (P-value) (n = 18†) (P-value)
Tier 0  Tier 2   Tier 0  Tier 2    
Physical  41.30 36.0 -0.99 40.20 38.1 -0.33 
  Functioning (31.8-50.7) (27.6-50.7) (0.32) (28.6-52.3) (29.7-52.8) (0.74) 
Role-Physical 43.40 42.2 -0.174 44.60 45.8 -0.88 
 (32.4-52.6) (29.9-54.4) (0.86) (37.3-52.0) (33.6-54.4) (0.38) 
Bodily pain 48.40 50.3 -0.63 62.10 52.8 -0.04 
(37.2-62.1) (33.0-62.1) (0.53) (37.6-62.1) (41.4-62.1) (0.97) 
General Health 31.50 26.7 -0.27 28.20 35.3 -1.14 
 (23.4-38.2) (25.8-44.8) (0.78) (23.4-41.6) (25.4-44.4) (0.26) 
Vitality  47.40 52.1 -1.33 49.00 50.5 -0.45 
(39.6-56.0) (45.9-58.3) (0.184) (45.9-55.2) (39.6-64.6) (0.65) 
Social   45.90 51.4 -0.27 51.40 56.9 -0.91 
  Functioning (37.8-55.9) (35.0-56.9) (0.79) (35.0-56.9) (40.5-56.9) (0.37) 
Role-Emotional 44.20 52.0 -0.50 48.10 50.0 -0.57 
  (36.4-55.9) (32.6-55.9) (0.62) (44.2-55.9) (39.4-55.9) (0.57) 
Mental Health 47.20 52.8 -1.27 50.00 58.5 -1.06 
  Perception (43.0-54.2) (44.4-58.5) (0.21) (44.4-55.6) (44.4-61.3) (0.29) 
Physical health 39.9 38.60 -0.79 40.7 39.7 -0.213 
  summary (33.9-47.1) (31.4-45.1) (0.43) (32.0-46.7) (34.0-47.7) (0.83) 
Mental health 49.9 52.60 -1.065 53.5 54.2 -0.024 
summary  (42.7-55.2) (42.0-59.5) (0.29) (46.4-60.6) (49.3-60.0) (0.98) 
# Interquartile range 
† refers to number of pairs for testing.
6.2.2.4  Disease-Specific health-related quality of life  
The results of SGRQ are presented in regard to the overall and subgroup scores of 
SGRQ, and scores comparison between groups and within groups. In Table 22, there 
were the scores for total SGRQ and its three subgroups. The participants scored most 
poorly in the ‘activity score’ with a mean score of 55.1 (SD = 24.1) and the best in 
‘impact score’ with a mean score of 43.1 (SD = 16.9). In the baseline comparison, 
independent samples t-test did not show any significant differences in the mean 
scores of the ‘total’ (F = 1.13, P = 0.29), ‘symptom’ (F = 1.17, P = 0.29), ‘activity’ 
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(F = 0.05, P = 0.83) and ‘impact’ (F = 0.12, P = 0.73) subgroups of SGRQ between 
the SMG and CG at T0, and so did not at T2. 
Table 22  The scores of total SGRQ and its subgroups and baseline comparison of 
SMG and CG 
Subgroup   All samples T0   Mean(SD)ᵟ F P-value 
  T0 (n=50) SMG (n=25) CG (n=23)     
Symptom score 47.9 (24.5) 48.1 (25.9) 47.6 (23.5) 1.17 0.95 
Activity score 55.1 (24.1) 54.2 (24.8) 56.1 (23.7) 0.05 0.77 
Impact score 43.1 (16.9) 44.5 (17.1) 41.6 (16.9) 0.12 0.55 
Total score   47.8 (16.1) 48.0 (17.7) 47.5 (14.5) 1.13 0.92 
ᵟ Higher score indicates worse quality of life.
Table 23   Comparison of SGRQ scores between T0 and T2 
Subgroup 
  SMG   Median (range*)ᵟ Z CG Median (range*)ᵟ Z 
 (n = 23†) (P-value)  (n=18†) (P-value)
  T0  T2    T0  T2    
Symptom  46.5 32.6 -2.04 50.7 39.6 0.00 
  score (24.7-70.0) (8.9-51.9) (0.042)* (26.6-66.9) (33.7-65.9) (1.00)
Activity  48.5 59.5 -0.94 48.1 47.5 -1.01 
  score (38.2-79.4) (35.1-80.3) (0.35) (38.3-77.6) (35.3-66.4) (0.31)
Impact 47.4 38.0 -0.34 39.1 34.2 -0.54 
  score (31.9-57.3) (22.7-58.2) (0.74) (28.1-52.6) (17.2-48.6) (0.59)
Total  47.0 47.1 -0.61 47.9 42.9 -0.33 
  score (31.4-61.3) (27.1-60.5) (0.54) (36.4-55.6) (28.0-58.6) (0.74)
# Interquartile range 
* P-value <0.05 
† refers to number of pairs for tesng.
ᵟ Higher score indicates worse quality of life. 
In Table 23, Wilcoxon signed ranks test revealed marginally significant decrease in 
the median in the ‘symptom score’ (Z = -2.04, P = 0.042) for the SMG across the two 
time intervals between T0 and T2 while that of the CG remained unchanged.  
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6.3  Part Three  Bivariate correlations for Self-efficacy and 
Illness representations 
In this section, the results of Pearson’s product moment correlation coefficient of the 
subscales of CSES and illness representations that explored the relationship between 
self-efficacy and illness perception beliefs in COPD patients are presented (as 
showed in Table 24). All variables, except ‘timeline acute/chronic’ of illness 
representations were found to be significantly correlated to one or more subscales of 
CSES. ‘Identity’ of illness representations was negatively correlated with ‘negative 
effect’, ‘intense emotional arousal’ and ‘total score’ of CSES. This relationship 
indicates that patients with more perceived symptoms were more likely to feel less 
confidence in managing difficulty in breathing at times of exacerbation and stressful 
condition and intense emotions. ‘Consequences’ and ‘timeline cyclical’ of the illness 
representations were positively and very significantly correlated with ‘negative 
effect’ and ‘total CSES’, and negatively and very significantly correlated to ‘intense 
emotional arousal’ and ‘behavorial risk factors’, additionally, ‘consequence’ is also 
negatively and significantly correlated with ‘physical exertion’. ‘Personal control’ 
was only positively and significantly correlated with ‘physical exertion’, indicating 
that the better personal control the patients perceived for themselves, the more likely 
they feel confident in managing difficulty of breathing when they exercise, climb up 
stairs, etc. For ‘treatment control’ of illness representations, it was positively and 
significantly correlated with ‘negative effect’, ‘intense emotional arousal’, ‘physical 
exertion’ and ‘total score’ of CSES. ‘Illness coherence’ was positively and 
significantly correlated with all CSES subgroups except for ‘physical exertion’. 
‘Emotional representations’ was negatively and significantly correlated with 
‘negative effect’, ‘intense emotional arousal’, ‘behavorial factors’ and ‘total score’ of 
CSES. This indicates that patients with worse perceived negative emotion were more 
likely to feel less confident in managing difficulty of breathing during exacerbation, 
anger and fear, and improper diet.  
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Table 24   Correlation between self-efficacy and illness representations. 
Predictors Negative Intense Physical Weather/ Behavorial Total 
  effect emotional exertion Environment risk CSES 
     arousal   factors  
Identity   -0.397*   -0.350* -0.231 -0.244 -0.237 -0.360*
Timeline  -0.113 -0.176 -0.144 -0.090 -0.077 -0.142 
Consequences  -0.440**   -0.461**  0.355* -0.270   -0.367* -0.445**
Personal control 0.206  0.232  0.360*  0.256  0.233  0.289 
Treatment   
  control 
 0.332*   0.318*  0.383*  0.232  0.256 0.350* 
Illness  
  coherence 
 0.329*   0.336*  0.221   0.323*  0.339* 0.339* 
Timeline cyclical  -0.491**   -0.522** -0.310  -0.385*  -0.503** -0.503**
Emotional   
 representations
 -0.354*   -0.386* -0.290 -0.192  -0.376* -0.376*
*P-value < 0.05;  **P –value < 0.01 
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6.4  Part Four  Factors affecting illness perception, 
self-efficacy and HRQoL of COPD patients 
In Table 25, Pearson’s product moment correlation coefficient was conducted on 
demographic and clinical variables to identify their potential association with the 
illness perception, self-efficacy and the generic and disease-specific health related 
quality of life of COPD patients. The table does not show all subscales of these 
measures, rather variables were selected according to two criteria: 1) significant 
changes indicated after the intervention; 2) association indicated in more than one 
demographic and clinical variables. Among all dimensions of illness representations, 
‘consequences’ was indicated to be associated with most variables, including ‘stage 
of disease’ (rho = 0.56, df = 38,  P <0.01), ‘post-BD FEV1% predicted’ (r = -0.58, 
df = 38,  P <0.01), ‘long-term treatment’  (rho = 0.35, df = 38,  P = 0.026), 
‘prescribed MDI’ (rho = 0.40, df = 38,  P <0.01) and ‘frequency of using SABA’ 
(rho = 0.52, df = 38,  P <0.01). This association indicates that patients with a 
perception of serious consequences with their disease were more likely to be in a 
severe stage of their disease, to have a poorer pulmonary function, to have been 
prescribed MDI and to be frequently using SABA. In the meantime, ‘timeline 
cyclical’ was also positively and significantly correlated with ‘prescribed MDI’ and 
‘frequency of using SABA’ while ‘timeline acute/chronic’ only has a positive and 
significant correlation with ‘long-term treatment’. The ‘total CSES’ was significantly 
correlated with ‘stage of disease’ (rho = -0.58, df = 38,  P <0.01), ‘post-BD FEV1% 
predicted’ (rho = 0.57, df = 38,  P <0.01) and ‘long-term treatment’ (rho = -0.34, df
= 38,  P = 0.035). The total SGRQ was found to be negatively and very 
significantly correlated with total and all subgroups of CSES (r = -0.41 to -0.53, df = 
38 - 39,  P <0.01) in additional to statistically positive association with ‘stage of 
disease’ (rho = 0.57, df = 40,  P <0.01), ‘post-BD FEV1% predicted’ (r = -0.58, df = 
40,  P <0.01), ‘prescribed MDI’ (rho = 0.32, df = 40,  P = 0.038) and ‘frequency of 
using SABA’ (rho = 0.57, df = 40,  P <0.01). In regard to SF-36, its physical health 
summary demonstrated significant correlation with ‘stage of disease’ (rho = -0.47, df
= 39,  P <0.01) , ‘post-BD FEV1% predicted’ (r = 0.47, df = 39,  P <0.01), 
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‘prescribed MDI’ (rho = -0.39, df = 39,  P = 0.012), ‘frequency of using SABA’ 
(rho = -0.56, df = 39,  P <0.01) and ‘negative effect’ (r = 0.36, df = 38,  P <0.021), 
‘intense emotional arousal’ (r = 0.34, df = 38,  P <0.034) and ‘total scores of CSES’ 
(r = 0.31, df = 38,  P = 0.048). Mental health summary did not show any significant 
association with any demographic, clinical variables and ‘behavioral risk factors’ of 
CSES, but showed significant correlation with all other subgroups (r = 0.33 to 0.41, 
df = 38 - 39,  P = 0.035 – 0.008) and total score of CSES (r = 0.41, df = 38,  P <
0.01).     
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Table 25  Correlation between demographic variables and IPQ subscales, total CSES, total and symptom score of SGRQ and PCS and 
MCS of SF-36  
Illness representations Total SGRQ SF-36   
Timeline Consequences Timeline CSES  Total  Symptom Physical health Mental health 
Variables   cyclical  SGRQ Score  summary summary  
Age 0.16 0.01 -0.30 0.21 -0.04 -0.02 -0.14 0.27  
Sex  0.14ᵃ  0.15ᵃ   0.17ᵃ -0.06ᵃ -0.08ᵃ  -0.26ᵃ -0.09ᵃ  0.10ᵃ  
Years of diagnosis -0.16ᵃ  0.08ᵃ -0.19ᵃ -0.23ᵃ  0.18ᵃ   0.17ᵃ -0.14ᵃ  0.05ᵃ  
Stage of disease   0.30ᵃ     0.56ᵃ ** 0.24ᵃ -0.58ᵃ **   0.57ᵃ **   0.08ᵃ   -0.47ᵃ ** -0.20ᵃ  
Post-BD FEV1 % Pred. -0.20 -0.58** -0.22 0.57** -0.59** -0.11      0.47** 0.20  
Concomitant disease 0.16 0.10 0.07     -0.16 0.11 0.06 -0.17 -0.15  
Smoke pack year(s) -0.10ᵃ 0.04ᵃ -0.07ᵃ 0.07ᵃ 0.18ᵃ   0.36ᵃ *  -0.05ᵃ   0.01ᵃ  
Secondary or above level  -- -- -- -0.04ᵃ -0.09ᵃ -0.08ᵃ  -0.01ᵃ -0.10ᵃ  
  of education 
Living with family -- -- -- 0.18ᵃ -0.08ᵃ 0.13ᵃ -0.01ᵃ  0.13ᵃ  
Married -- -- -- 0.28ᵃ -0.11ᵃ 0.23ᵃ  0.02ᵃ -0.12ᵃ  
Self-paid of medical expenses -- -- -- -- -- -- 0.23 -0.22  
Long-term treatment   0.36ᵃ * 0.35ᵃ * 0.17ᵃ    -0.34ᵃ * 0.27ᵃ 0.06ᵃ -0.27ᵃ -0.13ᵃ  
Prescribed MDI 0.26ᵃ 0.40ᵃ *   0.42ᵃ ** -0.14ᵃ  0.32ᵃ * 0.19ᵃ    -0.39ᵃ * -0.09ᵃ  
Frequency of using SABA 0.13ᵃ   0.52ᵃ **    0.32ᵃ * -0.23ᵃ   0.57ᵃ **   0.33ᵃ *    -0.56ᵃ **  0.05ᵃ  
Mastery rate of all inhalers -- -- --   0.17ᵃ -0.07ᵃ -0.09ᵃ  0.20ᵃ  0.03ᵃ  
CSES 
   Negative effect -- -- -- -- -0.53** 0.00    0.36 *   0.40 *  
Intense emotional arousal -- -- -- --   -0.52** 0.07    0.34 *   0.33 * 
   Physical exertion -- -- -- -- -0.46** 0.01 0.22  0.36*  
   Weather/Environment -- -- -- -- -0.50** -0.09 0.21    0.41**  
   Behavorial risk factors -- -- -- -- -0.41** 0.10 0.23 0.31  
   Total CSES score  -- -- -- -- -0.56** 0.01  0.31    0.41**  
*P-value < 0.05;  **P –value < 0.01;  ᵃ Spearman's rank-order correlation coefficient (rho) 
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6.5  Summary 
This chapter has reported the baseline characteristic of the sample and the findings in 
relation to the assessment of the effects of SMEP on COPD patients in Macau. 
Firstly, the SMG and CG were found relatively homogenous in terms of their 
demographic and clinical characteristics. Significant differences were 
comparatively identified more within groups in time than between groups in all 
measurements. To compare difference between groups, significant difference was 
indicated only in mastery rate of all inhalers at T2. On the other hand, significant 
differences were indicated for SMG between T0 and T2 in primary outcomes for 
instances, ’timeline acute/chronic’ subgroup of IPQ-R, ‘intense emotional arousal’, 
‘physical exertion’, ‘weather/environment’ subgroups and total score of CSES,  
mastery rate of all inhalers, MDI and dry powder inhalers; and in secondary 
outcomes for instances, post-BD FEV1 for SMG and CG, days of hospitalization, 
and symptom score of SGRQ. The result also revealed that the participants were 
more inclined to attribute COPD to their immune status and risk factors. In the 
bivariate correlations for self-efficacy and illness perception, all subgroups 
excluding ‘timeline acute/chronic’ of illness representations indicated significant 
correlation with one or more subscales of CSES. In identifying factors of affecting 
illness perception, self-efficacy and HRQOL of COPD patients, participant 
characteristics including stage of disease, pulmonary function variable, amount of 
smoking, long-term treatment, prescribed MDI and frequency of using SABA in 
varying degree correlated significantly with subgroups of illness representations, 
total CSES, ‘symptom’ and total score of SGRQ and physical health summary of 
SF-36. In addition, CSES subgroups significantly correlated to total SGRQ and 
mental health summary of SF-36. With these findings in place in the mixed 
methods design, qualitative data was concurrently collected to explore the 
subjective perspectives of the participants towards self-management. The next 
chapter will present the qualitative findings in terms of the analysis and 
interpretation of the focus groups. 
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Chapter Seven  Qualitative Findings 
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7.1  Introduction 
Based on thematic analysis from three focus groups, the qualitative findings were 
obtained in relation to the research question which explored the perceptions and 
experiences of COPD patients towards self-management in Macau. In these focus 
groups, two features in relation to the oral expression of the participants were 
identified. First, they did not express their ideas in well-structured speeches although 
they talked with their mother tongue – Cantonese. This may be due to their low 
education level. Therefore, the transcript of the focus groups which was translated 
from Cantonese to English with an intention to keep the original tone of the 
participants may be presented in irrelevant wordings or incomplete sentences. 
Second, the responses of the participants indicated that they did not distinguish 
between the concepts of perception and experiences. They simply mixed these two 
concepts up when sharing and commenting on self-management. Therefore, no 
distinct differentiation of these concepts was made throughout the thematic 
development process and the themes that did emerge reflect a unified meaning for 
both the perception and experience of self-management in Macau COPD patients. It 
should be noted that the term, SMEP, was regularly referred to as ‘workshop’ or ‘the 
education’ or ‘the programme’ by the participants in the focus group dialogue. The 
major theme that emerged from the focus groups was ‘Essentiality’. Under this 
overarching core theme, five sub-themes emerged: (1) helplessness, (2) mutual 
involvement, (3) control, (4) support and (5) beneficial. The categorical components 
of these themes are summarized in table 26.   
In this chapter, the findings related to this core theme and its associated sub-themes 
will be presented with quotations elicited largely in the forms of interactions and 
partially in significant individual dialogue. These findings are presented in an 
interpretative form of integrating the results and discussion of the focus groups. I will 
firstly address the main theme, ‘Essentiality’, in association with the five sub-themes 
and how they emerged from COPD patients’ experiences and perceptions of 
self-management. Then, the relationship of the theme and all these sub-themes will 
be illustrated with a diagrammatic framework.  
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Table 26  Main theme and sub-themes that emerged from Perception and 







Mutual Involvement  













                          Beneficial 
 Bodily improvement 
 Functional improvement 
 Spiritual comfort 
 Individual difference 
Table 27  Pseudonyms and demographic characteristics of participants in focus 
groups 
Focus Group Name Age / Sex COPD Staging Education Level 
Nick 61 / M IV Secondary 
Amy 57 / F II Primary 
Wilson  73/ M II Primary 
1 
Ivan  73 / M III Primary 
Lavin 63 / M III Primary 
Leon  64 / M III Primary 
Chris  61 / M III Primary 
2 
Karen  65 / F III Primary 
Winnie 47 / F II Primary 
Mr. Lee 63 / M IV Secondary 
3 
Mrs. Lee 62 / M III Primary 
Before exploring details of these themes, it is useful at the outset, to gain familiarity 
to some initials and symbols used throughout this chapter. To respect confidentiality, 
participants are given pseudonyms (See Table 27) and the moderator is given the 
initial “SL” and the workshop facilitator “Nurse MN”. In order to differentiate the 
only couple in the study from other individual participants, the couple are given a 
family name, whilst others are called by their given names. Transcript symbols are 
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listed and explained in Appendix 17. Quotations from two different focus groups or 
participants spoken at different times would be separate with ‘***’. 
7.2  Essentiality 
Essentiality, emerged as a main theme from the sub-themes following the process of 
analysis and comparison. The main concepts of the sub-themes were captured as: 
helplessness, mutual involvement, support, control and beneficial, and they elicit 
unified characteristics for the development of a more abstract theme. Essentiality 
refers to a thing that is absolutely necessary (Oxford, 2013); it implies here that 
self-management was something seen to be absolutely necessary by Macau COPD 
patients. The emergence of essentiality was prominently identified from two streams 
of information. First, it was explicitly expressed by the participants across the focus 
groups. Second, essentiality emerged as a construct transmitting the core message 
from the five sub-themes which demonstrated the meanings of self-management to 
the participants. These will be addressed and discussed in each of the sub-themes in 
the following. The term, essentiality, was not directly mentioned during the focus 
groups, participants in all focus groups generally described SMEP as important, 
necessary or better than nothing. This is evident when participants of all three focus 
groups spoke about their ignorance of COPD as indicated below:    
Karen:   But it’s better than not learning anything; in the past, I was like refusing 
to attend the workshop even though Nurse MN asked me to join several 
times.  [B543,653,22] 
*** 
    SL:  Is it necessary to have such a kind of workshop, what do you think? 
Mrs. Lee  At least we knew a bit.. 
[Winnie:  That’s true] 
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[Mr. Lee  That means, at least more basic knowledge to manage myself]  
Winnie:  It’s right, want to learn more…more.  [C791, GD]   
*** 
Wilson:  For now, the workshop teaches you how and how…..Well, although you 
don’t …don’t get all, to some extent, you know what it is about. Well, you 
act in accordance with it, then you become better in health.  
[SL  Um, understood]  
Wilson:  …If you don’t know, you are so ignorant that you don’t know what to do 
and which is good. Since there is a workshop, you can learn what is good 
and then follow it…..haha! 
SL: Got it…It means you know the skills through the workshop, maybe 
couldn’t learn them all, but learnt as much as possible, right? 
Wilson: Exactly..  [A941,1067,14] 
To be essential, SMEP is required to be vital to the COPD patients; and it was vital 
because SMEP was simply basic for any person who has this chronic condition and it 
provided irreplaceable good to these patients. In the first and second excerpts, 
participants expressed SMEP as a basic element for COPD patients. In the third 
excerpt, Wilson pointed out the importance of SMEP when encountering their 
disease. However, I am also aware that the participants did not directly claim to have 
engaged in self-management or how important or vital self-management was to them. 
They mainly referred to self-management in relation to the skills they learned from 
the workshop and how they derived benefit from it. They tended to uphold indirectly 
the essentiality of self-management through praising the importance of the SMEP. 
This may be due to their unfamiliarity with the term ‘self-management’. This is most 
likely to be because ‘self-management’ is not a popular term used among the Chinese 
population or in Chinese patients. In Chinese culture, patients are often in a more 
passive role when dealing with an illness. I say this because when Chinese patients 
say ‘going to see doctor’, they say ‘求醫’(qiúyī) which means asking or begging for 
treatment. This indicates their intrinsic passive status in carrying out their role as a 
patient. Self-management, in this case, has placed them into an active role which 
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they may be hesitant to take on. Although they did not verbally admit that they had 
adopted self-management or self-management was essential to them, they did 
implicitly by mentioning relevant meaning in the sub-themes. They expressed their 
inadequacy and need for SMEP in the ‘helplessness’ sub-theme; they anticipated for 
it in ‘mutual involvement’; they internalized it in ‘control’; they were supported by it 
in ‘support’; and they found it beneficial in ‘beneficial’. In the following section, the 
five sub-themes and the interrelationship that emerged between them and with the 
core theme in the focus groups will be delineated. 
7.2.1  Helplessness 
In each group session, participants consistently made a number of claims associated 
with three characteristics. These were grouped into three categories: miserable, 
futility and urgency. Helplessness was emerged among the participants who 
expressed the urgency for self-management after experiencing the misery of the 
disease and the futility of their coping. More importantly, they transferred the impact 
of the disease on themselves to COPD patients at large. The issue of miserable was 
expressed in two ways, with attention placed on how COPD greatly affects their 
general well-being and how the disease has a miserable impact on Macau society 
generally. One participant, Nick illustrated how severe he found his disease condition 
and this point was further echoed by another participant, Ivan. 
7.2.1.1  Miserable 
Nick:  My disease is so severe that I sometimes really cannot reach things put high 
up  
[Ivan:  Can’t use any force]  
Nick:  …Can’t use any force, I have never been able to carry anything. Sometimes 
when I went shopping in the supermarket, very close to my home, I got some 
tissue paper there, I had difficulty in breathing when I carried my things and 
got myself into the lift.  
SL: I see, I see, then about that… 
Nick:  Sometimes, it didn’t work even though I put great effort into it!  
[A954-962,GD] 
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*** 
Ivan:  I feel that he (Nick) became so serious, not being able even to carry 
something, that’s really suffering. 
SL:   Um Um.. 
Nick:  Yeah….I’m younger than him (Ivan) I am not that old, he (Ivan) is 10 
years older than me, older than me for 10 years, the condition is still very 
good even older than me for 10 years, can tell by how he talks, his 
complexion  
[Wilson:  haha]  
Nick:  …My complexion is not good, it shows…not quite enough oxygen.  
[A1155,1318,GD] 
The issue of negative impact of the disease was expressed across all the three focus 
groups. Howard et al.’s (2009) study also revealed that the majority of COPD 
patients expressed a moderately severe to a very severe impact on their lives. In 
another qualitative study on COPD patients, symptoms were interpreted as intruders 
as they interfere with the activities informants wanted to perform (Leidy and Haase, 
1996). However, participants in this study did not show such a perspective. They had 
neither expressed symptoms in a third person form nor described them as an external 
influence, whereas symptoms were more likely to be viewed as an internal impact, 
for instance, ‘I have never been able to carry anything’, was expressed rather than 
‘they (symptoms) made me…..’. This may imply that they did not see their disease 
with ‘resentment’ as the participants did in Leidy and Hasse’s study (1996). They 
may have accepted the disease as part of themselves.  
Moreover, Nick illustrated the impact with several scenarios highlighting ‘very close 
to my home’ ‘it didn’t work even though I put great effort into it!’ and his utterance 
was echoed by Ivan. They demonstrated a consensus by revealing how miserable 
they were when living under the impact of COPD. Miserable is indeed a collective 
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construct reflecting the symptom disturbance, physical disability, social role 
impairment and dreadful feeling the participants suffered from the illness and 
emerged throughout the focus groups. In addition, Lavin believed that this impact 
was not merely in the group, but existed in the majority of COPD patients. He even 
felt miserable for other COPD patients as he said:   
Lavin:  The symptoms of these diseases, I believe there are many patients, 90% 
of them having the same phenomenon  
[Chris:  must do it this way, it’s weird! We can have consensus at this point]   
Lavin:  …because they actually can’t control the breathing, some lung functions 
is gone, right!  [B21-25, GD] 
Participants further mentioned that Macau society was facing the prevalence of 
COPD and they believed that the problem would get worse and more people suffer 
ignorantly from it in time. 
Nick:  There are so many COPD patients nowadays..so many, when I was in 
the park I saw that all the elderly there were suffering from this disease, 
some of them didn’t know their trachea is not alright, the lung is not 
alright, that’s the situation. In fact, nowadays there are so many diseases, 
as well as COPD yeah, yeah, yeah quite a lot…now I think…  
[A802,908,8] 
The same perspective was also discussed in another focus group (Refer to the second 
dialogue in 7.2.1.3 Urgency) and additionally they said:  
Chris:  Macau is a small place  
[Lavin:  with poor quality of air] 
[Karen:  Yeah, yeah] 
Chris:  …this problem will become serious later on. 
[Lavin &Leon : um um..]     [B1583,1849,GD] 
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7.2.1.2  Futile 
In the sub-theme category ‘futile’, participants had tried various avenues to manage the 
disease before being assigned to the self-management education programme. However, 
they found most avenues that they had applied were either useless or ineffective coping 
measures.  
Lavin: If I have not met Nurse MN before, then I exacerbated frequently, then 
after frequent exacerbation, well…my neighbourhood is all elderly, so 
something like massaging the back, sometimes massaging with ginger   
[SL:  Massaging the back with ginger?]  
Lavin: …tried something like this to relax myself physically, but it’s not really 
helpful in terms for the condition of shortness of breath   
[Karen: For a time…temporary maybe fine]   
Lavin:  …Then, there were only those, the elderly…suggested me to go to…to 
try or to go to the balcony, was not that polluted, or to turn on the fan for a 
bit, something like this.  [B284,347,7] 
Apart from standardized medical treatment, participants also employed some folk 
avenues of care. These were usually shared amongst their peers and usually involved 
applying complementary therapies to seek a cure or remission. This is in line with the 
findings of self-management strategies employed by Taiwanese COPD patients who 
behave in similar ways (Chen et al., 2008a). In this study, participants even shared 
traditional or folk recipes with each other during and after the focus groups and some 
participants showed great interest in this form of intervention. Whether these 
traditional ‘folk’ remedies worked or not, they were neither scientifically based nor 
an official prescription. Thus, they can be regarded as a form of futile coping. Apart 
from peer advice, a participant also sought inappropriate medical measures, once 
again this was found to be futile.  
Nick:  I was working and fairly busy that time, went usually for injection, 
injection is for emergency case, means an one-off medication, intravenous 
injection, then ended up receiving the intravenous injection every 2 days, 
worsening the situation.  [A114,127,8]   
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7.2.1.3  Urgency 
Participants in two focus groups proposed that it was urgent for self-management to 
be introduced in wider sense to the COPD population in Macau.  
SL:  Then is this workshop is really what you guys needed?=  
Nick: =It is needed, needed, at least, there is quite a lot of knowledge that we 
need to know, not everyone understands this disease  
[Leon: Yes, yes]  
Nick:  …at least one should understand some of the skills: how to control the 
nutrition, how to manage during exacerbation and emergency situation, 
have some knowledge about this.  
[Leon:  It means…it means the nurses.…it means there is someone to introduce 
us to how to understand the illness condition, and how to adapt oneself to 
the disease, that would be quite good]  
Nick:  At least I’ve got a basic concept about this, you know we know nothing 
about medicine.    [A1258-1267,GD] 
*** 
Lavin:  I also hope that you guys can go on, because there are still some patients 
not yet…not yet known. 
Karen:  To search for more new patients to come here…hehe.. 
Chris:  It is true, this one is true. 
Lavin:  Maybe many don’t know, just don’t know.  
[Leon:  Recently in the park I saw, a lot of men in middle age, old men and old 
women] 
Lavin:  …if some people know this…learn a bit, it would definitely be helpful. 
SL:  Leon has just said able to, well…er.how..in the name of us..there could be a 
lot of needs for this in our community. 
Leon:  Aye…there are many. 
SL:   Maybe really don’t know  
Lavin:  Don’t know 
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Leon:  I saw some of them, really need a gimp stick to assist themselves to get 
up.   
Chris: Let’s think of one sentence I just said before, you would know it’s 
worthwhile, can’t you feel it? I really thought I was finished before the 
workshop, now I’m changed to another person after the workshop, now 
this…is the best part of our conversation! You…you…as the leading 
group, jot this point down immediately. I mean, there are still lots of 
people who don’t know it, you have to contact them, to draw them into 
this, with a Buddha’s heart, there are really so many people who can’t do 
this.   [B1556-1587,GD]   
Intriguingly, Chris mentioned in the last extract that self-management education 
programme as such was expected to be a Buddhist act working with an altruistic 
heart. Two potentially different meanings could be drawn from this statement. 
First, SMEP is so incredibly helpful as to compare with a benevolent, a Buddhist 
action. Second, Chris perceived SMEP as something which is ‘donated’ and 
cannot simply be asked for. I would argue in favour of the latter understanding 
because the previous lines of his statement, “You…you…you as the leading 
group, jot this point down immediately...” expressed that the patient presumed 
the implementation of SMEP to be controlled or influenced by a ‘leading group’. 
‘Leading’ usually means most important while its noun form ‘leaders’ means the 
person who leads or commands a group, organization, or country. I believe with 
reason that SMEP was not perceived as a causal service but was something 
influenced by the decision of higher power. This reveals a sense of tension 
between the urgency of COPD SMEP and the supply of it in reality. 
7.2.1.4 Negligence 
Negligence was identified as one factor influencing the tension between the urgency 
of COPD self-management and its actual implementation. This is because the 
participants offered comments that they have no access to knowing about the concept 
of self-management and the availability of SMEP. 
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Lavin :Really very suffering, because you didn’t know who to ask if there were 
any enquiry, to learn how to breath.  [B417,510,7] 
*** 
Leon :Not that usual, really!....... Not usual, really! Really, in this 20 something 
years of my life, I am, really….. [B1555,1817,12] 
In Lavin and Leon’s expressions, they showed that they did not have a notion about 
COPD self-management in prior to participating in this study. Leon even said that he 
had never heard or learned about it in the last two decades and he thought that it was 
not a common practice in society. This revealed either a lack of education provision 
or poor promotion of relevant service to COPD patients in Macau, resulting in a 
neglect of the needs of Macau COPD patients. Due to no relevant publication about 
COPD nursing care available, negligence could probably be caused by the absence of 
COPD education provision. Disler et al. (2012), however, addressed the impact of 
health literacy on patients’ ability to access resources and supports available in the 
community. Since health literacy was not the variable examined in this study, I 
cannot rule out the possible impact of health literacy in the participants. No matter 
what the reason may be, participants were helpless in accessing and receiving SMEP.  
The perception and experience of COPD as miserable, futile and negligent, revealed 
the helplessness of the participants in relation to the self-management of their disease. 
Due to the suffering and disability caused by the disease, they sought alternative or 
folk therapies from lay persons or relied on quick relief from hospital consultations. 
Some participants even denoted that the effective therapy was delayed and the 
condition of their disease was worsened. In this sense, their sympathy for peer 
patients consequently raised their concern for continuing the programme for helping 
more patients. It is because they found that SMEP as such was absolutely new to 
them and they had been completely neglected. A tension was highlighted between the 
urgent need for SMEP and the practical supply of it. More findings about this tension 
will be disclosed in the next sub-theme, mutual involvement. 
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7.2.2  Mutual Involvement 
Mutual involvement is a combination of two words: 1) mutual and 2) involvement. 
From the face meaning of this phrase, it is easily understood as actively engaging 
something together. However, it is not as direct as that in the present proposition. 
Involvement here indicates an active view of participation in self-management, 
whereas mutual requires endeavour for actualizing self-management by all parties. 
However, mutual involvement was not inevitable unless there was active engagement 
to SMEP by all levels, namely individual patient, healthcare system and macro-level 
authority. These three levels of participation form the three categories under the 
sub-theme of mutual involvement. Individual obligation was discerned as that the 
participants recounted their own responsibility for participating in self-management 
in a moral sense. For systematic participation, participants were in agreement about 
eliciting an expectation for integrated effort of professional contribution and familial 
involvement in disease management. From a wider perspective, patients even 
anticipated the concern and policies of the government in preventing COPD and 
supporting COPD patients and this forms the category of macro-level participation. 
7.2.2.1  Individual obligation 
Wilson : what I usually did is follow..mainly followed Nurse MN’s instructions to 
work on it.  [A72,76,14] 
*** 
Chris : means I ate more side dishes, vegetable, it is documented in the booklet, 
means reducing the portion of carbohydrate.  [B368,443,15] 
Wilson and Chris told how they practice the instruction from the SMEP. Similar 
claims of compliance to self-management frequently emerged in the groups after the 
intervention. Kara and Aşti, (2004) suggested that increases in self-efficacy in 
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self-management may promote compliance to prescribed activities instructed in the 
education. More interestingly, participants across the three focus groups elaborated 
their views of self-participation as one’s own obligation. They generally believed 
that self-management is one’s own responsibility and one’s own attitude of being 
well-behaved and cautious in relation to their own body.  
SL :  Then you think this is what the nurses should do? 
Ivan :  (.2) Not a must………………   
[Nick:  ha ha ha] 
SL  : Not a must!?..Why? 
Ivan:  Errrr……..if you don’t…if you don’t take care of yourself, it’s useless 
no matter how well the nurses teach you. 
SL:  I see…so you think that it is more like your own responsibility for 
taking care of your condition  
[Ivan: Yes, myself]  
[Nick:  hahaha] 
SL:  If there are any other suggestions, or Amy? 
Amy:  I think the same, just like, even if Nurse MN taught you, but you 
don’t manage yourself, then it means nothing no matter how you are 
taught.  [A1269-1285,GD] 
*** 
Chris:  Aye…on the other hand, played more attention to taking rest in daily 
life, for example.…there were so many examples, like stop smoking 
as before, now managing dietary with regard to avoiding sour, spicy 
and chilled food  
[SL :  take less carbohydrates] 
Chris:  …eat eat eat..less...ha...I mean those carbohydrate types, It means 
more behaved, we are finished if we don’t behave ourselves all the 
now for now.  
Lavin :  Chilled stuffs critical  
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[Karen:  it means a huge difference!]  
Lavin:  Wow, chilled stuffs are very irritating!  [B743-750,GD] 
Ivan hesitated for two seconds before responding to the moderator as he was 
potentially going to say something opposite to the stance of the question asked by 
moderator. I am also aware that Nick laughed out at two points of Ivan’s response. 
Although Ivan’s claim was finally supported by Amy, Nick did not comment on this 
idea. His laugh may imply disagreement to the statement or he indeed agreed with 
Ivan but he found Ivan too brave to challenge the moderator with a differing opinion. 
The latter might have driven him to just observe the process and tittered there. 
Unfortunately the moderator did not follow up with him about the reason for his 
laugh. Taking into account Ivan’s position throughout the interview and moderator’s 
observation at the scene, we are more confident to argue for the latter guess. This is 
supported by some other similar claims made by Nick.  
Nick:  In general, it is fine. It is indeed a matter of taking care of your own 
disease.....it is mainly teaching us people acknowledge the characteristics 
of the disease, and what do we have to pay attention, the most important 
thing is on us, that is all.  [A199,226,8] 
In the category of individual obligation, I feel strongly that the participants took full 
responsibility for disease management as this construct emerged across all the three 
focus groups. Judging the participants from the general view of constructionism 
(Silverman, 2011), they neither simply regarded themselves as receivers of education 
nor the nurses as taking complete professional responsibility for promoting the 
participants’ health. Instead of acting as a representative of the issue and talking 
about it, they described themselves as part of the issue themselves. They tended to 
own their problem and acknowledge their responsibility. Such an individual 
obligation may be simply an embodied belief about the management of a chronic 
disease amongst the patients. Therefore, they did not just participate, but participated 
with a feeling of involvement and responsibility (individual obligation). 
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7.2.2.2  Participation in Systematic level 
Since the goal of constructionist analysis is to show the meaning-making process 
during the interaction between interviewer and interviewees, in other words, 
interviewees construct aspects of reality in collaboration with the interviewer 
(Silverman, 2011). The following interactive dialogue clearly projected a construct of 
such collaboration. 
Chris:  This can be expanded, it will not be only one organization, e.g. let say, I 
am the Bureau of Health, distributing the job to each charity groups, like 
the unions, societies…er…apart from these, together with the promotion of 
flyers. Then, we could tell them our experience, what we are now, what we 
have been through and how we ended up like this, anyway, spell out the 
problem, formally to let them know. Then people with the same attitude as 
mine, already frustrated, those people will have a chance again, so they 
will be keen to join this. Then, through you guys’ hard-work, more people 
will be saved, their lives extended, so good. 
SL:   If according to the ideas that you guys just mentioned, through the charity 
group, it is possible to arrange for the community, something about 
health… health education for the community concerning COPD, then 
actually…er...er… its… its good, its good, from what you’ve said, then... 
er..er… I want to clarify one point that maybe the content of the workshop 
is focusing on disease management, well, maybe based on patient, I 
mean…to teach patients of how to manage their... their…concentrate on 
their disease. Well, if it is like this, what kind of organization do you think 
would be suitable for doing something related to disease management? 
Leon:  If it is like this…well, you yourself…I mean select from the 2 
hospitals…..I mean to select from nurses or doctors, whatever…I mean to 
take a comprehensively responsibility of this job, something like this..it’s 
good. 
Chris:  Aye...your idea is good… 
SL:   It means action by hospital? 
Leon: Well, 2 hospitals, it means like the Peak Hospital together with 
KWH…randomly select some staff from them, specifically responsible for 
this… 
SL:   Conducted by medical personnel, hospital to work on this type… 
Leon:  Yes….it would be better in this way  
Karen: Can select the patients, there must be some people seeking for consultation 
in the hospital 
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SL:   Yes yes yes, it mean, it is also good for conducting by hospital, can search 
for patients, can search for targeted patients  
Christ: The target is bigger, the target is bigger, it’s also better in regard to 
providing advice for drug usage.  
SL:   Because it will relate to drug usage.. 
Chris:  Yes…yes.  [B1633-1677,GD] 
As for indicating a meaning constructed by a group, attention could be directed both 
to the assembly of meanings and to what gets assembled (Silverman, 2011). At the 
beginning, Chris suggested self-management education to be run on a community 
based mode. The moderator interrupted to hint at the ‘professional’ content of 
self-management. The group immediately converted to a hospital-based 
professional-run idea. More importantly, special attention should be given to Chris’ 
change from his initial position to his final opinions. In the three responses he made 
after Leon’s recommendation, we can see Chris’ sincerity in concurring with Leon 
and this was particularly significant in his second response by reiterating “The target 
is bigger, the target is bigger…”. The group highlighted the participation of 
professionals in bringing about self-management and had a high expectation of this. 
This insight was a message emerging from the contributions of the local participants 
interacting together in the interview. In addition, a participant’s spouse also expressed 
her wish to be involved.  
Mrs. Lee: Could I request doctors and nurses to …..= 
SL:  =Sure, you are now given an opportunity to express.. 
Mrs. Lee: Well, I’m thinking….if so….I’m also ….because after a few times of 
emergencies, I always think…I think, if touch wood (knock the table), 
what should be done? 
SL:  you mean the management at the time of exacerbation, you wish to learn about 
this, you wish nurses can teach you about this? 
Mrs. Lee: Arr…I’m scared indeed, I’m just scared about this. [C688-692, 17W] 
SMEP may not be merely targeted at COPD patients, their family member also play 
a role in it. Families were indicated to provide emotional support and can be in 
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themselves a strong motivator for patients to continue to live and engage with the 
complex requirements of self-management (Disler et al., 2012). There is a claim that 
self-management is a family matter and it is about all family members being able to 
get on with their lives, accommodating the implications of chronic health problems 
as a feature of everyday activity (Jonsdottir, 2013). In Chinese culture, particularly, 
family was indicated as a necessary support system for self-care and should be 
provided relevant education (Chen et al., 2008a). These studies reaffirmed the 
requirement to respond to the need of Mrs. Lee. On top of this, a participant tried to 
indicate the merit of integrating the mutual effort of the professionals and the 
families. 
Lavin: At last, integrated the Chest centre and those things taught by Nurse MN, 
in addition to my daughter’s urge, is a bit effective.  [B922,1087,7]
Instead of receiving healthcare service in a fragmented way, an integrated effort of 
all parties was valued. It is not the effects of the participation of a single party, but 
an organized integration of participation. This was seen as an expectation for 
systematic participation in COPD self-management. The next category proceeds to 
understanding patients’ anticipation for macro-level participation in this regard. 
7.2.2.3  Macro-level participation 
In addition to individual and systematic participation in SMEP, the participants thought 
that the government should play a leading role to confront this serious health issue by 
supporting the implementation of SMEP. Moreover, they urged the prevention of COPD 
by suggesting the government put forward polices for promoting smoke cessation which 
was perceived as the main cause of COPD.  
Chris:  It is very important for the government to play close attention to this 
by playing a leading role in such issue.  [B1581,1847,15]
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*** 
Ivan:  For the situation as such, the government should do more promotion 
about quit smoking!  [A1140, 1301,19] 
Zhou et al.’s (2010) study made a similar conclusion that a policy-driven integrated 
community based intervention achieved more positive effects in preventing and 
controlling COPD. Participants in this study perceived the urgency for providing SMEP 
to COPD patients, and they also realized that its actualization requires participation 
systematically by the stakeholders as well as supporting policy in the macro-level 
aspects of a society. In this case, this could strengthen individuals’ ability in accessing 
supportive resources and moving smoothly between different parts of the health system 
(Disler et al., 2012). However, in reality, the participants were being deprived of this 
nursing care as discussed in the previous sub-theme of helplessness. The participants 
eagerly hoped for concerns to be shown for the support and development of COPD 
self-management at the systematic and macro-level dimensions. In this sense, mutual 
involvement does not yet exist in Macau in relation to promoting COPD 
self-management. This sub-theme further explains the tension between the expectation 
for COPD SMEP and the absence of support for COPD SMEP in reality.     
7.2.3  Support 
Four dimensions of support were highlighted by the participants in relation to 
self-management: emotional support, cognitive input, skills building and treatment 
support. Participants underwent stress to live with COPD and they regarded 
self-management as more than some functional tactics. They think self-management 
means caring, valuing life and brining hope to them. Another two categories, 
knowledge input and skills building were the major content of the self-management 
intervention, participants compared their situations before and after intervention with 
regard to these categories. Then, regarding a nursing intervention, participants also 
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gave credit to SMEP for supporting their medical treatment. This will be further 
illustrated in the treatment support category.  
7.2.3.1  Emotional support 
In the following three extracts, participants demonstrated a pattern of meanings 
clustered for reflecting self-management as emotional support to COPD patient. 
Firstly, Nick stated that the provision of self-management knowledge that he 
previously did not come across as ‘very caring’ to the patients.  
Nick:  It’s quite good, very caring for us. We...patients don't really know those
knowledge. [A854-892,8] 
Karen made a further remark that to some degree she had isolated herself from help. 
Her saying “I then have a chance to come here” expressed her gratitude at being able 
to learn of COPD self-management, and in another way her sense of being valued by 
the nurse.  
Karen:  Cause I got sick too frequent, too long. Macau is too small, I don’t want 
to let people know that I am seriously sick, I don’t have a sense to come here, 
she (Nurse MN) is really patient and considerate enough, I then have a 
chance to come here.  [B1263-1321,22] 
In additional to caring and gratitude, Chris emphasized that self-management 
provided him a new life. This indicates the hope given to the patient.    
Chris:  Well, I really have died if I have not joined the workshop! Had not much 
hope to life  
[SL:  haha]  
Chris:  …It’s real! I am saying the truth!! So joining the workshop provided me a 
second chance to my life, thanks Nurse MN (put the palms together)! 
Thanks SL (put the palms together) [B843,1003,15] 
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Support as such was recommended as it improved patients’ confidence in engaging 
in self-management activities, because patients experiencing positive healthcare 
professional relationships were found to be more likely to benefit from 
self-management interventions (Disler et al., 2012). As the spouse of a COPD patient, 
Mrs. Lee also expressed her stress of taking care of her sick husband during the 
interview. On several occasions, Mr. Lee became grumpy when he was wheezing. 
Mrs. Lee said,  
Mrs. Lee: You can give me a signal ..like this…as I’m asking you questions, you 
can give me a sign…like this, then ah.. I know you are wheezing, so it is 
indeed even suffering more to be his partner.  [C174-175, 17W] 
*** 
Mrs. Lee: So actually….Aiii….actually I have problem now (laugh with tears in 
eyes).  [C506,17W] 
This case revealed that the family member of the COPD patient also suffers mentally. 
Mrs. Lee’s body language (laugh with tears in her eyes) has drawn my attention. In 
accord with Krueger’s (1998) view on the interpretation of non-verbal 
communication, whether it happens spontaneously or by probing, it is important to 
incorporate verbal confirmation of its meaning into the analysis (Krueger, 1998). In 
this case, Mrs. Lee’s non-verbal expression (laugh with tears in her eyes) reaffirmed 
her statement ‘actually I have problem now’. Her verbal and non-verbal expression 
indicated a feeling of helplessness in herself and the pressing need for support. 
Instead of expressing all these needs for support in a rational way, the participants 
talked of it in an emotional way, like ‘very caring’, ‘considerate enough’, tears in 
eyes. Hence, emotional support emerged as a category of the ‘Support’ sub-theme. 
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7.2.3.2  Knowledge input 
Giving SMEP to COPD patients inevitably involves giving knowledge to recipients. 
Two participants in a focus group shared their view on this issue.  
Wilson:  Yes, really could learn a lot, it’s all because of Nurse MN...ha ha. 
SL:  Um…alright alright. Then what about Chris? 
Nick:  We know what is COPD through the workshop, in the past it’s not clear 
what kind of disease we are suffering from. 
SL: O…ic 
Nick: In the past what I know is coughing, lots of mucous..something like in the 
body is in the situation of heatiness, then now after attending the workshop 
know this is COPD..ha…   [A100,110,GD] 
Similar comments were also found in the other two focus groups. In Lemmens et al. 
(2010)’s study, COPD patients had improved disease-specific knowledge after 
disease-management education. This improvement was indicated in both objective 
and subjective knowledge, which were measured by true or false questionnaire and 
self-estimation of knowledge comprehension respectively. Participants in the study 
were not assessed by these measures, but all of them basically expressed 
improvement in disease-specific knowledge, and that may well correspond to 
subjective knowledge perceived after the programme. Furthermore, in Lemmens et 
al’s (2010) findings, subjective knowledge was found to be a significant predictor of 
changes in quality of life in COPD patients. Despite that, we can tell that Amy also 
showed an expectation for knowledge input from the workshop, as she said “then of 
course, we will have….”.In particular, she added “only after being taught” in her 
comment which possibly indicated that she perceived no other way of accessing 
relevant knowledge. 
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7.2.3.3  Skills building 
Two excerpts listing below present comment from the participants about acquisition 
of skills when the moderator inquired about what they had learned from 
self-management.  
Wilson:  It means…taught me those, I am impressed by the breathing  
[Nick:  Breathing… really…] 
SL:  Um..breathing, about how to breath? 
Wilson:  It is (demonstrating) the breathing that involves breathing in and 
breathing out.   [A250,283,GD] 
*** 
SL:  What have you learnt? 
Lavin : Learnt how to breath.  
SL:  Learnt how to breath, how to breath? 
Lavin: Ar….inhale with the nose…exhale with the mouth, and do it slowly. On 
top of that, stop carrying heavy stuffs…ar…don’t carry the heavy stuffs, 
don’t lie prone for a long time, too long would block the trachea.  
[B296,362,7] 
Breathing exercise emerged to be the most impressive skills acquired across all the 
participants and constantly practiced by them after the programme. Skills listed by 
Lavin were for multiple purposes and were related to managing various daily 
activities. Lavin’s eagerness to perform the controlled breathing additionally assured 
that the skills had been ‘built in’ him. As shown in Leidy and Haase’s (1996) study, 
healthcare providers were usually seen as enablers in this instance as skills taught 
enabled the patients to avoid and manage symptoms, and then the patients would 
maintain activities from which they derive the most satisfaction. 
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7.2.3.4  Medical support 
At least one patient in each focus group voiced the value of SMEP in supporting 
medical treatment as below.   
Nick:  There are some, like those concerning the dosage for using the drugs 
(inhaler), how to use them, and got to clean up after medication, all 
these..all these..all these were taught. 
SL:  O, how did Nurse MN tell you all these? 
Nick:  By using the samples, there are so many samples by that time.. 
SL: Ar, samples, she did it by showing you the samples= 
Nick:  =Showed the samples, gave them to us…demonstrate to us…then we 
followed what she did. People like myself, never followed the 
instructions. In the past decade, I used the same drugs, the UFO 
((Seretide)) one I’ve been using for 10 years=   [A683,776,8]   
Nick depicted that he had learned to use the inhalers correctly from the SMEP, and 
that is clinically regarded as especially important to COPD patients (Basheti et al., 
2007). Apart from this, his statement of having used the inhalers without following 
the instructions for ten years is most noteworthy. It makes one question: What does it 
mean to a patient, his attending physician and the overall healthcare delivery in the 
face of such a phenomenon? Further elaboration on this issue was found in the second 
focus group. 
Karen:  Well she taught me… in the past I inhaled that my lips…she said I 
inappropriately covered that thing ((mouthpiece)), cannot cover completely, 
then leakage, so wasted the drug.  
[Lavin:  Sometimes I would, I saw it leaks a little bit during the time when I 
inhaled myself, she taught me to force it completely, use the lips to seal it]  
Karen:  …have to cover it firmly]  
[Lavin:  Well, that really have tried. Ar Yee ((Lavin’s daughter)) scolded me 
several times (laugh).]  
SL: Haha…it means the inhalation skills should be correct. Har har, this is the 
thing that you guys remember mainly, or Chris any contents which 
impressed you? It means the drug inhalation skills. 
Chris: This one is very important, it’s equal to zero if you use inappropriately. So 
this one⋯⋯..not did well when managing, at the beginning I⋯took it 
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home but couldn’t⋯⋯at last, after the workshop⋯aii! I was actually 
wasting lots of efforts.  
[Karen:  hehe]  
Chris:  …No wonder I always suffer from mouth ulcer! It was because I have not 
rinsed my mouth after inhalation, always suffer from mouth ulcer, Aii…so 
bad! Then, wasted for several months.    [B985-1003,GD] 
The patients recognized what problems they had with the inhalation technique and 
that improper inhaler usage caused side effects. Chris was even upset about the futile 
effort he put in prior to attending the workshop. In other words, patients made use of 
negative experiences to elicit the merits of the programme. Most importantly, Chris 
emphasised the significance of mastering inhalation technique by stating “it’s equal 
to zero if you use inappropriately”, this highlights the interdependent relationship 
between nursing instruction and medical treatment. 
To sum up, support in emotion, support with knowledge and skill and in medical 
treatment from SMEP were identified in the participants. These were consistent with 
Lemmens et al.’s (2010) findings that improvements were found in medication usage 
and nonmedical self-care in an evaluation of COPD disease management. This 
perception makes explicit the difference in the participants between pre-intervention 
and post-intervention. After helplessness, mutual involvement and support, another 
emerging sub-theme ‘control’ will be presented in the next section.  
7.2.4  Control 
The participants often mentioned that they felt better control with their symptoms 
and their disease in general. The participants basically performed self-management in 
two different ways such as internalization and agency, but their level of performance 
was influenced by perceived incapability and interference of external factors. 
Whatever styles the participants adopted, they expressed sense of control to their 
disease and that was based on their own intention or ability.  
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7.2.4.1  Internalization 
Bandura (1989) defined self-management as a patient integrating the learned skills 
into their everyday lives. Disler et al. (2012) emphasized that after integration, 
self-management was viewed less as a burden and rather as a facilitator to a full and 
active life. Internalization, in this sense, refers to the participants who can internalize 
the self-management components they learned into their daily activities. The 
participants in this study cited a number of situations that they confronted with 
self-management skills, for instances, adopting controlled breathing when climbing 
up stairs, re-positioning when encountering short of breath during sleeping, applying 
an action plan when having sex with partners. Extracts from Lavin and Chris showed 
internalization of self-management skills into their shopping experience and sex 
activities respectively.   
Lavin : The worse condition I’ve faced is one I went to Gongbei…went to 
Gongbeiar, it’s like went out and bought something myself, then I became 
short of breath, but during the short of breath I thought…lean there, lean 
there then didn’t squat down, didn’t lean forward, lean on the back and 
breathed (demonstrates controlled breathing), then after a break, I use that 
thing and took a spray, not too long after the spray...then it became ok, then 
not so…not so suffered.  [B511,620,7]
The above experience shows that Lavin adopted multiple strategies including 
positioning, controlled breathing and inhalation technique at one time. He carried 
them all out step by step and in proper order. When he recalled this scenario, also 
when he said “I thought” and he enthusiastically demonstrated controlled breathing, 
this may indicate his own intention to seize control over his situation through 
applying tactics learned in SMEP. Internalization was also indicated in another 
participant, Chris who applied action plan to his sex activities.  
SL:  Would like to ask if you have tried following this method, action plan? 
Karen:  I have never been in such an emergency situation… 
Lavin:  I tried twice… 
SL: You tried twice… 
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Lavin:  I tried twice. 
SL:  Followed the method? 
Lavin:  Followed the method….followed that method twice  
[Chris:  Are you regularly trying?] 
Lavin:  …I…I am not trying this regularly 
SL:  During exacerbation……? 
Chris:  I did that when I was (making love).  [B866,1029,GD] 
Internalization as such is the end of self-management education in accord to 
Bandura’s (1989) definition. However, not all participants adopted internalization,
some of them performed the self-management instruction selectively. This will be 
presented in the category of agency in the following section. 
7.2.4.2  Agency 
As a health behaviour building intervention, the general principle of engaging 
patients in self-management is of most importance. However, the category of 
‘agency’ emerged when participants talked about their compliance to medical 
regimen and their implementation of action plan instructed in the workshop. Rather 
than seeing one as ‘non-compliance’, agency appears as a negotiation in the treatment 
of one who tries to adapt to imperfect treatment condition (Ho, 2007). It is a situation 
between ‘autonomous agent’ to ‘total compliance to prescribed treatment’ where one 
pursues freedom in drug-using. A perfect agency notion has been described as the 
situation where: 
“The DOCTOR is there to give the PATIENT all the information the 
PATIENT needs in order that the PATIENT can make a decision, and the 
DOCTOR should then implement that decision once the PATIENT has made 
it.”  (Williams, 1988, P.1183)
It is believed that medical doctors are not perfect agents and patient’s preferences are 
ignored (Williams, 1988). However, the patient is the best judge of the value to 
themselves of the healthcare process and its outcome (Bryan et al., 2006). In this 
study, partial adoption, self-adjustment and self-modification were common 
approaches of agency participants have undertaken. Partial adoption emerged from a 
divergent case, Leon, who did not follow prescriptions of doctors nor the instructions 
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for diet given in the workshop. On the other hand, he shared his satisfactory 
experience of applying controlled breathing. These are displayed in his expressions 
at different point of time during the interview.  
Leon:  I brought the list ((old prescription)) to get the drugs myself, the doctor at 
the pharmacy introduced me the drug …I mean the doctor who sells drugs 
introduced me that.  
SL:   I see…I see, it means you brought those over-the-counter drugs yourself= 
Leon:  =Correct! 
SL:   So you control the disease in this way= 
Leon:  =Correct. 
SL:   Um…then..its good. You tried to look for a way to control the disease, so, it 
was like this before the workshop, what about after the workshop? 
Leon:  It is the same.   [B189,231,12] 
Although the moderator attempted to explore further for difference in 
self-management before and after the intervention, Leon firmly stated “It is the same”. 
I thought he might be an exceptional case of opposition. However, he stutteringly 
made a comment as follows:  
Leon:  I’m most…most what…well, walking up stairs, I mean the breathe, those 
related to inhale and breath out were the best, that was good.  
[B1044,1225,12] 
Leon indeed adopted the self-management teaching partially which is also an 
expression of agency. Due to the lack of follow up inquiry, his reason for that 
remained unknown. It could just be a matter of choice or based on his trust in 
different given approaches. Financial difficulty may also drive one to prioritise those 
essential disease treatments while compromising on others (Disler et al., 2012). In 
this sense, his behavior could be affected by financial reasons. On the other hand, I 
observed that he may have taboo to doctor visit. My argument for the above two 
reasons is based on various context where Leon stated: 
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Leon:  For myself, I’ve never get sick.  
[SL:  Um um um]  
Leon:  …Have not been got sick for decades.  [B470,569,12] 
……I have never received any medical consultation.  [B477,577,12] 
…… I am not a driver, but a drudge, those for goods delivery. 
[B173,211,12] 
…... How much is this drug? Then could this be half price or sell it to 
patients with a cheaper price?  [B1470,1771,12] 
Either reason may independently affect the patient’s choice of approach in controlling 
his disease or both together produced a combined effect, then resulting in a partial 
adoption. Another way of control most patients adopted was self-adjustment. They 
performed what they learned from the workshop, but difficult or forgotten content 
were replaced with their self-adjusted way. They said : 
Wilson:  For those movements I was able to learn, I followed the instruction, for 
those I couldn’t remember, I did it in free style with my own movements.  
SL:  In what way do you mean? 
Wilson:  Ha ha ha…it means those…movements that freely done by myself. 
SL:  Which particular style do you mean? because Nurse MN has taught you guys 
several movements… 
Wilson:  Ha, I’ve forgotten most of those movements…ha ha ha (everyone 
laughs). 
SL:  Mostly forgotten..ha ha! 
Ivan:  Not good at memory…ha ha ha.. 
SL:  Because apart from those health exercise, breathing exercise, there are some 
others about energy saving, those movement that help saving energy= 
Nick:  =Yes, those technique, breathing technique, energy saving technique 
SL :  Those techniques, yes, those techniques, which particular you could 
remember? 
Wilson:  Ha ha…some of them can be remembered, but not much memory about 
them now, mostly do it myself in free-style….(Every one laughed) 
Nick:  Free-style 
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Wilson:  Move freely   [A264,291,14] 
The group made adjustment to the exercise by replacing it with similar gestures. This 
denotes recognition by the participants of the benefit of exercise, and adjustment as 
such was regarded as harmless to them. A Taiwanese study also revealed that the 
COPD patients there tended to choose alternative methods of exercise when they 
encountered limitation in health condition or environment (Chen et al., 2008a). From 
the laughs the group made in the conversation, it could easily be presumed that they 
shared the same feeling in regard to their difficulty in memorizing the styles of the 
breathing exercise. Such laughs may also imply their embarrassment for admitting 
that they have forgotten the teaching content. This may give rise to a sense of guilt 
from being a ‘poor’ student. This again broke the interpersonal equilibrium within the 
group and this was an offence of assuring ‘ren 仁’ in the Confucian relationalism 
(Hwang, 2012). Interpersonal equilibrium is the moral goal that Chinese generally 
pursue in a social relationship. Furthermore, the action plan was the main 
self-treatment strategy delivered to the patients in the workshop. Instead of following 
the instruction, some patients modified the dosage recommended for quick reliever. 
Nick told his experiences: 
SL:  Umum, then do you think this method of using 4 dosages during wheezing, 
then 1-hour self-observation, then 4 more dosages afterward (Action Plan) is 
helpful..erer..when responding to the exacerbation? 
Nick:  (.2) Still fine…after I sprayed for 2 times I sat still, lie down, sat still, once 
recovered, then..then..then..no need to use it again.   [A609,694,8] 
Nick took two puffs of bronchodilators rather than four dosages as instructed. He 
showed a bit of hesitation (.2) before responding. He even tried to stress that his 
modified approach was effective and no addition dosage was needed. Moreover, I 
have identified a common attitude that self-modifying dosage according to the 
changes of disease was a normal practice among the patients. Special attention has to 
be paid on the comments made by Nick and Amy on Ivan in the following dialogue.    
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Ivan:  I..I seldomly wheezed, I’m like..like going up slopes..like going up stairs. 
Once wheezed, I stopped for a while then the symptoms were gone, no 
problem= 
Nick:  =Not that serious= 
SL:  = Ar…just like Mrs. Au, stopped when wheezed… 
Ivan:  I have not tried inhaling those gases, but those with the shape as an UFO, I 
approximately take once every 2 days. 
SL:  I see, once every 2 days  
[Amy:  You take once every 2 days, for me it is twice per day]  
SL:  …Um, um, um. 
Nick:  (.3) The instruction is twice per day= 
Ivan:  =I really seldomly wheezed, only a little bit when I was going up stairs fast, 
not that serious. 
Amy:  (low voice) It varies between people.   [A746-762,GD] 
I notice a few time points in the dialogue: First, Nick’s comment “Not that serious” 
and Nick’s pause (.3) before he pointed out that Ivan was taking less dose than the 
instruction requested. Second, the explanation Ivan provided urgently in his last 
response. Third, Amy’s understanding concluded for Ivan’s behaviour in the end of 
the dialogue. It is obviously that the peer identified a medical non-compliant 
behaviour in Ivan in that he reduced the dose by himself. After Ivan explained about 
his mild condition, the group tried to interpret again by stating that it is an acceptable 
behaviour for mild condition. There was a general tolerance among the participants in 
relating to self-modification of a prescription according to one’s understanding of the 
disease. In other words, agency was common and generally accepted among them. 
7.2.4.3  Incapability 
It is also noticeable that the participants also attribute their poor mastery of 
self-management to personal incapability. The group interaction below demonstrated 
this:   
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Lavin:  =Completely memorized…completely memorized, couldn’t memorize all 
of them! e.g. that (the gesture for the breathing exercise) that couldn’t 
completely memorize  
[Karen:  O, I have totally forgotten as well]  
Lavin:  …I really couldn’t memorize! That book… 
[Karen:  those styles, couldn’t memorize those styles.]  
Lavin:  …those like that what so called ‘The Dragon Sways its Tail’ really don’t 
know  
[Karen:  Totally forgot]  
Lavin:  …totally forgotten, really have this problem, confused me.. 
[B609-614,GD] 
The group mainly highlighted poor memory to be their obstacle of practising 
self-management. They also tried to identify other possible obstacles in the following 
dialogue.  
Lavin:  Confusing…how to move like this, that and that (shaking both hands)  
[Leon:  we have no memories! I am like him, not even finished my elementary 
education.]  
[Karen:  then I am the same, I am the same]  
Lavin:  …those talk totally confused me.  
Karen:  We were in the village in the past = 
Chris:  =To learn is not emphasis on culture, these are simple stuffs = 
Leon:  =Well you (Lavin) and I are the oldest here.. 
Karen:  Are you 65 years old yet? Which year were you born?   [B762-766,GD] 
Leon pointed out “we have no memories” and regarded this as their personal deficit 
in learning. Additionally, he regarded his low education level as another obstacle and 
Karen agreed with his comment. In contrast, there was a notable comment made by 
Chris who believed education level did not necessarily affect one’s capacity for 
comprehending the content of the workshop. More interestingly, Leon and Karen just 
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ignored Chris’s divergence and continued with the topic of age which followed on 
the educational issue. Ignoring this may simply imply their disagreement with 
Chris’s opinion by avoiding direct objection which may cause embarrassment. This 
can be explained by the Chinese conception of ‘仁’ (ren) which implies that one may 
maintain a satisfactory level of psyche and interpersonal equilibrium without causing 
offense as mentioned earlier in category of agency (Refer to 7.2.4.2) (Hwang, 2012). 
An alternative interpretation to this phenomenon is that they just found it 
comfortable to stay with the explanation of bad memory and low education for their 
inadequate mastery of certain content of the workshop. Clinical evidence 
demonstrated that education was associated with self-care ability and self-efficacy in 
hemodialysis patients (Bağ and Mollaoğlu, 2010). Increasing frequency of memory 
problems with advancing age, in particular, also created challenges to education for 
diabetic patients (Gazmararian et al., 2009). Older patients may have higher 
incidence of impairment to memory, abstract reasoning and coordination, 
consequently information comprehension and recall was diminished leading to lower 
compliance with complex self-management regimens (Disler et al., 2012). However, 
Leon and Karen were only two to three years older than Chris. An alternative 
explanation was that participants found that the symptomatic or psychological 
discomfort occurred during practising those taught exercise styles may have 
outweighed the anticipated satisfaction derived from them, then they chose to give up 
practicing them (Leidy and Haase, 1996). Notwithstanding, personal factors could 
probably be perceived as a barrier to harness self-management and this perception 
varies among people.  
7.2.4.4  Interference 
Apart from personal factor, external factors appeared as interferences and affected the 
effectiveness of self-management in COPD patients. Weather changes, air quality, 
smoke and gas were all interferences as they happened or appeared in a way that 
participants felt unpredictable and uncontrollable.   
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Lavin:  It happened many times that it comes suddenly, means sometimes the air, 
or the change of weather, then the lung..became short of breath naturally. 
[B316,385,7] 
The wording ‘comes suddenly’ and ‘naturally’ caught my eyes because it indicated a 
free-from-human-control nature in the environmental factors. It also presented a 
sense of compromising in the participants when encountering these factors. If so, 
environmental factors could be impersonal adverse factors affecting the overall 
outcome of self-management. To encounter this problem, the introduction of 
integrated intervention which included smoking cessation, air quality improvement, 
environmental tobacco smoke reduction in additional to self-management education 
was recommended (Zhou et al., 2010). This was definitely a comprehensive way of 
preventing and managing COPD. 
From the above four categories, namely internalization, agency, incapability and 
interferences, the intention of COPD patients in seizing control on managing their 
disease can be seen. Participants varied in different degree in controlling their disease 
and their variety tended to be influenced by their level of agency on self-management, 
personal financial status, personal ability and environmental factors. For patients 
who internalized the teaching into their everyday lives, it was an ideal outcome for 
the programme as the participants integrated self-management activities into daily 
living. It is a process of internalizing external knowledge to becoming a built-in 
capability of the participants. Although Searle et. al.(2007) claimed that patients 
under self-management could implement appropriate changes under varied 
circumstance, changes to the dosage of prescribed medication without professional 
instructions appeared to be problematic. Agency as such could induce potential risk 
of inadequate or over-treatment in the participants. A better agency role needs to 
encompass patient empowerment and be based on a more collaborative approach to 
decision making on healthcare between patients and professionals (Bryan et al., 
2006). 
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7.2.5  Beneficial 
Participants in this study generally expressed favourable outcomes in terms of 
symptom control, symptom alleviation, better breathing, increased activity tolerance 
and more positive life view. There were categorized into three aspects of 
improvements and one aspect of limitation. They were bodily improvement, 
functional improvement, spiritual comfort and individual difference respectively.   
7.2.5.1  Bodily improvement 
Bodily improvement includes improvement in biological body and symptom 
alleviation in the participants after carrying out self-management approaches. In 
regard to biological body improvement, the participants believed that controlled 
breathing helped to expand the lung and enhance lung function.  
Ivan:  I am most impressed by breathing in and breathing out, it’s good for lung 
function. 
SL:  I see, breathing, those involve breathing out, that’s true, it’s good to the 
lung…O…what made you having such a feeling? 
Ivan:  It means the feeling of…you are long-term, its better now for lung inflation 
when taking deep breathing; In the past when I was smoking, my lung could 
not be expanded even I took a deep breath, now is really better, my chest 
expanded when I was deep breathing, I could feel it.  [A321,340,19] 
*** 
Wilson:  It is (participant demonstrates) the breathing that involves breathing in 
and breathing out. Arh..then to the lung it is more comfortable.  
[A260,290,14] 
*** 
Chris:  I….about breathing, when tried working on something..e.g. making 
movement that need forces, walking up stairs, this breathing is mainly 
emphasis on breathing out, and breathing in as a supplement, breathing 
out longer, it mean I know my lung is deeper, with few CO2 inhalation. 
[B9,9,15]   
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The moderator followed up with Ivan’s positive comment on controlled breathing and 
he emphasized his personal feeling of lung expansion. Wilson and Lavin indicated 
that their lungs were more comfortable and they could breathe in deeper during 
controlling breathing. Empirical evidences confirmed that controlled breathing 
increases tidal volumes by 500 mL and improves oxygen saturations by 2.5% 
(Roberts et al., 2009). These clinical changes might result in appreciable day-to-day 
benefit for patients. Although Roberts et al.’s (2009) review concluded that benefit of 
controlled breathing was only significant in moderate to severe COPD, all 
participants in this study commented positively to it regardless of their disease 
severity. It is noteworthy of Ivan’s unfinished sentence “you are long term, its better 
now…”, he might intend to state that the suggested effect on lung required a 
long-term practice of controlled breathing. It is not an overnight effort. Moreover, 
another patterned meaning emerged was how self-management approach has 
controlled or alleviated the ‘stubborn’ symptoms.  
Karen:  But then the dietary, after I ate those, it was..the disease((symptoms)) was 
gone…not so much phlegm, not so much stuffs means controlled…mean 
memorized.  [B695,833,22]   
Karen mainly adopted diet measures to manage her symptoms, and the favourable 
outcome reinforced her memorizing the relevant dietary. In addition to relieving 
symptoms, COPD also largely impacts on mobility or activity tolerance of the 
patients. The meaning of how functional improvement relates to the participants is 
presented in the next section.  
7.2.5.2  Functional improvement 
An individual’s mobility and activity tolerance determines his or her physical 
functional status. It forms one of the fundamental characteristics for a person to live 
as a social being. When a COPD patient is in a very severe stage, they can entirely 
lose this characteristic. Walking and climbing stairs are basic ability for most people, 
however, COPD patients suffer in varying degree from losing these abilities. 
   165 
Therefore, controlled breathing is usually recommended in most disease-management 
programmes as its given short-term benefits experienced over a longer period in 
everyday life may then translate into longer-term benefits in the form of reduced 
exertional dyspnoea and improved functional performance (Roberts et al., 2009). 
Participants in this study excitingly share Ivan’s experience of improving his 
functional status after applying self-management approaches. He said, 
Lavin: After you’ve learnt, it helped you breath, then followed exactly…ha…nurse 
MN’s lesson, then I can do that, can breath. Then afterward, anyway I 
breath usually every day as well, at night also…at night, wake up I breath 
like this…practised like this, sometimes practiced like this during walking, 
then..it is indeed better for the lung. Usually, I…when walked around….not 
even for half a floor, now I can walk for around 4,5 floors.  
[SL:  O..so great. Ar..good good]   
Lavin:  …Really, really what a distance, not kidding!  
[Chris:  (Clapping hands) Excellent, excellent!]  
Lavin:  …not kidding!  
[Karen:  Not really…those stuffs about breathing is really helpful]   
Lavin: …So it is real these things, I usually…ar, went to KWH’s 
emergency…….the place at the outpatient… walked up to the second floor, 
very suffering! My kids helped me for walking up, now I can walk up 4, 5 
floors by myself  
[Chris:  Ok ok fine, U are great]= 
SL:  =Basically what do you feel about this breathing skills no matter in the case 
of exacerbation or in normal situation 
Lavin, Karen:  It’s helpful, really very much helpful!   [B511-540,GD] 
Although the participants have not directly declared that controlled breathing 
improved their mobility or activity tolerance, this can be inferred from their dialogue. 
Lavin recounted this issue by illustrating his improvement in climbing stairs when 
going to the outpatient. Similar performance of doubled stair climbing was also 
indicated in the participants of another educational intervention for COPD patients 
(Kara and Aşti, 2004). Also the enthusiastic response of Chris and Karen added even 
more light to this achievement. Chris’s comment ‘Excellent excellent!’ was 
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spontaneous and confirmed his non-verbal presentation (Clapping hands), hence he 
was sincerely showing his applause (Krueger, 1998). Their applause to Lavin’s 
achievement reflected that they feel what each other feels and functional 
improvement is notably meaningful to them. Functional ability is one of the essentials 
for social activities. As social activities were found to be prominent in an individual’s 
daily life and where solitary recreational activities could be performed and primary 
source of satisfaction could be derived from it (Leidy and Haase, 1996). A study of 
Chinese COPD patients also indicated that social coping strategies could help an 
individual reduce their psychological distress and increase their psychological 
well-being (Hsu et al., 2008). Therefore, functional improvement can make much 
difference in COPD patients. 
7.2.5.3  Spiritual comfort 
COPD cannot be cured and patients frequently have experiences of suffocation, 
inevitably there are experiences of near death and worries about life. Considering life 
and death issues, or specifically the meaning and purpose of life and the nature of 
death takes one already into the dimension of spirituality (Cockell and McSherry, 
2012). Spiritual needs involve questioning like ‘is life no longer worthwhile?’, ‘what 
is the meaning of life?’ (Murray et al., 2004). Here below, two participants of two 
different focus groups provided their life view after the intervention. 
Nick:  It means I understand what kind of disease we are having through the 
workshop, the main problems of it, so, we learnt all these through the 
workshop, although it is dreadful, still if you pay enough attention to all 
these, the lifespan is still able to be extended, can be treated well in time.. 
[A926,1049,8]   
*** 
Chris:  Original was waiting for death, its finished, its finished this time, this time 
the journey of life stop here, face the fate…!! Then the workshop, learnt a 
lot, to practice those theories…ar…it was really effective! I still have few 
years left for my life, I still can finish something which I really want to do.  
[B605,733,15]   
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Nick and Chris are two patients among the groups in a very severe staged (Stage IV) 
disease. Both of them had experienced respiratory failure before participation in this 
study, their perception to COPD has now drastically changed from dreadful and fatal 
to treatable and hopeful. They presented with the belief that self-management can 
help to prolong their life span. No matter life prolongation would eventually happen 
or not, a positive life view established would sufficiently support the spirituality of 
these patients. It is because life prolongation did not mean prolonging suffering to 
them, rather they were looking forward and anticipating living life with more 
meaning.   
In nursing, we often put emphasis on delivering holistic care where we care for the 
totality of a human being. According to American Holistic Nurses Association’s 
definition (2012),  
“holistic nursing is all nursing that has healing the whole person as its 
goal.” (Thornton, 2008). 
In this section, patients delineated improvement in biological, functional and spiritual 
aspects which covered the targeted physical, emotional, mental and spiritual 
dimensions in holistic nursing. SMEP thus has provided varying degree of healing 
for the whole person. Healing in this case does not mean becoming sound and 
healthy again, but refers to alleviation and attainment for best possible well-being. 
Nevertheless, nothing is perfectly good or free from obstacles. SMEP indeed was not 
beneficial in all circumstances. Limitation of SMEP was found in the words of the 
participants and it forms the next category, individual difference, under the 
sub-theme of beneficial. 
7.2.5.4  Individual difference 
Effectiveness of SMEP or self-management in COPD patients was believed to 
depend on one’s disease severity and one’s personal health belief across the focus 
groups. These two aspects vary from person to person and they largely determined 
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the success of self-management approaches. In terms of disease severity, COPD is a 
progressing chronic disease which pathological changes in the respiratory system 
deem to be largely irreversible (GOLD, 2013). Based on this fact, the effectiveness 
of SMEP may have its limitation as the disease severity of the patient increases. 
Relevant meanings emerged in two participants as below: 
Nick:  during exacerbation, you really can’t do much……..You will not be ok 
once this kind of disease became serious, you totally couldn’t stand for that 
when you found difficulty in breathing.  [A881,1001,8] 
*** 
Ivan:  I think its sufficient now  
[ SL :  It’s sufficient already…I see]  
Ivan:  …seems like I can feel it, maybe I have recovered a little bit better, not as 
serious as him (Nick), so I think it should be sufficient.  [A1076,1230,19] 
Nick and Ivan were in different severity stage of the disease with Nick in stage IV 
and Ivan in stage III of COPD. Ivan thought the programme had helped to improve 
his condition and the content is sufficient to him. However, self-management 
approaches seemed to have made less difference in Nick’s case. I particularly noticed 
that the participants automatically related this difference to their severity of disease. 
The quantitative results of this study were also inconsistent on this point as the 
participants demonstrated poor self-efficacy and HRQoL when the severity of their 
disease increased (Refer to Chapter six, Part 4). In contrast, Lefevre et al.’s (2002) 
systematic review suggested that benefit from SMEP was presumed more likely to be 
seen among asthma patients with higher baseline severity of illness. This may be due 
to the comparably irreversible and progressive nature of COPD. Failing in fulfilling 
the expectation of improvement could lead to disappointment and failure in the 
minds of the participants with unjustified hopes (Jones et al., 2005). It is painful to 
come to realize that there is a limitation in the meaningful enhancements for COPD 
patients that SMEP can bring. This indicates that the delivery of this programme to 
COPD patients should not be delayed and should be conducted at their earlier stage 
of the disease. On the other hand, the participants also believed that the impact of 
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self-management varied from person to person in accordance with the individual’s 
concept or philosophy of health and health maintenance. Some participants 
repeatedly highlighted this individual difference in the focus groups, one of them 
said:  
Karen:  My stomach can’t tolerate food in cold nature, it means the food like 
melons those people, some people said, papaya is good for some 
diseases like having constipation, I can’t take those. Also like banana, 
both food are not suitable to me, my body is like this.  [B245,299,22] 
Generally Chinese people in Macau have a mixture of ideas from the Western 
Medicine and Traditional Chinese Medicine (TCM). Relevant concepts have been 
included in diet instruction as suggested by the TCM physician during the 
development of the SMEP. Obviously, in the above extract, Karen adopted in her 
choice of diet the Yin-Yang theory of TCM, according to which cold and heat 
properties can help to regulate the pathophysiological condition of the body (Yin et 
al., 2012). Thus Karen believed that individual difference would induce varied effect 
even with the same diet. This implies that the adoption of self-management might 
vary from person to person under this cultural influence.   
To conclude the beneficial perception and experiences of the participants derived 
from self-management, the pattern of positive impact covered the holistic well-being 
of an individual, ranging from biological, functional to spiritual improvement. This 
corresponds to the complex construct of SMEP which aims at improving 
multi-aspects of the COPD patients. However, the benefits from self-management 
were not perceived and happened in all participants. Individual difference in relating 
to disease severity and personal health belief was emerged as limiting factors to the 
success of the intervention. Disease severity was negatively associated with the 
effectiveness of self-management while one’s personal health belief may filter 
certain self-management content which contradicts pre-existing health belief. In the 
following section, discussion will be made on how the theme and sub-themes 
correlated with each other.         
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7.3  Relationship of the Main Theme and Sub-themes 
All the theme and sub-themes illustrated in the previous sections were not emerged 
exclusively in independence from each other, conversely, they were interactively 
correlated to comprehensively express the perception and experience of 
self-management by COPD patients. They were interweaving in a way that a 
converging message of essentiality in self-management or SMEP was prominent 
among the participants and among the sub-themes. A diagrammatic framework of 
these relationships is developed and shown in diagram 2 below.  
Firstly, essentiality appears at the top of the diagram and it is related to helplessness 
and support on the left wing, mutual involvement and control on the right wing and 
beneficial sub-theme on the bottom. Secondly, self-management made COPD 
patients turn from helplessness to feeling supported and at the same time mutual 
involvement promoted control, both support and control ultimately achieve 
beneficial perception and experiences in
Diagram 2  Emerging theme of Essentialtiy 
them. However, the variation of beneficial perception and experience could reverse 
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the level of involvement of COPD patients in self-management or result in more 
helplessness in them. Due to the adverse influence of incapability, interference and 
individual difference on the success of SMEP, self-management is in no way 
taken-for granted in the participants’ view. In the following sections, more 
elaboration, with focus group extracts, is presented to articulate the relationships as 
mentioned. 
7.3.1  Relationship of Helplessness, Support and Beneficial 
The relationship of these three sub-themes is revealed, in a way, that the more 
participants felt helplessness (miserable, futile, urgency and/or negligence) in 
managing their illness, the more support they may feel after engaging in 
self-management. Subsequently, they might feel that this approach was even more 
beneficial, and converse happens as well. In an extract provided from Chris, it 
explicitly displayed the relationship of these concepts: 
Chris:  (.2) Before, my condition…was very serious, through the check up by 
doctor, it was certified…ha…certified by KWH, the coefficient my lung 
function was only 31, normal people is 80, so I thought it’s hopeless when I 
knew the fact! Waited for my death at home, just a matter of time! Then 
afterwards learnt from nurse MN…learnt a lot, improved, in terms of 
improvement, in particular the dietary, in term of dietary… means I ate 
more side dish, vegetable, it is documented in books, means reducing the 
portion of carbohydrate, the intake of carbohydrate would be resulted in the 
production of CO2 of the body, I know it should be very careful as 
mentioned here. Sometimes I took vegetable as rice.  [B364,438,15] 
In the first three lines, Chris expressed how miserable he was when confronted with 
the diagnosis and it then drove him to having a futile feeling. In the fourth line, he 
pointed out the knowledge support gained from nurse MN and he believed that this 
support improved his condition. His improvement was indicated as a spiritual comfort 
which enable a change from previously feeling hopeless of life to becoming actively 
engaged in self-management. It is also noteworthy that prior to receiving SMEP, 
Chris showed no anxiousness about finding coping measures. Instead, he gave up on 
himself by waiting for death at home. This behaviour was also suggested in Yuet et 
al.’s study that the psychosocial adjustment of Chinese COPD patients was indicated 
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to be poor. Their use of various coping strategies was moderate to low in frequency 
and a fatalistic coping style was generally adopted to manage their chronic condition 
(Yuet et al., 2002). This remarkably indicates that SMEP should be undertaken in a 
pro-active approach when delivered to the COPD patients. Once Chris received 
information about self-management from Nurse MN, he realized the essentiality of 
self-management to his condition, as he stated in his second last sentence that ‘I know 
it should be very careful as mentioned here’. The ‘as mentioned here’ clearly referred 
to the information given in the workshop and he conceived it as essential to improve 
his condition. 
7.3.2  Relationship of Mutual involvement, Control and Beneficial 
Following the line of reasoning in previous section, I also noted that the relationship 
of the sub-themes of mutual involvement, control and beneficial were interactive in 
COPD patients when they adopted self-management. Basically, when the participants 
take part to a greater extent, they could feel stronger control on their disease and thus 
perceive and/or experience beneficial element from self-management. Here, through 
the following extract, the group has demonstrated the suggested interactive 
relationship:    
Leon:  the best part is when you are short of breath…well..well teach you to use a 
several pillows, that part…that gesture really is quite good…it was a bit 
useful, don’t say it is of no use!  
Karen:  Useful, absolutely useful. 
SL:  I see..I see 
Leon:  Lifting up the back to …to.. 
[Lavin:  the contrast is big!]   
[Karen:  Those things are in the clip]  
[Lavin:  If you are having those symptoms, the pillow is very important, high or 
low very important to breathing] 
Leon:  …the effect is great!  
Karen:  For me, since kid..I need almost 2 pillows. 
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Chris:  I didn’t feel it! 
Lavin:  I felt it. 
Chris:  I don’t have experience in this, now have to learn for a bit  
Lavin:  When you can’t breathe because of putting flat  
[Karen:  not working when seriously suffered]  
[Chris:  got to a bit higher!?]  
Lavin:  …the back and the breath were smoother.  
[Chris:  I see!]  
Lavin:  if it is in a more serious case then lift up a little bit  
[Leon:  turn on the fan during severe situation...well, taught by Nurse MN]  
Lavin:  …because you push against your lung, then no space for it.  
[Karen: those ((turn on the fan)) depends on individual body status]  
[B1422-1446,GD] 
In the first and second last sentences of the extract, Leon mentioned twice about the 
teaching from the professional where he in turn participated in it. He then 
internalized the tactic to his sleeping position. At this point, Lavin reported similar 
experiences. Both of them were even able to adjust the height of the pillow in accord 
to the severity of the breathing problem. This implies a sense of control in them and 
the participation and control gained in self-management led to the alleviation in 
breathing. This indicated an improvement in the biological aspects of the patients. 
This extract thus presents the interactive relationship suggested in the beginning of 
this section. Furthermore, the way Leon and Lavin spoke revealed that benefiting 
from such an internalized experience has strengthened their involvement and 
confidence in controlling the disease. Since the tactic was repeatedly commented as 
‘absolutely useful’ and ‘important’, essentiality was identified to be recognized 
among the group for self-management approaches. Hence, Leon and Lavin were 
promoting the tactics persuasively to Chris and Amy. This suggests perception 
and/or experiences of benefits through involvement and seizing control and this 
positive feedback probably further stimulates one’s further involvement and control 
in COPD self-management. Consistent with self-efficacy theory, one’s performance 
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accomplishments produce high coping efficacy and self-capability judgment as such 
determines the choice of activities and performance mastery, in turn, can boost 
perceived self-efficacy in a mutually enhancing process (Bandura, 1982). It therefore 
helps to explain how beneficial perception and experiences gained from 
self-management enhance one’s enthusiasm in participation in self-management and 
in control of the disease.  
Nonetheless, it is noteworthy to identify the response of Karen throughout the above 
conversation. Although she thought that sleeping on several pillow was helpful to 
improve breathing condition during sleeping, she still had offered two divergent 
opinions in her last two comments. She stated “not working when seriously suffered” 
and “those depend on individual body status”. In her first opinion, she tried to 
explain that the tactic was ineffective for severe COPD, and that means such a 
self-management approach could not resolve the breathing problem for all stages of 
COPD patients. Her response implies that the severity of disease diminished the 
sense of control over the disease. Another participant, Mr. Lee, also commented how 
disease severity affected his perception on managing his illness. 
Mr. Lee:  Now the doctor said, you have already been using the best treatment  
[Mrs. Lee:  Has done all we should]   
Mr. Lee:  …Has done all we should, at the moment just hope it would not 
progress, it is impossible to get well  
[Mrs. Lee:  Therefore, so worrying]   
Mr. Lee:  …Then what solution do you have? You teach me, how can I still have 
confidence!?   [C618,17] 
Mr. Lee was in the very severe stage of COPD and he expressed that the disease 
severity prevented him from achieving improvement from any means. The 
expression of ‘have done all we should’ has raised a pessimistic emotion in the Lee 
couple. This in turn adversely affected their confidence in participating in the control 
of the illness. Mr. Lee made a frustrating remark of ‘Then what solution do you have? 
You teach me’ and this challenged the limited effect of SMEP on his relatively 
severe condition. Due to his belief of having used the best treatment and having done 
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everything, it is likely that is what causes his poor participation in any avenues other 
than medical treatment, and his low motivation of control over his disease with 
self-management measures, resulting in low beneficial perception from SMEP. This 
relationship is demonstrated on the right wing of the diagrammatic framework in 
diagram 2 above.  
In Karen’s second opinion in the previous extract, she thought that fanning 
recommended by Leon was not suitable to all patients, but was dependent on 
individual bodily status. What she was stating about the adaptability of one’s bodily 
status reflected her own belief of body health balance. Having such personal belief 
could possibly affect her activeness in applying that particular self-management 
tactic. In this point of view, personal health belief demonstrated individual difference 
in perceiving and accepting intervention, and this affected the motivation of applying 
self-management approach. Therefore, individual difference as a limitation in 
perceiving benefits may influence one’s degree of involvement in COPD 
self-management.  
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7.4  Summary 
The findings of this chapter are derived from thematic analysis on three focus groups 
which revealed the perceptions and experiences of Macau COPD patients of 
self-management. As subjects of a complex intervention study, the participants of the 
focus groups from time to time compared their perceptions and experiences of 
self-management before intervention with that of after intervention. Among all data, 
essentiality emerged as a major theme and coordinated with five sub-themes namely 
helplessness, mutual involvement, support, control and beneficial. Essentiality 
represented what the participants perceived, experienced and eventually anticipated 
for COPD self-management. Initially, I laid out how the concept of essentiality 
authentically underlies the perception and experiences of participants in 
self-management. Then, I further illustrated the meaning of essentiality in other five 
sub-themes and how each sub-theme represents the meaning of self-management in 
the participants. Lastly, I have demonstrated the interactive relationship of these 
theme and sub-themes. When the participant perceived self-management as essential 
to themselves, they were more likely to feel helpless if they were not able to get 
access to it, otherwise it was supporting and beneficial to them. Active participation 
in self-management and effective control on the disease may enable the participants 
to perceive or experience benefits from COPD self-management. Nonetheless, there 
was a tension between the desire for SMEP in the participants and the provision of it 
in the society in reality. Incapability, interference and individual difference also 
appeared as limitations among the participants with regard to the possible success of 
self-management intervention. Mutual involvement of individuals, medical 
professionals, families and government in promoting and participating in COPD 
self-management was a future hope of the participants. In this study, a divergent case, 
participant’s spouse joined in one focus group and she provided a different angle of 
COPD self-management. In future research directions, it will be valuable to explore 
the perception and needs of spouse or caregiver towards COPD specific 
disease-management. A different set of themes may emerge from this special group 
of participants in COPD management. All in all, belief of essentiality in 
self-management was found in this study as a pre-condition for successfully 
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promoting, implementing and practicing COPD self-management in all levels of 
stakeholders in the society. In the following chapter, both the quantitative and 
qualitative findings will be mixed and examined in relation to the research aims and 
discussed with reference to the established literatures. 
   178 
   179 
Chapter Eight  Discussion and Conclusion 
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8.1  Introduction 
COPD is an incurable disease, but it is preventable and treatable. Historically, COPD 
patients in Macau have been mostly managed in the acute care setting and there is no 
demonstrable evidence for the effectiveness of nursing management in this patient 
group. This study has adopted an embedded mixed methods approach to examine the 
effectiveness of SMEP in COPD patients in Macau. This discussion chapter provides 
a meta-inference through connecting the findings from the quantitative and 
qualitative data. Attention has been given to proposed theoretical framework 
throughout the process. This chapter is divided into six distinct sections. Section one 
will discuss the demographic and clinical characteristics of the subjects within the 
study. In section two, findings derived from the illness perception and self-efficacy 
scales will be critically explored, with a specific focus on how these beliefs 
interrelate and influence self-management of COPD patients. The effects of SMEP 
on inhaler technique in the COPD patients will be discussed in the third section. A 
critical review of the biomedical findings, healthcare utilization and HRQoL of the 
patients after the programme is provided in fourth section. In section five, factors 
which were identified to have a statistical association with domains of illness 
perception, self-efficacy and HRQoL will be examined. Finally, I will present a 
conclusion of the study in terms of the significance, nursing implication, practical 
application and limitations of the study and potential directions for future research.  
8.2  Comparable characteristics of the study samples 
The recruitment rate of the study sample was 57.3%, comparatively low in 
comparison to those reported in previous studies which ranged from 70.8% to 84.6% 
(Lin et al., 2012, Bucknall et al., 2012, Watson et al., 1997). These studies also 
adopted similar recruitment methods of screening diagnosed COPD patients in 
settings of hospital, general practitioner clinic and/or community health for eligibility. 
In this study, however, the lack of standardized diagnostic criteria for COPD in the 
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clinical setting in Macau may have led to wide variation among the Macau 
physicians in the clinical diagnosis. This factor could potentially induce a number of 
‘false positive’ diagnosis of COPD patients.  Despite these findings, the general and 
between groups dropout rates were similar to those reported in previous studies 
(Watson et al., 1997, Monninkhof et al., 2003, Lin et al., 2012, Bucknall et al., 2012, 
Effing et al., 2007, Swerissen et al., 2006, Siu et al., 2007). Thus, Macau COPD 
patients generally presented with similar characteristics of participation as 
participants in previous reported COPD studies. 
In terms of sex distribution, mean age and amount of smoking, the sample of this 
study is consistent with those demographic characteristics reported in previous 
COPD interventional studies (Kara and Aşti, 2004, Blackstock and Webster, 2007, 
Bucknall et al., 2012, Lin et al., 2012, Zhou et al., 2010). When comparing the 
clinical characteristics, the sample was consistent with that in previous studies in 
regard to year of diagnosis (Howard et al. 2009) and mean pre-BD FEV1 and mean 
pre-BD FEV1 % predicted (Bucknall et al., 2012, Howard et al., 2009, Blackstock 
and Webster, 2007, Lin et al., 2012, Jean, 2003, Bourbeau, 2003, Watson et al., 1997, 
Gallefoss, 2004), and that indicated moderate to severe levels of COPD. Despite 
these similarities, these participants still possessed unique factors, such as, low 
education, less current smokers and less concomitant diseases. These factors will be 
explored in the subsequent sections of this chapter. 
8.2.1  Low educational levels 
Most participants in this study had received either primary or lower level of 
education, which appears lower than levels of COPD patients in studies in Western 
Europe (Rootmensen et al., 2008), in the United Kingdom (Howard et al., 2009), in a 
region with similar culture, like Hong Kong (Siu et al., 2007) and Guangzhou city of 
Mainland China (Zhou et al., 2010). Interestingly, the educational levels of our 
participants was higher than that of COPD patients in one Turkish study (Kara and 
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Aşti, 2004). It could be speculated that lower educational level of Macau patients 
may impose effects on the learning and mastery of the content of given SMEP in 
them. To resolve this problem, clear and picture-based educational material with 
simple language and in easily understandable format was developed to reinforce 
patient understanding (DeWalt et al., 2004). 
8.2.2  Fewer Current Smokers 
This study reported a lower proportion of current smokers and larger proportion of 
ex-smoker than seen in other recent studies (Bucknall et al., 2012, Lin et al., 2012, 
Zhou et al., 2010). In other words, COPD patients in Macau are more likely to have 
stopped smoking before the study than has been reported in earlier studies. As 
smoking is one of the greatest contributing factors to the development of COPD, the 
participants in this study may have already actively ceased smoking following 
diagnosis. Another reason may be the impact of the new regime of tobacco 
prevention and control which took effect in Macau on 1st January, 2012 when the 
data collection was taken place (SSM, 2012b). Participants might have ceased 
smoking in response to this law before participating in this trial.     
8.2.3  Less number of Concomitant Diseases 
As reported in earlier COPD studies, some participants in this sample suffered from 
disease(s) other than COPD, but they were prone to report less concomitant diseases 
than reported by Bucknall, et al (2003) (1.18 < 2.8, SD 0.98 < 1.9). Therefore, 
concomitant diseases potentially impose less influence on the Macau sample in 
relation to symptom-management and quality of life. However, this may also happen 
if their concomitant diseases have been underdiagnosed due to lack of standardized 
diagnostic systems in Macau.   
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In summary, the sample of this study shared many similarities like gender 
distribution, age, dropout rate, pulmonary function, year of diagnosis and amount of 
smoking with previous related COPD studies. Conversely, it showed a comparatively 
lower recruitment rate, educational level, less current smoker and concomitant 
disease as well as higher proportion of ex-smokers. Due to limited and heterogenous 
reports of working status, living conduction and medical expense payment, no 
conclusive discussion can be made on these aspects. Based on the general 
demographic and clinical characteristics of the sample, Macau COPD participants 
were generally found to be comparable to the COPD patients in other studies.  
8.3  Relationship of illness perception and self-efficacy in 
self-management behaviour  
The theoretical framework of this study implies that the beliefs of illness perception 
and self-efficacy supplemented each other to induce health-related behaviours. The 
following paragraphs explore and examine the findings from the IPQ-R, CSES and 
the correlation analysis of their subgroups against the proposed interrelationship of 
the two beliefs.   
8.3.1  Perception of Illness identity of COPD patients in Macau  
The reporting of illness identity is the process of matching somatic symptoms to an 
illness label. It is an expression of one’s experience and beliefs about the illness 
symptoms (Moss-Morris et al., 2002). The sample of this study reported a relatively 
lower mean number of symptoms (4.69, SD=2.63) than that revealed by the COPD 
patients in two other studies (> 5.3, SD ±2.2 – 2.86) (Fischer et al., 2010, Scharloo et 
al., 2007, Howard et al., 2009). The lower education level of the participants may be 
associated these lower identity scores (Yan et al., 2011). Moreover, this identity 
dimension was seen to be positively related to reports of poor functioning, disability 
and inversely related to patients’ own ratings of control over their health problems 
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(Weinman et al., 1996, Kaptein et al., 2008, Scharloo et al., 1998). The results of 
bivariate correlation in this study provides further support to the view that more 
illness identity perceived by the patients was likely to hinder their overall 
self-efficacy and particularly their self-efficacy in managing shortness of breath and 
their ability to deal with intense emotions. Perception of lower levels of illness 
identity in Macau COPD patients may relate less adverse effect on building 
self-efficacy to manage their disease.   
Breathlessness was the most commonly symptom perceived in this sample, 
consistent with findings of Howard, et al. (2009) and Scharloo et al. (2007) studies. 
According to Weinman et al.’s (1996) notion, identity dimension is assessing the 
patient’s ideas about the label, the nature of their condition, for instance, associated 
symptoms and the connections between them. On this basis, most patients (98%) in 
this study have labelled breathlessness as the main identity of their illness. Following 
breathlessness, sleeping difficulties (63.3%) and fatigue (61.2%) were also identified 
as the illness labels. COPD patients often suffer from chronic cough, sputum 
production or exertional dyspnoea caused by progressive impairment of pulmonary 
function. Chronic cough may disturb sleeping patterns and be influential among 
these patients. When their disease severity reaches stage III (Severe COPD) in 
accordance with GOLD’s classification, repeated exacerbations and fatigue are 
prevalent in them. These were the chief complaints of patients with COPD. 
Surprisingly, the patients also identified pain (16.3%) and stiff joints (14.3%) which 
are not very commonly associated with COPD. Scharloo et al. (2007)’s study 
reported similar findings in 171 COPD patients who were claimed to be less sure to 
attribute these symptoms to their COPD. In one focus group, Winnie expressed the 
following view:
“Sometimes, do you find very very painful with here (chest) when wheezing?” [B493] 
If the patient has experienced some unidentified pain during the time that they are 
suffering from wheezing, they then tended to relate this sign of pain to their lung 
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problems as it appeared consistent with their breathing disorder. In relation to the 
symptoms of stiff joints, Mrs. Lee (Mrs. Lee’s wife) mentioned the following: 
 “He is kind of avoiding moving around, I’m now worrying ….I don’t want to, 
especially lately…perhaps he suffers from wheeze…he is basically unable to walk, 
and just lie there. But the doctor said this is not good, you couldn’t be just like that, 
this is what I’m worrying about him.”  [C347] 
Although Mrs. Lee has not exactly expressed what consequences she was worrying 
about Mr. Lee’s behaviour, it was probably condition resulting from long time 
restricted mobility, for instance, wasting syndrome. Stiff joint, as one of those 
symptoms, may be identified to be related to the outcomes of COPD. Additionally, 
the possibility of their lack of knowledge about the symptoms of the illness cannot be 
ruled out.  
8.3.2  Perception of Illness representations of COPD patients in Macau  
The study sample, generally, perceived COPD as a chronic, cyclic illness with 
serious consequences that could be controlled through treatment and adaptive 
personal behaviour, and they believed that they had a negative affective response and 
poor understanding to COPD. This finding is not fully consistent with the illness 
representations indicated in studies performed on COPD patients in Europe where 
patients reported better understanding of the disease, but had poorer personal or 
treatment control over their disease (Scharloo et al., 2007, Howard et al., 2009). 
However, this sample was consistent with the illness representations reported by 
Chinese patients with myocardial infarction (Yan et al., 2011). It could be suggested 
that this may potentially be the general pattern of perception in Chinese patients 
across chronic illnesses.   
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8.3.2.1  Perceived Timeline after Self-management Education Programme 
The results suggest that participants who underwent SMEP perceived COPD to be 
more chronic in nature than pre-intervention. The above mid-point score (SMG 3.49, 
SD 0.84; CG 3.43, SD 0.84; score range 1-5) on the timeline acute/chronic 
dimension in this study sample showed that, in general, patients believed their illness 
to be permanent. It was argued that even in the natural course of having a COPD 
diagnosis, patients’ perception of chronic timeline of their condition increases with 
time from diagnosis as the patients’ illness experience changes (Fischer et al., 2010, 
Weinman et al., 1996). Fischer et al. (2010) explained that one may initially tend to 
perceive their health threats as acute, as a result of medical care response which is 
primarily focused on treatment of acute conditions, so the individual may expect 
illnesses to be an one-off condition. However, as time goes by, patients gradually 
suspect or realize that their condition may have a chronic timeline, rather than one 
–off acute episode. Fischer et al. (2010) supported this notion by indicating that 
COPD patients who were diagnosed five years or more had stronger perceptions 
about the chronicity of their illness. The chronic timeline of COPD patients condition 
grew stronger after the self-management education in this study, this may be due to 
the educational content on exacerbations and disease trajectory provided in the 
workshop, that highlighted the chronicity of COPD.  
Scharloo et al. (2007) indicated that if people perceived their condition to be less 
chronic then they displayed better physical function. Conversely, chronic timeline 
perception may drive the patients to adopt a more long-term management approach 
rather than relying only on acute coping strategies. This may be because perception 
of the illness duration has directly affected the willingness of the patient to commit to 
changes in their lifestyles. That is, the longer the time participants anticipate the 
impact of the condition, the higher their specific self-efficacy to maintain a change of 
diet or exercise regime (Lau-Walker, 2004, Lau-Walker, 2006). This was not 
apparent in the bivariate correlation analysis of chronic timeline and self-efficacy in 
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this study. One possible reason for this may be that CSES used in this study is a 
general self-efficacy assessment scale and it was not particularly designed to assess 
self-efficacy in relation to specific dimension. However, Lau-Walker (2004)’s study 
on cardiac patients suggested that they perceived general self-efficacy and specific 
self-efficacy as quite different concepts. General self-efficacy is defined as “an 
individual patient’s perception of the effects of physical, social, economic and 
emotional consequences on their life after their diagnosis “(Lau-Walker, 2004). 
Therefore, a patient’s general self-efficacy may not reflect his or her confidence in 
making and sustaining specific changes in exercise or diet. In one diabetic study, 
Searle et al. ‘s (2007) further supported this point by indicating that partners’ 
timeline representations mediated patients’ levels of physical activity and dietary 
regimen. As this study neither attempted to assess specific self-efficacy of the 
patients nor their partners’ illness representations, no conclusive inference could be 
drawn whether such an association was missed. Meanwhile, the focus group 
interview findings presented these relevant and insightful comments: 
Amy:  Ar, don’t know it is like this not until it became like this, so got to start 
protecting myself now.   [A245,276,10] 
*** 
Karen:  I…played attention on diet, tried to avoid those food which I usually take, 
it exacerbated once I took those food…became more serious, then I stopped 
taking those food another time.   [B211,255,22] 
Amy expressed the urgency to adapt to a more protective mode of management 
after realizing the nature of the disease and her words displayed her enthusiasm 
to adopt such protective health measures promptly. Karen wished to alter her 
dietary habits to avoid progression of her disease. They both sensed that they still 
have to live with their COPD for a long time, and as such they tended to respond 
to it with readiness adopting appropriate changes in their lifestyle as required. 
These comments reflect a level of confidence in making such specific 
behavioural changes. Nonetheless, an alternative explanation for the lack of 
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correlation between chronic timeline of illness and self-efficacy is that the 
self-efficacy of COPD patients in Macau is predicted by factor(s) other than the 
duration of timeline of the condition. 
8.3.2.2  Perceived Personal control after Self-management Education Programme 
Instead of improving the personal control of COPD patients through SMEP, my data 
showed that those patients who were not allocated to the interventional programme 
significantly perceived themselves to have less personal control over their disease. 
Fischer et al.(2010)’s study indicated that perception of personal control in COPD 
patients decreased over time. They argued that as the disease progresses steadily over 
the years, it is usually associated with more intense symptoms and more frequent 
exacerbations and disease-associated disability. Therefore, COPD may potentially 
impose increasingly difficulties on patients to perform or cope with daily activities. 
This may lead patients to gradually lose confidence in their ability to control the 
illness. Provided the disease severity of the participants of both SMG and CG were 
homogeneous and they were under same length of time for follow-up, participants in 
CG perceived significant lower personal control at the follow-up assessment while 
those in SMG remained unchanged. SMEP, in this case, may still have helped to 
maintain or sustain the patients’ losing confidence in personal control over time. 
However, perception of personal control in uneducated patients appeared to diminish 
naturally. In addition, perception of a low sense of control appears to be associated 
with poorer outcomes, exemplified by, functional status, disability, depression and 
anxiety (Kaptein et al., 2008, Scharloo et al., 1998). The bivariate correlation 
analysis in this study also demonstrated similar findings that the more one perceived 
better personal control the more confident one could be confronting physical exertion. 
Lau-Walker (2004) reported corresponding results that patients who felt capable of 
controlling their situation were more likely to show high general self-efficacy and 
also high self-efficacy specifically in exercise which requires physically exertion. 
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One patient in the focus group who proclaimed herself to have a stable and 
controlled condition of COPD made the following statement: 
Winnie:  I just feel better this year, when I carry one whole bin of trash in previous 
years, cos I’m a cleaner, I had to stop and rest for two to three times when I 
carried a bin of trash…carried to the corner of the street, really 
[SL:  Feel better this year..]  
Winnie:  …feel much better this year.  [C92,9] 
The qualitative data in this study supports and enhances a better understanding of the 
bivariate correlation quantitative findings in this study. The previous quote highlights 
that when the participant felt of in control of their condition, she identified 
appropriate activities for improvement. The physical sensations that patients 
experienced can be used as a sensory information to alter their representation of the 
event (activity of physical exertion) and coping process (Johnson, 1999). Therefore, 
it may be equally important to provide informational material as well as experiential 
instructions in the SMEP as this may help to enhance the patients’ sensations and 
confidence in performing activity of physical exertion.   
8.3.3  Perception of causal attributions to COPD in COPD patients in Macau 
Causal attribution analysis has rarely been reported and often been neglected in 
COPD research which has employed self-regulatory theory or self-perception theory 
(Howard et al., 2009, Fischer et al., 2010, Kaptein et al., 2008). Macau COPD 
patients were more likely to attribute immune factors and risk factors more to their 
disease than psychological factors or by chance. This was quite different from the 
findings in Scharloo et al. (2007)’s study. Own behaviour (own behaviour and 
smoking) and psychological causes (i.e. stress, mental attitude, family problems, 
emotional state, and personality) were the commonest perceived cause of COPD than 
immune factors and by chance. It is worth noting that the same tool for assessing this 
causal dimension was not used in this study. The own behaviour subscale used in 
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Scharloo et al. (2007)’s study was integrated with a larger risk factor subscale used in 
the current study. In this sense, patients in both studies believed that external factors 
(i.e. risk factor) were the main causes of COPD while Macau patients tended to 
attribute their COPD more to physical reason (i.e. immune factors) than to 
psychological factors. These perceptions remained generally consistent before and 
after participation in the SMEP.    
An altered immunity, pollution and ageing factors were the three causal attributions 
most strongly as individual causative factors believed by the participants throughout 
the study. These were closely followed by smoking and overwork. However, after 
SMEP, more participants tended to report smoking as attributable to the development 
of their disease and less patients reported “don’t know or never thought of”. These 
findings are in contrast with studies by Hoth et al. (2011) and Scharloo et al. (2007)’s 
studies where smoking and own behaviour were perceived as the main causes by the 
COPD patients. Improved cognitive understanding of causal attributive belief after 
SMEP implies that patients who reported “don’t know or never thought of” prior to 
the commencement of the study may be due to inaccessibility to disease-related 
information or uncertainty about the stated propositions. Their low educational level 
may have hindered their access to and appraisal of information. ‘Optimistic bias’ was 
indicated in Hong Kong Chinese to affect their perception of risk of coronary health 
disease, this optimistic bias may also have existed in this sample (Chan et al., 2011). 
‘Optimistic bias’ or ‘unrealistic optimism’ refers to people who tend to underestimate 
their own risk of disease. On the contrary, we cannot exclude the responsibility of the 
Macau healthcare workers in Macau to provide appropriate disease-related 
information to these patients. As the principle researcher, observations revealed that 
most patients were neither told the proper or full name of their diagnosis nor 
disclosed of diagnosis in an open manner. This might potentially mislead the patients 
into adopting a less attentive way of confronting their chronic illness.  
Nick:  then now after attending the workshop know this is COPD.  [A109,120,8]   
*** 
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Nick:  Umum…if not that I didn’t pay much attention to this disease before, and I 
also didn't know the severity of it.  [A932,1057,8]   
COPD patients in Macau appeared more prone to attribute external (pollution) or 
uncontrollable factors (i.e. altered immunity and ageing) to the onset of their 
condition. Conversely, patients in Hoth et al. (2011) and Scharloo et al. (2007)’s 
studies attributed own self’s behaviour as the main attribute. It may be speculated 
that a comparatively large proportion of participants in this study ceased smoking 
before study participation and their COPD has not subsequently resolved. These 
individuals may be more likely to attribute their illness to external or uncontrollable 
factors. Alternatively, patients may simply deny or avoid their own personal 
responsibility for causing their disease, and be embarrassed to confront or admit any 
wrongful behaviour. In relation to these findings, two patients in different focus 
groups stated, 
Leon:  For myself, I’ve never get sick  
[SL:  Um um um]  
Leon:  Have not been got sick for decades, It was since...now I mean before the 
workshop I went to KWH, that time, maybe went out to those road, cause I 
am a delivery worker, inhaled some dust, together with smoking, it then 
became like this.   [B470,569,12]   
*** 
Nick:  This is, this is a kind of environmental problem, related to pollution, some 
related to job duty, some related to smoking.  [A818,929,8] 
Under the influence of Confucian relationalism, Macau Chinese COPD patients 
might try to restore ‘face’ by pulling in various causal factors other than own risk 
behaviour. ‘Face’ is a kind of ‘social contingent self-esteem’ which is diminished 
through negative social evaluation of one’s social or moral acts and vice versa 
(Hwang, 2012). Hoth el al. (2011) suggested that attributions about the cause of 
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COPD may be particular important for one to determine their disease management 
approach. Therefore, it is crucial to provide understandable, ‘face-protecting’ and 
evidence-based preventive information in the educational programme to assist them 
to effectively avoid the attributing factors of their disease. 
8.3.4  Relationship between Illness perception and Self-efficacy 
Quantitative analysis of the eight illness representations with subgroups of 
self-efficacy revealed that improvement in three dimensions (personal control, 
treatment control, illness coherence) and the reduction in four dimensions (identity, 
consequences, timeline cyclical, emotional representations) of illness perception are 
more likely to enhance self-efficacy in general, whereas ‘timeline’ did not 
demonstrate association with all aspects of self-efficacy. Discussion on ‘personal 
control’, ‘identity’ and ‘timeline’ received critical review earlier in this chapter, the 
association of the other illness representation variables and self-efficacy will now be 
discussed in this section. Improvement in the perception of ‘treatment control’ in 
COPD patients is found to be more likely to improve their confidence in managing 
negative effect, intense emotions and physical exertion and general self-efficacy. In 
other words, patients may perceive that the treatment controllability helps with the 
management of exacerbation, to stabilize emotions and to tolerate physical exertion. 
Howard et al. (2009)’s study stressed that individuals reporting a greater impact had 
apparently less perceived control of the treatment for COPD. This study 
demonstrated that when the patients perceived a better understanding of their illness 
(i.e. illness coherence), they were more likely to have confidence to manage 
exacerbations, stabilize their emotions, avoiding adverse effects of weather or 
environment, abstaining from behavourial risk factors and generally manage their 
disease more appropriately. Sense of coherence to the illness was regarded as the 
self-management resource which most likely fosters persistence in older COPD 
patients in chronic illness situations, so that in facing of ongoing issues related to 
COPD, sense of coherence and self-efficacy together may enable patients to find 
their lives comprehensible and manageable (Warwick et al., 2010). A consensus for 
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this relationship was constructed by this example of a dynamic conversation in a 
focus group:   
SL:  Then does this workshop is really what you guys needed?=  
Nick:   =It is needed, needed, at least, there is quite a lot of knowledge that we 
need to know, not everyone understands this disease  
[Ivan:  Yes, yes]  
Nick:  …at least some one should understand, meanwhile there are some skills, 
how to control the nutrition, how to manage during exacerbation and 
emergency situation, have some knowledge about this.  
[Ivan:  It means…it means the nurses.…it means there is someone there 
introduce us of how to understand the illness condition, and how to adapt 
myself to the disease, it’s quite good.]  
Nick:  At least I know what’s going on, you know we know nothing about 
medicine. 
This quote stresses that improvement in understanding the illness has strengthened 
the participants’ confidence in adapt more appropriately. Meanwhile, this study 
found that a strong belief in the more severe consequences and cyclical nature of the 
illness was related to poorer self-efficacy in the participants. This is consistent with a 
study by Lau-Walker (2004) which revealed that patients reporting a greater impact 
of the illness had significantly lower self-efficacy to cope with the condition. 
Moreover, this present study indicated that COPD patients experiencing strong 
emotional upset for their illness hampered their general self-efficacy and 
self-efficacy in managing exacerbations, stabilizing emotions, abstaining behavourial 
risk factors. Together with the strength of correlation, illness perception belief and 
self-efficacy appeared to associate in most aspects moderately to determine 
health-related behaviours of COPD patients. Therefore, this study on one hand 
provides supporting evidence for possible relationship between illness perception and 
self-efficacy beliefs in guiding health-related behaviours in COPD patients after it 
was initially proposed in cardiac patients and diabetes patients (Lau-Walker, 2004, 
Lau-Walker, 2006, Bean et al., 2007). On the other hand, it indicates that each belief 
holds some elements independent from each other but essential to guide 
health-related behaviours. Nonetheless, conclusive inference about their causal 
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relationship cannot be made from bivariate correlation analysis in this study. 
Multivariate analysis with a larger sample is suggested in further research in this 
area.  
8.3.5  Self-efficacy of COPD patients in Macau 
One of the primary aims of this study was to improve the self-efficacy of Macau 
COPD patients to enable them to manage their illness and daily living through 
implementation of SMEP. In the post-trial follow-up assessment, the patients 
allocated to educational intervention showed greater improvement in general 
self-efficacy and three aspects of self-efficacy (intense emotional arousal, physical 
exertion and weather/environment) than the control group. Results from earlier 
studies have varied in relation to SMEP or cognitive-structured education improving 
self-efficacy in COPD. Bucknall et al. (2012) and Lemmens et al. (2010) indicated 
no evidence about improvement of self-efficacy through self-management education. 
However, several COPD studies have demonstrated varying aspects of self-efficacy 
improvement for patients (Kara and Aşti, 2004, Wong et al., 2005, Stellefson et al., 
2012, Davis et al., 2006). One RCT study reported significant improvement in total 
and all subgroups scores of CSES in experimental group at post-education and after 
one month follow up (Kara and Aşti, 2004). Lorig and Bandura (2001) and Siu et al. 
(2007) achieved improvement of self-efficacy in managing chronic illness, like 
perform self-management behaviours in COPD patients at one week and maximum 
two years respectively after self-management education. Improvement solely in 
functioning aspect (i.e. walking and physical exertion) was indicated in two studies 
(Wong et al., 2005, Davis et al., 2006), these findings are consistent with the findings 
of this study.  
Discrepancies in the overall findings of the effects of self-management education in 
COPD patients’ in relation to self-efficacy among studies may be attributed to 
several reasons. The lack of standardization for the content or structure of 
   195 
self-management education, different measurements used for self-efficacy 
assessment (Stellefson et al., 2012). In this study, three aspects of self-efficacy 
showed improvement in the experimental group, this provides encouragement for 
several reasons. Firstly, patients express higher confidence in encountering or 
avoiding difficulty in breathing when they had adverse emotion, for example, fear, 
anger and anxiety. This concept also emerged among participants in a focus group: 
Mr. Lee:  I don’t have those emotions, I’m not anxious, I’m not so.. 
[Winnie:  (hehehe) Mr. Lee is similar with me, I’m not anxious too]   
Mr. Lee:  …I don’t even have pressure, I have nothing of so  
[Mrs. Lee:  (laugh gently)]  
[Winnie:  I only have problem when I climb up staircases, I would wheeze a 
bit ….quite a bit when I carry heavy stuff.] 
SL:  That means you don’t have problem with emotion. 
Winnie:  I don’t have temper (haha) 
SL:  is calm….no temper.. 
Winnie:  I don’t have temper (hehe)  [C343,GD] 
They mainly thought that periods of intense emotion did not bother them as they do 
not have fluctuating emotions or they took an easy mind to live a relatively relaxed 
life. However, they were generally more concerned about managing an activity that 
demanded exertion. Secondly, the experimental group in this study reported higher 
levels of confidence than the control group in relation to avoiding breathing 
difficulties during physical exertion. Self-appraisal of efficacy is enhanced by 
selective recall of past successes, whereas reduced self-appraisal of efficacy appears 
to be linked to recall of failures (Bandura, 1989). Data from the qualitative 
interviews highlights that the patients had applied some strategies taught in the 
workshop and had successfully coped with physical exertion events, this may explain 
the reason for higher self-efficacy levels in the physical exertion subgroup indicated 
in the follow-up assessment. Relevant quotes from the focus groups have been 
referred to the ‘Functional improvement’ category of the theme ‘Beneficial’ in the 
qualitative findings chapter. Most importantly, application of self-health behaviours 
   196 
with success in various situations of everyday life may let patients feel more 
energetic and further enhance patients’ sense of self-efficacy which in turn leads to 
better disease control and improve better patient outcomes (Bourbeau and van der 
Palen, 2009, Siu et al., 2007). 
Weather or environmental factors are the known risk factors for COPD (GOLD, 
2013). Thirdly, quantitative results in this study demonstrate that COPD participants 
felt little confidence associated with the effects of weather changes and 
environmental triggers in relation to their disease. Given that part of the teaching 
content of the SMEP focused on specific coping strategies towards dealing with 
weather changes or environment hazards, the patients may have learned and put into 
daily practices. This can be explained as self-efficacy governs the interrelationship 
between knowledge and action (Bandura, 1986). A participant in the focus group 
described: 
Chris:  For me I mainly followed the instruction for breathing, and also to 
avoid…mean those tobacoo, or those temples, or those car park, those related 
to exhaust, tried hard to avoid all these factors.   [B296,489,15]
According to Chris’ description, environmental adverse effects are triggers for 
exacerbations for COPD patients. With regard to confidence in managing breathing 
during weather changes, the participants expressed concerns towards the threat of 
adverse weather conditions upon their health condition. When they were asked about 
the content learned from the SMEP, they responded: 
Nick:  …weather is cold, most important is to keep yourself warm when the 
weather is cold, don’t caught a cold, it’s not ok once caught a cold.  
SL :  I see..this is important as well, the method of self-protection. 
Nick:   Cause coughing…once you cough, you are infected, the solution to 
infection nowadays is taking antibiotics, in addition we are now at ‘high 
risk’ weather, will be very dangerous once got sick.  [A904,1021,8] 
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Hence, any measures that were instructed in the SMEP that assist to manage or 
relieve the suffering caused by triggers could have been perceived as supportive. 
Interestingly, SMEP appears to only affect the perception of ‘timeline’ and ‘personal 
control’ in the participants and they showed limited association to the self-efficacy 
variables. This may imply that in some way SMEP might have directly enhanced 
self-efficacy of the COPD patients without the mediation of illness perception. Due 
to the potential association of illness perception and self-efficacy, it is recommended 
that further SMEP should integrate more elements of imparting the illness perception 
so as to foster better self-efficacy in the COPD patients.  
To conclude this section, SMEP appears to give COPD patients in Macau perception 
of a more chronic timeline of their condition, this may enhance their willingness to 
engage in more healthy behaviours. In addition, SMEP appears to maintain patients’ 
perception of personal control, which may decrease over time and this tends to 
improve patients’ self-efficacy in managing physical exertion. Moreover, SMEP can 
improve patients’ general self-efficacy and self-efficacy in managing intense 
emotions, physical exertion and weather/environment effects. With the exception of 
timeline perception, all other dimensions of illness representation showed association 
with patients’ self-efficacy in managing their illness. The greater the number of 
symptoms perceived, the longer the duration of the illness, the stronger the cyclical 
nature of the illness perceived, the stronger the emotional representation of the illness, 
the participants perceived lower self-efficacy in managing COPD. Alternatively, the 
stronger the perception of personal control, treatment control and illness coherence, 
the participants perceived better self-efficacy. On one hand, this study provides 
further evidence to support the relationship of illness perception and self-efficacy 
beliefs in establishing health-related behaviours among the chronically ill. On the 
other hand, the SMEP developed in this study has to some extent directly enhanced 
the self-efficacy of the participants, rather than through changing their illness 
perception. This may be potentially due to inadequate integration of promoting 
illness perception element in the development of SMEP, or the participants’ 
background of low education affecting their ability to cognitively understand the 
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teaching aspects of the programme and consequently their illness perception remains 
largely unchanged. 
8.4  Effects of Self-management Education Programme on Inhaler 
technique of COPD patients
Inhalation therapy is a common mode of treatment for COPD patients, however, 
incorrect use of inhaler devices is not uncommon among them and is usually due to 
problems with comprehension or coordination(NAC, 2008, Vincken et al., 2010, 
Australia, 2008). Consistent with the findings of previous relevant COPD 
educational studies, SMEP appeared to lead to improved inhaler technique of COPD 
patients in my study (Lemmens et al., 2010, Hämmerlein et al., 2011, Basheti et al., 
2007). Nonetheless, amongst all available inhaler devices, patients using MDIs were 
found to have made more inhaler technique mistakes than those using other devices 
(Hesselink et al., 2001, Melani et al., 2004). MDI users were also found to be less 
likely than DPI users to be adherent to their inhaled therapy (Roy et al., 2011). This 
finding was also discussed in Hesselink et al.’s (2001) review that patients using 
MDI tended to fail to synchronize inhaler actuation with inspiration (for instance, 
hand lung co-ordination) and patients stated preference toward using dry powder 
inhalers. Patients confirmed this view during one of the focus groups.
SL:  Which steps are difficult for you to comprehend? What do you think? 
Winnie:  =I think using ventolin ((MDI device)) is very difficult to inhale, mine 
((Turbuhaler)) is very easy to inhale.  See, inhale….mine ((dry powder 
inhaler)) is (demonstrate) inhaling one dose like this, mine is. 
Mr. Lee:  Yours need not to press for the dose? 
Winnie:  No. 
Mr. Lee:  See see…let me have a look. 
Winnie:  Next time, you request…that that ..doctor prescribes this one to you, 
really very good, better than your ventolin ((MDI device))!  [C536-542] 
In this quote from the focus group, Winnie’s enthusiasm towards introducing the dry 
powder device and Mr. Lee’s interest in knowing it possibly indicated the need for 
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more user friendly devices. A user friendly device may enhance their confidence and 
ability to comprehend efficient inhaler technique which in turn potentially improves 
the effectiveness of the treatment in terms of perceived control (Basheti et al., 2007). 
It was found that the type of inhaler was the strongest determinant associated with 
incorrect inhalation technique (Hesselink et al., 2001). Moreover, ageing, negative 
emotions or emotional problems (e.g. shame, helplessness, dependency, restlessness, 
temper, confusion or depression) were more likely to induce incorrect inhalation 
technique in COPD patients (Hesselink et al., 2001, Vincken et al., 2010, NAC, 
2008). Importantly, although there was not a statistically significant decline in the 
inhaler technique in SMG patients between post-intervention assessment and six 
month after intervention, there was a slight clinical decrease in the mean mastery rate 
of inhaler technique. Similar findings was reported that such decline happened over 
time and was associated with a decrease in some disease outcomes (Basheti et al., 
2007). One-time intervention was not sufficient for all patients to fully harness 
error-free inhalation technique (Hämmerlein et al., 2011). Repeated instruction is 
recommended as it appears to be associated with good adherence to the inhalation 
regimen and this related to less exacerbation and better quality of life in asthma 
patients (Takemura et al., 2010) 
In summary, SMEP in this study demonstrated favourable outcomes relating to 
mastering inhaler technique, which may in time influence adherence to inhalation 
therapy, disease control and disease-related quality of life of COPD patients. As for 
supporting long-term mastery of inhaler technique over years, this study data could 
not provide a definitive conclusion and a large scale longitudinal study on evaluating 
the long-term effect of self-management education on the mastery of inhaler 
technique is recommended. 
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8.5  Effects of Self-management Education Programme on 
biomedical outcomes, healthcare utilization and health-related 
quality of life of COPD patients 
In addition to examining the primary outcomes of SMEP, some secondary outcomes 
were examined in this study and these demonstrated significant improvement for 
COPD patients and included less days of hospitalization and better disease-specific 
health-related quality of life. The following section provides an overview of these 
secondary outcomes in relation to current established literature. 
8.5.1  Pulmonary function 
Improvement in pulmonary function with statistical significance for both SMG and 
CG was seen in the present study, however, this was deem to be clinical insignificant. 
It is because the size of variability of FEV1 between the two time point assessments 
was less than 12% and 200ml. This limited variability may indicate a presence of 
fixed airway narrowing in COPD patients regardless of the effects of the intervention 
(GOLD, 2010). The absence of clinical improvement in pulmonary function of 
COPD patients on a SMEP is consistent with reports from systematic reviews 
(Adams et al., 2007, Effing et al., 2007, Monninkhof et al., 2003). One rationale for 
this outcome is that SMEP is not intended to act as a curative intervention, it 
however may have limited effect on reversing the accelerated decline in pulmonary 
function in COPD patients who are in a chronic disease state and bearing 
characteristic of irreversible airway limitation (Monninkhof et al., 2003).  A study 
participant made the following comment on his pulmonary function:  
SL:   Um…got  it, got it. May I also ask you? What do you feel about your lung 
function in the past six months? Better or worse? 
Mrs. Lee:   Should be worse  
[Mr. Lee:   So so, not really worse]   
[SL:  Persisting]  
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Mrs. Lee:  …still weak. 
SL:  Still weak, still persisting…er er…that means similar to that before the 
workshop? 
Mr. Lee:  So so..   [C82-86] 
Despite that, the improvement in the pulmonary function of the self-management 
group in this study showed no poorer benefits in relation to pulmonary function of 
COPD patients than that indicated in the trial of comparing the combination therapy 
of long-acting bronchodilator and inhaled corticosteroids with placebo (Aalbers et al., 
2002, Calverley et al., 2007). In TORCH (Towards a Revolution in COPD Health) 
study (2007), the mean FEV1 in the combination-therapy group demonstrated an 
increase of 29ml and an decrease of 62ml in the placebo group, resulting a net 
improvement of 91ml in the combination-therapy group. Whereas the participants of 
this study demonstrated an net increase of 128ml in the median FEV1 after receiving 
SMEP. (Calverley et al., 2007) (Refer to table 14). The extent of increment in the 
pulmonary function of the COPD patients after SMEP may be due to the effects of 
their significantly improved inhaler technique which could enhance the effectiveness 
of the treatment (Basheti et al., 2007). This could happen as the baseline mastery rate 
of inhaler technique of the participants of this study was less than 60% with some 
even using it incorrectly.  
Nevertheless, improvement in pulmonary function is not intended to be the sole aim 
of SMEP. Clinical evidence suggests that this form of intervention may work better 
as part of a multi-component approach. They may include delivery system design, 
decision support, and clinical information systems. This combination of approaches 
has demonstrated greater improvement in pulmonary function than implementing 
self-management education alone (Adams et al., 2007). Therefore, SMEP has not 
brought direct benefit to the pulmonary function of Macau COPD patients, however, 
further studies in exploring the exact effects of a multidisciplinary organized chronic 
care model on the pulmonary function of COPD patients are recommended.  
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8.5.2  Healthcare utilization 
The findings of the study suggested that SMEP reduced number of days of 
hospitalization, despite this it did not reduce frequency of using rescue medication 
and numbers of unplanned emergency room or outpatient visits. These findings are 
more in line with previously reported results in the majority of similar studies 
(Adams et al., 2007, Monninkhof et al., 2003, Swerissen et al., 2006, Bourbeau, 2003, 
Bucknall et al., 2012). Educated patients have been found to be less likely to suffer 
from exacerbations compared to patients in the control groups (Rootmensen et al., 
2008, Zhou et al., 2010). The aim of using an action plan was to lead to increased 
ability for COPD patients to recognize and react appropriately to an exacerbation, but  
current best evidence does not show any association between these effects of 
self-management intervention with reduction in healthcare utilization in patients with 
COPD (Walters et al., 2010, Bourbeau, 2003). This phenomenon is illustrated in the 
following extract:  
Amy: =I am the same. Having no knowledge before the workshop, went to the 
emergency when it happened, got to go to the emergency immediately 
when it happened. 
SL: Go to the emergency immediately when it happened. What about now? 
Amy: I don’t scare now…he.. 
SL: Don’t scare now means..? 
Amy: Cause no need to go frequently to the emergency now, it the past, it’s 
almost like around a week, really= 
SL: =What are the reasons? 
Amy: It means maybe I am now taking medicine, and doing those breathing 
exercises, those, I changed a bit of others. It’s not easy to get cough or 
short of breath once changed.. [A1080-1117,GD] 
Amy showed her belief that what she has applied from learning in the workshop has 
helped her in reducing exacerbations and thus reduce healthcare utilization. However, 
in Adams et al.’s (2007) systematic review, multiple chronic care components were 
found more likely to demonstrate significantly shorter hospital length of stay than 
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single self-management intervention. Of special significance is the evidence that, 
reduced utilization was associated with the improvement in perceived self-efficacy in 
COPD patients (Lorig et al., 2001). As there was an improvement in the perception 
of self-efficacy in the SMG in this study, participants may feel more confident and 
better prepared to manage the periods of stability and exacerbation of their condition. 
Additionally, this sample was largely recruited from a private hospital where patients 
had to pay for care. Due to additional financial burden, it is speculated that patients 
may be more likely to reject hospitalization or request early discharge once the acute 
stage has overcome to avoid additional costs.    
8.5.3  Health-related Quality of Life 
Previous studies have indicated that SMG could improve the symptomatic domains 
of disease-specific HRQoL (Zhou et al., 2010), however usually it had little impact 
on the general aspects of HRQoL (Effing et al., 2007, Monninkhof et al., 2003, 
Bucknall et al., 2012, Lemmens et al., 2010). This would also appear to be the case 
in this study. These associated ideas were expressed in the focus group:    
Wilson:  =Right, now with the skills that taught by Nurse MN…it is like, if 
suffering from walking…ar…control the breathing  
[Nick:  (Murmur) The breathing skills]  
Wilson:  …take a rest, then physically comparatively better, then not..not…not so, 
you know.  
SL:    So, you have learnt some breathing and resting skills = 
Wilson:  =Hehe…yes…if there is no one to teach you, you will not know how to 
relieve the symptoms, after the workshop then you know how to relieve, 
like controlling the breath, and taking a rest, then it becomes fine 
afterward.    [A1003,1142,14] 
In other studies, significantly higher HRQoL scores have rather been seen in the 
activity domain in the educational group (Monninkhof et al., 2003). It was suggested 
that cognitive processes imposed direct influence on quality of life since direct 
relations between knowledge gain and investment beliefs (independent variables) and 
quality of life (dependent variable) were found (Lemmens et al., 2010). Of particular 
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significance is the evidence that, even though disease-specific HRQoL improved, 
COPD patients do not demonstrate improvement in generic HRQoL after 
self-management intervention (Lemmens et al., 2010, Monninkhof et al., 2003). This 
may be due to the relatively higher baseline scores in the generic HRQoL scale than 
that revealed in previous study (Desikan et al., 2002) and that could have 
underestimated health status assessment of the participants of this study (Sato et al., 
2004). Alternatively, disease management for COPD bears a multidimensional and 
multidisciplinary nature and takes time to detect changes. The six months follow-up 
period may have been too brief to observe quality of life improvements resulting 
from the intervention (Lemmens et al., 2010). Therefore, SMEP in certain extent 
may improve specific aspects of quality of life of COPD patients.  
8.6  Factors affecting illness perception, self-efficacy and quality of 
life of COPD patients 
It is important to identify factors that may enhance or hamper the outcomes of 
self-management intervention in order to improve the effectiveness of this type of 
intervention. Among all variables, clinical characteristics (Stage of disease, post-BD 
FEV1% Pred., long-term treatment, prescribed MDI and frequency of using SABA) 
rather than demographic characteristics of the participants revealed a relationship 
with illness perception, self-efficacy and HRQoL. These results indicate that clinical 
characteristics could have a stronger influence than demographic factors on 
psychosocial conditions in COPD patients living in Macau. In addition, psychosocial 
characteristic (self-efficacy) was also associated with the levels of HRQoL. Thus, 
patients with more severe disease condition and under long-term treatment may have 
perceived more serious consequences and lower levels of HRQoL. When perceived 
self-efficacy is higher, overall HRQoL is more likely to be better.  
In previous studies, the relationship between patients’ illness perception and 
demographic and clinical characteristics remains controversial (Lau-Walker, 2004, 
Lau-Walker, 2006, Bucknall et al., 2012, Fischer et al., 2010). Howard et al. (2009) 
and Lau-Walker (2006) supported that both demographic characteristic and clinical 
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characteristic were inversely related to the perception of illness nature or illness 
impact in the patients. Meanwhile, this study only demonstrates association of illness 
perception with clinical characteristic. In contrast, such relationships were not 
revealed in other studies (Bucknall et al., 2012, Fischer et al., 2010). In spite of the 
ongoing debate about the relationships between illness perception and these factors, 
Lau-Walker’s (2004) study on cardiac patients found that those with severe illness 
condition perceived their illness consequences more negatively, resulting in being 
more capable of responding effectively to self-management interventions 
(Lau-Walker, 2004).    
Kohler et al. (2002) supported the findings of this study that clinical characteristic 
(pulmonary function) correlated with self-efficacy and HRQoL, and self-efficacy 
also correlates with HRQoL of COPD patients. However, the correlation between 
pulmonary function and HRQoL were modest, much of the variance in the latter was 
not explained by clinical characteristics (Jones and Kaplan, 2003). On top of that, the 
strength of these relationships was found to be unstable as psychosocial variables 
have shown to have stronger influence than biomedical variables on HRQoL in the 
patients after the intervention (Kohler et al., 2002). Their analysis suggested the 
relationship between HRQoL and pulmonary function varied depending on a 
person’s level of self-efficacy for specific activities. This change could be identified 
in the following conversation extracted from one of the focus group participants. 
Chris:  Before, my condition…was very serious, through the check up by 
doctor, it was certified…ha…certified by KWH, the coefficient my 
lung function was only 31, normal people is 80, so I though it’s 
hopeless when I knew the fact! Waited for my death at home, just a 
matter of time! Then afterward learnt from nurse MN…learnt a lot, 
improved, in terms of improvement, in particular is the dietary, in term 
of dietary..means I ate more side dish, vegetable, it is documented in 
books, means reducing the portion of carbohydrate, the intake of 
carbohydrate would be resulted in the production of CO2 of the body, I 
know it should be very careful as mentioned here. Sometimes I took 
vegetable as rice.  
SL:   =I see…taking more vegetable now. 
Chris:  Yes   
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[Leon:  You are great!…It is the worst that I..I..I never take any caution in 
dietary.]  
Chris:  Secondly, secondly as said before…in term of dietary; secondly 
is..is…is, ar do some exercises in the morning after wake up, those 
taught us the style of “The Dragon Sways its Tail” those type, finished 
all of them, but recently, recently I have stopped because of the hot 
weather, since I scare of being heated up, on the contrary, I am not 
afraid of cool weather, but scare of hot weather, so I stopped the 
exercises. But I focus on taking caution of the dietary, why I cough 
before, I didn’t have any cough that time, recently..seems seems there 
are some problem with the throat, I don’t have the cough problem even 
when I was suffered from that pharyngolaryngitis.  
[SL:  Um um]  
Chris:  So I used mainly these two methods, I really tried my best, So, even 
though I am counting down now…my lung function counted down to 
31, but I am still optimistic.   [B364,438,GD]
Therefore, patients with severe illness conditions may have poorer HRQoL, if an 
educational intervention is given and their perceived self-efficacy improves, this may 
eventually mediate an improvement in their HRQoL. In my result, this improvement 
only happened in disease-specific HRQoL dimension and the overall mental aspects 
of generic HRQoL. This may imply that the effect of SMEP is limited to promote 
disease-affected well-being and at the same time merely serve as a 
psychological-and-mental support to general well-being of the participants. This 
point is supported by the following interaction from the focus group: 
SL: Then what about Wilson? How do you feel about the follow-up telephone 
interview from Nurse MN  
[Wilson:  She she she]  
SL:  How was it? 
Wilson:  She sometimes called me from time to time and updated my situation, we 
do appreciate her consideration to us. 
SL: Ar…is it helpful to your learning? I mean, would it strengthen or help 
remind you the knowledge that you have learnt? Any effects that help your 
learning? 
Wilson:  Yes yes, there were of course some effects, I mean followed her 
instruction and worked on it…to help keep my body well…more scientific.  
   207 
SL: Ar…it means followed her instruction, what you mean is she could remind 
you? Right? 
Wilson:  Yes yes.. 
SL: It’s not bad. What about Ivan? About this follow-up telephone interview… 
Ivan: Follow-up telephone interview is quite good. 
SL: also good..? 
Ivan:  I mean she cares for us.   [A854-892,GD]   
Apart from disease severity, pharmacological therapy may also have played an 
adverse role influencing the perception of illness, self-efficacy and HRQoL in this 
study. When the participant of this study was prescribed short-acting bronchodilator 
or/and they have increased the frequency of using short-acting bronchodilator, they 
were more likely to have a perception of having a chronic, cyclical and severe 
consequence of illness, and that also adversely affect their self-efficacy, 
disease-specific HRQoL and general physical aspects of generic HRQoL. This may 
be due to the fact that the higher the dose of medication the COPD patient received 
the more likely they were to have more severe illness condition or poorer pulmonary 
function which could affect his perception of psychosocial status as discussed earlier 
in this paragraph. Alternatively, this effect may be related to embedded negative 
impressions that the patient may hold towards pharmacological intervention. Leidy & 
Haase’s (1996) study indicated that medications were often seen by the patients as 
adversely affecting mood, appearance, and activity levels. Treatments designed to 
help COPD patients may help symptomatically but may also indirectly cause adverse 
effects.  
Interestingly, the symptom domain of SGRQ did not correlate with any demographic 
and clinical characteristics except the association with amount of smoking. A 
participant in the focus group highlighted this association:  
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Leon:   Now it isn’t, now…well now, sometimes there are phlegm when I 
smoke…it means cough with phlegm, then I..er…bought some liquid 
medicine, or that mycolytics that one called PoDaLing.  [B183,223,12]    
Smoking damages and eventually destroys cilia which become less effective at 
keeping the lungs clear, smokers may develop a habitual cough as they attempt to 
remove the mucus from their lungs (CDC, 2010). Thus, smokers have higher 
prevalence of respiratory symptoms (GOLD, 2013). The amount of smoking of the 
COPD patients in this study could probably have influence on level of the 
symptom-related QoL.  
In summary, the severity of the illness state (for instance, clinical characteristics) and 
pharmacological intervention acted as the main roles in influencing the psychosocial 
aspects of COPD patients in Macau. Although we cannot reverse the COPD disease 
severity, we can help patients better understand their treatment regimen and enhance 
their self-efficacy in managing their disease condition through implementing SMEP. 
Their strong perception of self-efficacy may ultimately enable them to perceive 
better HRQoL, their disease-affected well-being and overall mental well-being in 
particular. One factor that would appear to be upmost importance in this study is that 
the SMEP might have delivered messages which enabled the participants to cope 
with their symptoms and that in turn helped to improve their HRQoL.  
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8.7  Conclusion 
8.7.1  Significance of the Study 
This study successfully employed the Medical Research Council framework in 
designing an exploratory trial for initiating a SMEP developed in the West to the 
Chinese population in Macau. SMEP was used to be in high variability and lack of 
uniformity in structure and content combination, hence, a SMEP was formulated by 
following the MRC framework for developing and evaluating complex intervention. 
A mix of quantitative approaches (objective clinical measures and validated 
questionnaires) and qualitative approach (focus groups) were adopted in an 
embedded design to reflect the subjective and objective outcomes of the study in the 
COPD patients in Macau. These outcomes confirmed the hypothesis that SMEP 
would appear to have a positive effect on COPD patients in Macau. This 
improvement was seen specifically in terms of enhancing inhaler technique, illness 
perception, self-efficacy and disease-specific domains of HRQoL, and reducing 
healthcare utilization. However, it did not have positive effect on their pulmonary 
function and generic HRQoL, consistent as reported in previous studies. Although, to 
date, COPD educational programme was not used widely in everyday clinical 
(Bucknall et al., 2012, Rootmensen et al., 2008), COPD patients in Macau 
emphasized the essentiality of such programme in the focus groups. This study has 
also identified the potential mediating effect of illness perception on self-efficacy in 
the formation of health behaviour in COPD patients. In addition, this study has made 
an attempt to identify the characteristics of patients who may benefit from the 
programme and support in self-management. Clinical characteristics (Stage of 
disease, post-BD FEV1% Pred., long-term treatment, prescribed MDI and frequency 
of using SABA) were shown to relate with their illness perception, self-efficacy and 
HRQoL. As defined in MRC guideline (2000), this study has obtained evidence for 
supporting the theoretically expected experimental effect, to identify appropriate 
outcome and estimates of recruitment required for a definitive RCT.   
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8.7.2  Implication for Nursing Application and Clinical Practice 
Despite the overwhelming evidence that SMEP does not have a direct effect on 
improving pulmonary function and HRQoL in COPD, it has shown to improve 
patient engagement of appropriate medication management, to confront their 
condition with relevant illness perception, to manage their illness with better 
confidence and to reduce the number of days of hospitalization in Chinese COPD 
patients in Macau. These findings also suggest that the concept of self-management 
could be fostered within the programme through delivering cognitive information 
about the consequences and cyclical and chronic nature of COPD, to strengthen the 
patients’ expectations and confidence in compliance to self-management initiatives 
(Kara and Aşti, 2004). It is of particular importance that SMEP, such as the one 
developed in this study, can be easily understood and implemented by clinical 
nursing personnel. Use of SMEP as such should not require a multidisciplinary effort 
which demands extra manpower or additional administrative costs. For those 
healthcare systems which have yet to introduce any form of chronic care to COPD 
patients, SMEP is recommended as an initiative approach for delivering continual 
care for this group of patients.  
Nurses who conduct SMEP potentially play the roles of programme designer, 
coordinator, health educator, counsellor and consultant. A programme designer 
designs the structure and flow of the programme whilst the coordinator 
communicates with the institute administrators to gain support for running the 
programme and communicates with frontline doctors and nurses for referral of 
patients. Health educator delivers health-related information and skills to the 
participants for managing their illness. Counsellor provides emotional and mental 
support to the participants. Consultant helps to identify and solve difficult or hidden 
health problems of the participants. To gain the most benefits from SMEP, the 
findings of this study indicate that patients should be recruited to the programme 
before their condition has been developed into very severe stage of COPD. SMEP 
nurses could be more likely to foster self-management behaviour in these patients 
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through teaching proper inhaler technique and management of symptoms and 
exacerbations. In spite of the fact that the effectiveness of the action plan in a SMEP 
was inconclusive, it is still recommended as part of a standard self-management 
programme for COPD (Walters et al., 2010). Especially when a programme is 
multi-faceted or one which involves ongoing follow-up, it should allow repetition 
and practice in content delivery in order to assure continual engagement by the 
patients (Kaþýkçý, 2011). These approaches are recommended to design the 
structure and mode of chronic care delivery for COPD patients in Macau.  
8.7.3  Limitations of the Study  
This section identifies potential limitations in this study. These are mainly related to 
the potential bias underlying the research design and to the sampling structure. 
Although block randomization and blinding were adopted in the research design, the 
influence of participant preference may still be a potential confounder of true 
randomisation (MRC 2000). This could happen when the participants had a treatment 
preference, then they were likely to expect and achieve more positive outcomes; 
where relevant, compliance is likely to be improved. Participant preferences as such 
may result in bias which would limit the generalizability of results. Moreover, the 
favourable outcomes derived in the study may not purely be the results of the SMEP 
itself. They may also be due to the participant preference to the researcher or the halo 
effect. The halo effect is generally defined as the influence of a global evaluation of 
individual attributes of a person simply by colouring interpretation of the meaning or 
affective value of individual trait (Nisbett and Wilson, 1977). This should be 
especially taken into consideration as traditional Chinese culture upholds helping 
members of communal relationships. They help through manifesting appreciation as 
a response of role requirements and maintaining social relationship (Hwang, 2012). 
However, it is very difficult to avoid this type of bias in this type of study, as the 
researcher held a compulsory role for conducting and implementing the complex 
intervention. Another external factor which could potentially interfere with the effect 
of the SMEP could be peer influence or the use of alternative therapies voluntarily 
adopted by the participants during the research process. For example, a CG 
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participant reported that they took herbs and animal soup and a participant in SMG 
has received a course of herb application to acupuncture points. On the other hand, 
recruitment of participants from Health Bureau was rejected as my sample has 
excluded COPD patients who solely rely on public healthcare service. Additionally, 
this may have hindered the recruitment of larger sample and inhibited the formation 
of a third group, the placebo group, which would have controlled for the halo effect 
in the study. The limited sample size also made impossible to run statistical tests of 
minimal clinical significance for the primary end outcomes. Despite these limitations, 
this study did employ possible measures to ensure rigor in the research process and 
obtain outcomes confirming the hypothesis.  
8.7.4  Directions for Future Research 
Quantitative and qualitative approaches in this study show that COPD patients in 
Macau did derive benefit from SMEP. This supports the proposed theoretical 
framework of this study and provides the foundation for a larger RCT. On top of that, 
other forms of measurement, analysis methods, research design possible for 
answering further research questions have been identified during the time of the 
study. First, direct observation of self-management behaviour through objective 
measures have been recommended in a very recent study. It has indicated that only 
42% of intervention group patients learnt to self manage and that was expected to act 
as a threshold of improving other biomedical and psychosocial outcomes (Bucknall 
et al., 2012). Moreover, a newly validated disease specific HRQoL named COPD 
Assessment Test (CAT) was developed whilst this study was being conducted. CAT 
is an eight-question quality of life instrument assessing the impact of symptoms in 
COPD. It was strongly correlated with SGRQ and hence can be considered to replace 
the more time-consuming SGRQ in further COPD research studies (Jones et al., 
2011). This study has indicated the potential mediating role of illness perception 
belief in self-efficacy in COPD patients. However, further investigation of illness 
perception belief-driven intervention and its predictive role through multivariate 
analysis is recommended. Understanding of this may help clinicians to better 
incorporate illness perception belief into the SMEP to enhance the self-efficacy for 
self-management efficiently and effectively in COPD patients. In order to minimize 
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placebo effect and differentiate the actual effect of SMEP from potential placebo 
effect, three groups which comprise one interventional group, one control group and 
one placebo group are suggested to the study design. Furthermore, evaluation of the 
implementation process of the SMEP is advised. This would provide a check of 
whether the planned improvement activities had been executed uniformly and 
whether the target population has actually been exposed to activities as planned 
(Lemmens et al., 2008). If SMEP has been run maturely as well as a growth of 
multidisciplinary cooperation in the healthcare system, further studies for exploring 
the effects of a self-management integrated chronic care model are recommended to 
Chinese COPD patients. 
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8.8  Summary    
To date, there has been no scientific investigation of COPD care delivery to Chinese 
patients in Macau. In this study, examination of the effect of a self-management 
education programme on these patients was conducted and the role of both beliefs of 
illness perception and self-efficacy in their engagement to self-management was 
critically explored. This knowledge will contribute to improve the understanding of 
how Macau Chinese COPD patients benefited from self-management intervention. It 
also provides insight into the perception of these patients towards SMEP. However, 
it should be noted that the current findings were obtained from an exploratory trial 
which has affirmed the modelling of the study framework. This should be 
acknowledged in overall generalization of the effectiveness of SMEP in Chinese 
COPD patients. On the contrary, this study also provides important information and 
experiences for the development of similar SMEP in other chronic illness (for 
instance, diabetes, hypertension, coronary heart disease) in South East Asia.  
SMEP is not intended as a curative intervention. It does not aim to reverse the 
deteriorating pulmonary function and generic HRQoL of COPD patients. In this 
study, when the patients’ COPD deteriorated and they became more dependent on 
pharmaceutical therapy, they tended to perceive worse consequences of their illness 
and display weaker self-efficacy to manage their condition. However, SMEP 
managed to alter their perceptions with a realistic timeline and maintain their 
declining personal control of COPD. Also, SMEP helped to enhance various 
dimensions of self-efficacy and that may in turn improve the HRQoL, particularly 
limited to the disease-affected well-being and overall mental well-being of COPD 
patients. Echoing by the qualitative findings, the essentiality of SMEP was affirmed 
among these Chinese COPD patients, while its limitation in reversing the progressive 
nature of the disease was also stressed. Preliminary evidence for the relationship 
between illness perception belief and self-efficacy belief in mediating health 
behaviour was initially indicated in COPD patients in this study and this provides a 
foundation for developing and examining further cognitive-behavioural 
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beliefs-integrated intervention on this population. To actualize COPD 
self-management, it is not only important to develop an effective and cultural 
applicable intervention, a mutual involvement from national level to individual level 
of stakeholders in paying concern and effort in promotion and implementation of 
self-management is prominently indicated. Thus, this study highlighted that Macau 
Chinese COPD patients demonstrated readiness to receive self-management 
intervention and they derived benefits from it. In conclusion, SMEP can serve as an 
acceptable and preferable mode of chronic care for COPD for the healthcare system 
of Macau.  
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Appendix 
Appendix 1  Brief Introduction to Macau 
Geographical characteristics 
The Macau Special Administrative Region (Macau SAR) is one of the two special 
administrative regions of the People's Republic of China, the other one is Hong Kong. 
Macau, which had been the colony of Portugal for over 400 years was handover to 
China in 1999 and is currently ruled under the policy of “One country, two systems”. 
Macau is located in Guangdong province, on the western bank of the Pearl River Delta 
(MGOT, 2013). Macau has an area of 29.9 km2, comprised of the Macau Peninsula and 
connected to Mainland China, the islands of Taipa and Coloane. According to the data 
of the Statistics and Census Service in Macau (DSEC) (2012), the population of 
Macau is estimated to be 582,000. Therefore, Macau is one of the most densely 
populated region in the world, with population density of around 19,465 persons per 
km2 (DSEC, 2012). The ethnic distribution of its population is 94.3% Chinese and 
the remainder is of Portuguese or mixed Chinese-Portuguese ancestry. The Per-capita 
Gross Domestic Product (GDP) at current price was MOP 531,723 which is 
equivalent to approximately £45,838400 (DSEC, 2012).   
Healthcare System 
According to Government Information Bureau (2012),  the healthcare delivery of 
Macau is mainly served by the public sector “Health Bureau” , and two private 
hospitals and one day hospital, namely Kiang Wu Hospital (established for 142 years) 
and Macau University of Science and Technology Hospital (established for seven 
years), and MALO Clinic Health and Wellness (established for less than two years). 
There were 379 private clinics running by general practitioners in which 243 clinics 
providing Traditional Chinese Medical (TCM) therapy and care (GCS, 2012). The 
Health Bureau runs a public hospital, the Conde S. Januário Hospital Centre (CHCSJ) 
(established for more than 130 years), six health centers, two health stations and the 
Center for Disease Control and Prevention, providing specialized and primary health 
care to the public in Macau (SSM, 2012a). The number of accumulated hospital bed of 
all the three hospitals Macau is around 1,300, with CHCSJ and Kiang Wu Hospital 
each sharing about 45% of them (GCS, 2012, KWH, 2008). Currently, none of the 
Macau hospitals is independently assessed through international healthcare 
accreditation. There are no western-style medical schools in Macau and all aspiring 
physicians receive their medical education elsewhere. Meanwhile, there are two 
nursing educational institutes, the Kiang Wu Nursing College of Macau and Macau 
Polytechnic Institute, both have ever been training local nurses for Macau.  In regard 
to the demographic data of the healthcare professionals, there were only 2.6 doctors 
and 2.9 nurses for every thousand population of Macau in (DSEC, 2012). These 
figures were much lower than that in UK which was 2.7 and 10.1 for every thousand 
population for doctors and nurses respectively (WHO, 2012).   
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Health-related Policy 
The Health Bureau provides acute, rehabilitative, in and out-patient care and primary 
care to the public. In particular, the primary health care net spread on different districts 
of the community providing free primary health care services to the residents of 
Macau (SSM, 2012a). In addition, the Health Bureau also covers the healthcare 
expenses of the following residents of Macau in terms of law: 
• Pregnant, parturient, puerperal patients (until the end of the first month after 
birth), (present the identity document); 
•  Children until ten years-old (present the identity document); 
•  Students of primary and secondary schools (present the Student Card issued by 
the Department of Education and Youth); 
•  Indigents (present a valid Certificate of Indigence issued by the Macau Social 
Welfare Department); 
•  Persons over 65 years-old (present the identity document); 
•  Cancerous patients, the mentally-handicapped, carriers of 
infectious-contagious diseases and drug-addicts (present the respective Access 
Card to Health Care, which is issued by presentation of Medical Certificate); 
•  Access Card to Health Care holders, those card must be issued by Social Work 
Service of the Department of Health, Macau SAR; 
•  Users who are Macau Resident Identity Card holders and have access to the 
Health Centres. 
Macau residents who neither require primary healthcare service nor fulfill the above 
criterion, have to pay for the healthcare at their own expenses. Also, the Health Bureau 
is mainly responsible for coordinating the activities between the public and private 
organizations in the area of public health, setting public health guidelines for hospitals 
and private health care providers, but by no means regulating the quality of healthcare 
service and professionals. 
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Appendix 2  Ethical Approval from the University of Edinburgh 
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Appendix 3  Hospital approval  [No.(11)001] 
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Appendix 4  Study Information Sheet for Experimental group 
participants 
Study Information Sheet  (No. E1) 
Study Title : An exploratory trial for examining effects of self-Management 
education programme on patients with chronic obstructive pulmonary 
disease (COPD)  in Macau 
You are cordially invited to take part in a research study which is carried out by NG 
Wai I, a doctoral student of University of Edinburgh and a lecturer of Kiang Wu 
Nursing College of Macau. The study is officially approved for implementation here 
by Kiang Wu Hospital.  
Aims of the Study
This study is to examine the effects of self-management education and to identify the 
elements of nursing care that are most suitable to the patients with COPD in Macau. 
The findings obtained from this study may probably help to construct a more 
effective and appropriate local care delivery mode for COPD and to provide a 
framework for developing a nursing care model for chronically ill of Chinese 
population in Macau. 
Why are you chosen?
This is a study which is particularly exploring the self-managing experiences and 
better care delivery for COPD patients in Macau. You are one of this target patient 
group who can provide help and contribute to this work. Your taking part means a lot 
to the improvement of COPD care and to my doctoral study.  
How will the study be carried out?
Consented participants may be invited to attend a programme which consists of three 
1.5 –hour workshops given by experienced respiratory educator or nurse. Participants 
have to fill in some questionnaires before and after the programme and this will take 
around 30 minutes. Some may have to attend a group audio-recorded interview six 
months after the programme and the interview may last 45 to 60 minutes. The 
physician visit and service to the participants would be as usual in the due course. 
Is it compulsory to take part?
Taking part is completely voluntary; you are not obliged to take part. You are free to 
withdraw at any time during the process without any adverse treatment. 
What will happen if I want to take part?
If you decide to take part in this study, you will be given a pulmonary function test. If 
you are eligible, you will be asked to sign a consent form. You will be told when and 
where you will attend the workshops. The workshops will be about information of 
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COPD and the ways of managing this disease through oral-teaching, demonstration 
and re-demonstration. The workshops will be held in the out-patient department of 
Kiang Wu Hospital. The information you provide in questionnaires and interviews 
will be kept confidential to ensure anonymous. The data will be discarded 3 year 
after the whole study is deemed completed.  
Can you know about the results of the study?
If you want to know about the results of yourself, you can be feedback the results of 
your assessments done in the study.  
If you have any query or complaints about the study throughout the process, 
please feel free to contact the following persons. 
Thank you very much for your concern and support to the development of 
nursing care for COPD patients!! 
Researcher Contact Details
Milly Wai I NG 
PhD Student in Nursing Studies 
University of Edinburgh 
Tel No: XXXXXXXXX  
Email : XXXXXXXX@sms.ed.ac.uk 
Alternative Contact Details
Dr. Graeme D Smith 
Senior Lecturer 
Medical School, Teviot Place 
School of Health in Social Science 
University of Edinburgh 
Tel No: XXXXXXXX 
Email : XXXXXXXX@ed.ac.uk 
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Appendix 5  Informed consent form for experimental group 
participants 
Informed Consent Form 
An exploratory trial for examining effects of self-Management education 
programme on patients with chronic obstructive pulmonary disease in Macau 
Consent to participation 
1) I have read and understood the study information sheet (No. E1)  
for the above project and have been clarified doubts and questions.   □
2) I understand the potential risk for participating in the study and I have  
  right to withdraw from the study at any time without any adverse effects □
3) I understand that all information taken by the researchers during the  
  process of the study will be treated confidentially and will be anonymised. □
4) I understand that the data collected will be carefully destroyed three year   
  after the study is completed.           □
5) I agree that I am randomly allocated to self-management education  
  programme.                    □
6) I understand that the study will last nine months, and I agree to provide data 
  through questionnaires and audio-recorded group interviews.    □
7. I agree to participate in the study.          □
_____________________     ___________________    ___________________  
Participant name (Print)             Date                 Signature 
_____________________     ___________________    ___________________  
Researcher name (Print)             Date                 Signature 
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Appendix 6  Study Information Sheet for control group 
participants
Study Information Sheet  (No. C1) 
An exploratory trial for examining effects of self-Management education 
programme on patients with chronic obstructive pulmonary disease (COPD)  
in Macau 
You are cordially invited to take part in a research study which is carried out by NG 
Wai I, a doctoral student of University of Edinburgh and a lecturer of Kiang Wu 
Nursing College of Macau. The study is officially approved for implementation here 
by Kiang Wu Hospital.  
Aims of the Study
This study is to examine the effects of self-management education and to identify the 
elements of nursing care that are most suitable to the patients with COPD in Macau. 
The findings obtained from this study may probably help to construct a more 
effective and appropriate local care delivery mode for COPD and to provide a 
framework for developing a nursing care model for chronically ill of Chinese 
population in Macau. 
Why are you chosen?
This is a study which is particularly exploring the self-managing experiences and 
better care delivery for COPD patients in Macau. You are one of this target patient 
group who can provide help and contribute to this work. Your taking part means a lot 
to the improvement of COPD care and to my doctoral study.  
How will the study be carried out?
Consented participants would be invited to be under monitor for 9 months. During 
this period, participants have to fill in some questionnaires at two time points and this 
will take around 30 minutes for each time. Some may have to attend a group 
audio-recorded interview and the interview may last 45 to 60 minutes. The physician 
visit and service to the participants would be as usual in the due course. 
Is it compulsory to take part?
Taking part is completely voluntary; you are not obliged to take part. You are free to 
withdraw at any time during the process without any adverse treatment. 
What will happen if I want to take part?
If you decide to take part in this study, you will be given a pulmonary function test. If 
you are eligible, you will be asked to sign a consent form. Then, you will be arranged 
to be interviewed at your best convenience. During the 9 months monitoring, 
researcher will call you regularly to update your condition. The information you 
provide in questionnaires and interviews will be kept confidential to ensure 
anonymous. The data will be discarded 3 year after the whole study is deemed 
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completed.  
Can you know about the results of the study?
If you want to know about the results of yourself, you can be feedback the results of 
your assessments done in the study.  
If you have any query or complaints about the study throughout the process, 
please feel free to contact the following persons. 
Thank you very much for your concern and support to the development of 
nursing care for COPD patients!! 
Researcher Contact Details
Milly Wai I NG 
PhD Student in Nursing Studies 
University of Edinburgh 
Tel No: XXXXXXXX 
Email : XXXXXXXX@sms.ed.ac.uk 
Alternative Contact Details
Dr. Graeme D Smith 
Senior Lecturer 
Medical School, Teviot Place 
School of Health in Social Science 
University of Edinburgh 
Tel No: XXXXXXXX 
Email : XXXXXXXX@ed.ac.uk 
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Appendix 7  Informed consent form for experimental group 
participants 
Informed Consent Form 
An exploratory trial for examining effects of self-Management education 
programme on patients with chronic obstructive pulmonary disease in Macau 
Consent to participation 
1) I have read and understood the study information sheet (No. C1)  
for the above project and have been clarified doubts and questions.   □
2) I understand the potential risk for participating in the study and I have  
  right to withdraw from the study at any time without any adverse effects □
3) I understand that all information taken by the researchers during the  
  process of the study will be treated confidentially and will be anonymised. □
4) I understand that the data collected will be carefully destroyed three year   
  after the study is completed.           □
5) I agree that I am randomly allocated to be under monitoring.    □
6) I understand that the study will last nine months, and I agree to provide data 
  through questionnaires and audio-recorded group interviews.    □
7. I agree to participate in the study.          □
_____________________     ___________________    ___________________  
Participant name (Print)             Date                 Signature 
_____________________     ___________________    ___________________  
Researcher name (Print)             Date                 Signature 
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Appendix 8  Questionnaire for Pre- and Post-assessment 
自我管理教育對澳門慢性阻塞性肺病(COPD)患者的影響 ~ 臨床探索性實驗 





X1.1. 性    別：(1)男 / (2) 女    
X2.2. 年    齡：___________________ 
X3a. 
X3b.
3. 醫生診斷：(1)肺氣腫 / (2)慢性支氣管炎 / (3)COPD (可多選) 
患病年數：____________________ (最長患病年數)  X3c.
X4a  
. 




FEV1：Pre-BD _____________________ ( _________% Pred.) 
      Post-BD_____________________ (__________% Pred.)  
Post-BD FEV1 / FVC _____________________ 





5. 其它慢病診斷：(0)沒有 / (1)心血管系統 / (2)神經系統 /  
(3)骨骼肌肉系統 / (4)內分泌系統 /  
(5)泌尿系統 / (6)消化系統 /  
(7)其它 _________________ (可多選) 
X5d.
6. 工作情況：(0)退休 / (1)就業 / (2)失業 / (3)因病喪失工作能力 / 
(4)其它_______   X6.
7. 居住狀況：(0)獨居 / (1)與妻子同住 / (2)與伴侶及子女同住 / 
(3)與親朋同住 / (4)其它__________ X7.




調查日期 ：________________ (Pre / Post ) 
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X9a.9. 疾病開支：(0)政府支助 / (1)自付 / (2)家人付 / (3)保險 /  
(4)慈善支助 / (5)其它 ______________ (可多選) X9b.
X10a.10. 吸煙情況：(0)不吸煙  (1) 吸煙 ________pack year (包數 x 總年數)
(2) 戒煙 X10b
X11. 教育程度 : (0) 沒有接受過教育 (1) 小學程度  
(2) 中學程度       (3) 大學或學位後教育 

















12. 你有否使用儲霧器? (0)沒有 





(1)平均每週 1~2 次 
(2)平均每週>2 次, <7 次 















   (____次，合共_____天) X15c.
16. 過去 6 個月有否接受流感/肺
炎鏈球菌疫苗接種? 
(0)沒有 
(1)有    X16.
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聖 佐 治 胸 肺 科 問 卷 (SGRQ) 














的頻密程度是：      B1.
二. 於過去四星期內，我有痰
的日子是：      B2.
三. 於過去四星期內，我感到
呼吸困難的次數：      B3.
四. 於過去四星期內，我遇上
「牽哈」的日子：      B4. 
B5.
五. 於過去四星期內，你有多少次嚴重的胸肺病發作？ 
超過三次   三次     二次     一次     沒有
B6.
六. 最嚴重的一次胸肺病發維持了多久？ 
(若題五選擇答案   ‘沒有’  ，不用作答此題) 
一星期或以上  三天或以上 一至兩天 少於一天 不適用
B7.
七. 於過去四星期內每星期你平均有多少天沒有被胸肺問題困擾？ 
沒有  一至兩天   三至四天   幾乎每天    每天
B8.
八. 若遇有「牽哈」時，是否在朝早較為嚴重？ 
不是     是
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乙部
B9. 




 沒有構成問題 ----------------------------------------------- 
B10. 
若你曾有受薪工作，請在以下最適當的答案。 
 我的胸肺問題令我要停止工作 -------------------------- 
 我的胸肺問題影響我的工作或令我要轉換工作 ---- 









是   否 
 坐或躺臥 ------------------------------------------------ 
 梳洗或更衣 --------------------------------------------- 
 在家中步行 --------------------------------------------- 
 在戶外走平路 ------------------------------------------ 
 上一層樓梯 --------------------------------------------- 
 行山 ------------------------------------------------------  







是   否 
 我的咳嗽令我感到不適 ------------------------------ 
 我的咳嗽令我感到疲倦 ------------------------------ 
 說話時，我感到透不過氣來 -----------------------  
 彎腰時，我感到透不過氣來 -----------------------  
 我的咳嗽或呼吸問題影響我的睡眠 -------------- 









是   否 
 在公眾場合中，我的咳嗽或呼吸問題令  
 我感到尷尬 ---------------------------------------------- 
 我的胸肺問題令家人，朋友及鄰居感到討厭--- 
 當我不能控制呼吸時，我便會驚惶失措--------- 
 我覺得不能控制自己的胸肺問題 ----------------- 
 我不期望自己的胸肺情況會好轉 ----------------- 
 我因自己的胸問題而變得脆弱或無用 -----------  B29. 
   245 
B30.  運動對我來說是不安全的 --------------------------- 







是    否
 我的藥物對我幫助不大 ------------------------------ 
 在公眾場所用藥令我感到尷尬 -------------------- 
 我對所用的藥物有不良的副作用 ----------------- 











是   否 
 我梳洗或更衣需時良久 ----------------------------- 
 我不能洗澡或淋浴，或需時良久 ---------------- 





















是   否 
 令我不能做運動或比賽 -----------------------------  
 令我不能外出消遣或娛樂 --------------------------  
 令我不能外出購物 -----------------------------------  
 令我不能做家務 --------------------------------------  
 令我不能走動離開我的床或椅子太遠 ---------- 














 它不阻礙我做任何我喜歡做的事 ---------------------- 
 它阻礙我做一至兩件我喜歡做的事 ------------------- 
 它阻礙我做很多我喜歡做的事 ------------------------- 
 它阻礙我做一切我喜歡做的事 ------------------------- 
(Direct translated from The St. George’s Respiratory Questionnaire  P.W. Jones , F.H. Quirk and .M.Baveystock.) 




  (1) = 非常有信心     
(2) = 相當有信心 
(3) = 有少許信心 
(4) = 無信心 
(5) = 非常無信心 


















1. 當我感到太累時。     1 2 3 4 5 
C1.




1 2 3 4 5 
C3.
4. 當我覺得情緒緊張或不開心時。 1 2 3 4 5 
C4.
5. 當我上樓梯上得太快時。 1 2 3 4 5 
C5.
6. 當我否認我有呼吸困難時。 1 2 3 4 5 
C6.
7. 當我周圍都有香煙的煙霧時。 1 2 3 4 5 
C7.
8. 當我生氣時。 1 2 3 4 5 
C8.
9. 當我運動或付出很大的體力時。 1 2 3 4 5 
C9.
10. 當我爲我的生活而感到苦惱時。 1 2 3 4 5 
C10.
11. 當我感到性交不足或不舉時。 1 2 3 4 5 
C11.


















12. 當我感到無奈時。 1 2 3 4 5 
C12.
13. 當我舉起重的物件時。 1 2 3 4 5 
C13.
14. 當我大叫或大聲說話時。 1 2 3 4 5 
C14.
15. 當我躺床上休息時。 1 2 3 4 5 
C15.
16. 在非常炎熱或寒冷的天氣裏。 1 2 3 4 5 
C16.
17. 當我笑得很多時。 1 2 3 4 5 C17.
18. 當我沒有跟隨適當的日常飲食時。 1 2 3 4 5 
C18.








1 2 3 4 5 
C21.
22. 當我覺得焦慮時。 1 2 3 4 5 
C22.
23. 當我在污染的環境中。 1 2 3 4 5 
C23.
24. 當我吃得過多時。 1 2 3 4 5 
C24.
25. 當我感到沮喪或意志消沉時。 1 2 3 4 5 
C25.
26. 當我在空氣不流通的房間運動時。 1 2 3 4 5 
C26.




1 2 3 4 5 
C28.
29. 當我家中有問題時。 1 2 3 4 5 
C29.
30. 當我感到不能勝任時。 1 2 3 4 5 
C30.
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31. 當我匆忙時。 1 2 3 4 5 
C31.





















我有(無)此症狀    此症狀和我目前的病有(無)
關 
            (1)  (0)                 (1)  (0) 
疼痛   有  無  _____________  有   無 
喉嚨痛  有  無  _____________  有   無 
噁心作嘔 有  無  _____________  有   無 
呼吸困難  有  無 _____________  有   無 
體重減輕  有  無 _____________  有   無 
疲倦   有  無  _____________  有   無 
關節僵硬  有  無  _____________  有   無 
眼痛   有  無  _____________  有   無 
頭痛   有  無  _____________  有   無 
胃部不適  有  無  _____________  有   無 
睡眠問題  有  無  _____________  有   無 
頭暈   有  無  _____________  有   無 









IP1* 將在短時間內痊癒      IP1.
IP2 是永久性而非短時間的      IP2.
IP3 會拖很長一段時間      IP3.
IP4* 應該很快就會好了      IP4.
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IP5 會跟著我一輩子，永遠好不了      IP5.









IP7 對我的一生，帶來嚴重的後果      IP7.
IP8* 對我的人生沒什麼大影響      IP8.
IP9 嚴重影響到別人對我的看法      IP9.
IP10 為我帶來十分沉重的經濟負擔      IP10.
IP11 對我身邊的 人帶來很多困難      IP11.





IP15* 無論我怎麼做都影響不了我的病      IP15.
IP16 我認為我有力量可以改變我的病      IP16.
IP17* 不管怎麼做，最終對我的病，都沒什
麼幫助 IP17.













IP24 有很多症狀讓我很不解      IP24.
IP25 對我來說跟謎一樣,十分神秘      IP25.
IP26 對我來說，我是一點概念也沒有      IP26.
IP27 我實在無法理解我的病      IP27.
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我認為我的病⋯.. 完全
不同意















IP35 我對自己得這個病非常生氣      IP35.












不同意 沒意見 同意 非常
同意
C1 壓力或煩惱      IPC1.
C2 遺傳 ( 家族性 )      IPC2.
C3 細菌或病毒引起      IPC3.
C4 食物或飲食習慣      IPC4.
C5 純粹個人運氣，可能是我倒楣 IPC5.
C6 過去不良的醫療結果      IPC6.
C7 環境汙染      IPC7.
C8 由於我自己的行為所導致      IPC8.
C9 我的心態問題，例如，我對人
生想法太悲觀 IPC9.
C10 家庭問題、或過度煩惱所致      IPC10.
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我認為讓我生病的原因是⋯⋯. 完全不
同意
不同意 沒意見 同意 非常
同意
C11 工作過勞      IPC11.
C12 由於我情緒不好，比如說我
常感覺沮喪、寂寞、焦慮、或空虛 IPC12.
C13 自然的老化過程      IPC13.
C14 飲酒      IPC14.
C15 抽煙      IPC15.
C16 意外或受傷      IPC16.
C17 因為我個人的性格所導致      IPC17.
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Appendix 9  The Illness Perception Questionnaire (IPQ-R) 
(Moss-Morris et al., 2002) 
Name……………………………… Date………………………………… 
YOUR VIEWS ABOUT YOUR ILLNESS 
Listed below are a number of symptoms that you may or may not have experienced since 
your 
illness. Please indicate by circling Yes or No, whether you have experienced any of these 
symptoms since your illness, and whether you believe that these symptoms are related to 
your illness. I have experienced this symptom since my illness 
This symptom is related to my illness 
Pain   Yes No ________________ Yes No 
Sore Throat  Yes No ________________ Yes No 
Nausea   Yes No ________________ Yes No 
Breathlessness  Yes No ________________ Yes No 
Weight Loss Yes No ________________ Yes No 
Fatigue   Yes No ________________ Yes No 
Stiff Joints  Yes No ________________ Yes No 
Sore Eyes  Yes No ________________ Yes No 
Wheeziness  Yes No ________________ Yes No 
Headaches  Yes No ________________ Yes No 
Upset Stomach  Yes No ________________ Yes No 
Sleep Difficulties Yes No ________________ Yes No 
Dizziness   Yes No ________________ Yes No 
Loss of Strength Yes No ________________ Yes No 
We are interested in your own personal views of how you now see your current illness. 
Please indicate how much you agree or disagree with the following statements about 
your illness by ticking the appropriate box. 
VIEWS ABOUT YOUR ILLNESS STRONGLY DISAGREE  DISAGREE NEITHER  AGREE NOR DISAGREE  AGREE STRONGLY 
AGREE 
IP1 My illness will last a short time 
IP2 My illness is likely to be permanent rather than temporary 
IP3 My illness will last for a long time 
IP4 This illness will pass quickly 
IP5 I expect to have this illness for the rest of my life 
IP6 My illness is a serious condition 
VIEWS ABOUT YOUR ILLNESS STRONGLY DISAGREE  DISAGREE NEITHER  AGREE NOR DISAGREE  AGREE STRONGLY 
AGREE 
IP7 My illness has major consequences on my life 
IP8 My illness does not have much effect on my life 
IP9 My illness strongly affects the way others see me 
IP10 My illness has serious financial consequences 
IP11 My illness causes difficulties for those who are close to me 
IP12 There is a lot which I can do to control my symptoms 
IP13 What I do can determine whether my illness gets better or worse 
IP14 The course of my illness depends on me 
IP15 Nothing I do will affect my illness 
IP16 I have the power to influence my illness 
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IP17 My actions will have no affect on the outcome of my illness 
IP18 My illness will improve in time 
IP19 There is very little that can be done to improve my illness 
IP20 My treatment will be effective in curing my illness 
IP21 The negative effects of my illness can be prevented (avoided) by my treatment 
IP22 My treatment can control my illness 
IP23 There is nothing which can help my condition 
IP24 The symptoms of my condition are puzzling tome 
IP25 My illness is a mystery to me 
IP26 I don’t understand my illness 
IP27 My illness doesn’t make any sense to me 
IP28 I have a clear picture or understanding of my condition 
IP29 The symptoms of my illness change a great deal from day to day 
IP30 My symptoms come and go in cycles 
IP31 My illness is very unpredictable 
IP32 I go through cycles in which my illness gets better and worse. 
IP33 I get depressed when I think about my illness 
IP34 When I think about my illness I get upset 
IP35 My illness makes me feel angry 
IP36 My illness does not worry me 
IP37 Having this illness makes me feel anxious 
IP38 My illness makes me feel afraid 
CAUSES OF MY ILLNESS 
We are interested in what you consider may have been the cause of your illness. As people are 
very different, there is no correct answer for this question. We are most interested in your own 
views about the 
factors that caused your illness rather than what others including doctors or family may have 
suggested to 
you. Below is a list of possible causes for your illness. Please indicate how much you agree or 
disagree that 
they were causes for you by ticking the appropriate box. 
POSSIBLE CAUSES STRONGLY  DISAGREE DISAGREE NEITHER  AGREE NOR DISAGREE  AGREE STRONGLY   
AGREE 
C1 Stress or worry 
C2 Hereditary - it runs in my family 
C3 A Germ or virus 
C4 Diet or eating habits 
C5 Chance or bad luck 
C6 Poor medical care in my past 
C7 Pollution in the environment 
C8 My own behaviour 
C9 My mental attitude e.g. thinking about life negatively 
C10 Family problems or worries caused my illness 
C11 Overwork 




C16 Accident or injury 
C17 My personality 
C18 Altered immunity 
In the table below, please list in rank-order the three most important factors that you now believe 
caused 
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YOUR illness. You may use any of the items from the box above, or you may have additional 
ideas of your 
own. 
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Appendix 10  The COPD Self-efficacy scale  (Wigal et al. 1991) 
Read each numbered item below, amid determine how confident you are that you 
could manage breathing difficulty or avoid breathing difficulty in that situation. 
Use the following scale as a basis for your answers: 
(a) = Very confident 
(b) = Pretty confident 
(c) = Somewhat confident 
(d) = Not very confident 
(e) = Not at all confident 
1 . When I become too tired. 
2. When there is humidity in the air. 
3. When I go into cold weather from a warm place. 
4. When I experience emotional stress or become upset. 
5. When I go up stairs too fast. 
6. When I try to deny that I have respiratory difficulties. 
7. When I am around cigarette smoke. 
8. When I become angry. 
9. When I exercise or physically exert myself. 
10. When I feel distressed about my life. 
11. When I feel sexually inadequate or impotent. 
12. When I am frustrated. 
13. When I lift heavy objects. 
14. When I begin to feel that someone is out to get me. 
15. When I yell or scream. 
16. When I am lying in bed. 
17. During very hot or very cold weather. 
18. When I laugh a lot. 
19. When I do not follow a proper diet. 
20. When I feel helpless. 
21 . When I drink alcoholic beverages. 
22. When I get an infection (throat, sinus, colds, the flu, etc). 
23. When I feel detached from everyone and everything. 
24. When I experience anxiety. 
25. When I am around pollution. 
26. When I overeat. 
27. When I feel down or depressed. 
28. When I breathe improperly. 
29. When I exercise in a room that is poorly ventilated. 
30. When I am afraid. 
31 . When I experience the loss of a valued object or a loved one. 
32. When there are problems in the home. 
33. When I feel incompetent. 
34. When I hurry or rush around. 
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Appendix 11  Checklist for assessing inhalation technique 
Metered-dose Inhaler technique Checklist 
Participant No :     Name of drug:  






1. Tell the function of the drug 
2. Check the expiry date of the inhaler 
3. Shake the inhaler and open the lid 
4.  Slow breathing and make a slow and 
deep exhalation 
5.  Place the lips tightly around the 
mouthpiece of the inhaler 
6. Breath in slowly and deeply at the time 
of pressing a dose of the inhaler  
7. Hold the breath for 10 seconds or as 
long as possible 
8. Breathe out    
9.* If second dose is necessary, take a rest 
for 30 seconds before repeating step 4 
to 8 
10. Wrap the mouthpiece thoroughly with 
dry tissue 
11. Cover the inhaler properly with the lid    
12.* Always bring along the short-acting 
bronchodilator 
13.* Rinse the mouth after inhaling     
Assessor’s code: 
Total
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Appendix 12  Certificate for purchase for SF-36v2 Questionnaires  
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Appendix 13  Topic guide for the focus group 
Two main foci to be covered :  
1) How do you find the self-management workshops? 
Possible prompts:
-  Are those content related to your daily management of your disease? And 
how? 
- What content impressed you most? 
- How do you find about the action plan? Difficult to carry out? Effectiveness? 
- How do you find the delivery of the workshop? For example, time, venue, 
duration of the workshop.  
2) What are your experiences of being self-managed with your disease? 
Possible prompts:
- During exacerbations? Daily management? Before and after the programme 
-   How do you find the effectiveness of the management strategies you applied?
Overall Question 
3)  As a COPD patient, do you think conducting self-management education 
programme as such is necessary? If so, how should it be run? 
Possible prompts: 
-  As a COPD patient, what do you most expect a nurse to do for you?  
-  Any further opinions and recommendations 
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Appendix 14  Patient Handbook 
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Appendix 15  Action Plan 
GREEN Zone：Doing Well Take these Long-Term Control Medicines Each Day 
 No cough, wheeze,  
chest tightness or shortness  
of breath during the day or  
night 
 Can do usual activities 
Before exercise               Take ________________________________  □ 2 puff or □ 4 puff    5 to 60 minutes before exercise 
YELLOW Zone: Getting Worse
 Cough, wheeze, chest tightness 
or shortness of breath, or 
 Waking at night due to wheeze  
    or 
 Can do some, but not all 
Usual activities 
** If your sputum appears yellowish or greenish, or increases in volume and thickness or you have fever, you may probably be infected 
Go to OUT-PATIENT 
RED Zone：Medical Alert
 Very short of breath, or 
 Above management do not help 




How much to take 
____________________
____________________




_________________________□ 4 puff 
**And keep taking your GREEN Zone 
medicine 
If your symptoms persist after 1 hour of previous 
treatment 
________________________________  □ 4 puff 
Go to the Hospital or Call for an ambulance NOW !!!!!! 
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Appendix 16  Transcript symbols 
The interviews were transcribed with the application of Silverman’s simplified 
transcription symbols (Silverman, 2011). The symbols could help to understand the 
dynamic of the interacted subjects during the interviewing process as well as to 
capture the contextual situation within the focus groups.  
= Equal signs, one at the end of a line and one at the beginning, indicate no 
gap between the two lines. 
[   ] Left brackets indicate the patient at which a current speaker’s talk is 
overlapped by another’s talk.  
(.3) Numbers in parentheses indicate elapsed time in silence in tenths of a 
second. 
(   ) Empty parentheses indicate inability to hear what was said.  
(word) Parenthesised words are possible hearings. 
((word)) Double parenthese contain author’s description rather than transcriptions. 
WORD Capitals indicate especially loud sounds relative to the surrounding talk. 
Word Underscoring indicates some form of stress, via pitch and / or amplitude. 
On top of the above, I added two more symbols: 
(word) Italicized words in parentheses indicate facial, gestural or emotional 
expressions  
…word  Three dots at the beginning of one’s talk indicate continuing of his talk 
after interruption.   
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Appendix 17  Focus Group One Transcript (Sample) 1 
2 
Participants :  3 






E008 Nick 61 / M IV Secondary 48 
E010 Amy 57 / F II Primary  52 
E014 Wilson  73/ M II Primary  60 
E019 Ivan  73 / M III Primary  60 
4 
SL (2 - 2.55) First, would like to ask how you guys feel about the COPD self management 5 
workshop that took before? Any feeling to the workshop? Can you share? 6 
7 
19 Like acquired knowledge, related to the condition of the disease= 8 
9 
SL =Acquired knowledge related to the condition of the disease, Um..for example? 10 
11 
19  It means recuperation.. 12 
13 
SL  Recuperation…...it means.. err? Whats the meaning of recuperation? 14 
15 
19  Recuperation means……..means…err…means, means…to try...how to control 16 
breathing. 17 
18 
SL  Ar…how to control breathing..um.. 19 
20 
19 And those….those taught us the Tai Chi exercise…those I have forgotten already. 21 
22 
SL Arr…can remember the Tai Chi exercise, although the content is forgotten, but 23 
those movement right? So, recuperation, control breathing and the understanding to 24 
the disease= 25 
26 
19 =Mainly about the understanding of the disease progress. 27 
28 
SL Understanding of the disease progress means which content? 29 
30 
19  Means how to…to..to.. regulate the health of your own self. 31 
32 
SL  Recuperation in a self-based, mainly focus on recuperation. Um, good good 33 
good…or any other follow-up?.. any other..any other patients? 34 
35 
10  should do the similar things. 36 
37 
SL  How to do it? How will you do it? 38 
39 
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10  Like be cautious of your own self, as I did. 40 
41 
SL  Be cautious of your own self..um…. 42 
43 
10  Or most importantly to keep warm, don’t catch a cold or the flu, something like 44 
that. 45 
46 
SL  To carefully protect your own self, don’t catch a cold or the flu. 47 
48 
10  Um..um..when I caught a cold or a flu, I would become…become…start 49 
becoming anxious and short of breath, that’s how I work. It means, everyone’s 50 
method is different. 51 
52 
SL  Um..so, everyone has differernt needs, is that what you mean…? 53 
54 
10  Um Um 55 
56 
SL So, be carefully recuperating yourself, and that will stop worsening the 57 
symptoms. 58 
59 
10  Um um.. 60 
61 
SL  Um..then if there are still any content that you think you have learnt from the 62 
worksop? 63 
64 
10  Those things I have learnt..may be something I have forgotten from the 65 
workshop…and stopped doing those….something like working on deep breathing, 66 
that’s something I keep doing… 67 
68 
SL  Ooo, you have done deep breathing, alright, alright, anything apart from deep 69 
breathing? [19 Deep breathing is good..it’s good..can help enlarging the lung 70 
volume..its real] Right right..deep breathing is helping. [10  Went and visited Doctor, 71 
Dr. Yeung kept saying: “remember”.. ”remember” .. always reminded me for keep 72 
working on it!] I see, I see…Dr. Yeung also reminded you to work on it..UmUm…good, 73 
what about you Old Wong? 74 
75 
14  O about myself, ..for me..like sometimes I might get tired during my work, then I 76 
would take a break and worked on deep breathing again…Ar…things like walking on 77 
stairs, doing housework at home, I also follow her instruction then really became 78 
easier, but working through morning exercises, then..sometimes could learn what 79 
she taught us to do, sometimes would work on those breathing exercise myself, work 80 
on those little gestures…then…ha..then…it means the physical condition became 81 
progressively progressively better..ha= 82 
83 
SL  =O..you have tried the controlled breathing? 84 
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85 
14  Yes…like work on those little gestures..= 86 
87 
SL = Learnt incompletely…but the general situation is known= 88 
89 
14  =Yes…yes… worked on something like these…now at work didn’t feel it..not so 90 
suffering…even  long-distance walk is ok now, at the beginning in the past was not 91 
ok= 92 
93 
SL  =At the beginning was suffering= 94 
95 
14 =At the beginning if walk for too long is not possible, now during the walk…in 96 
the past when I went to Gongbei Port, I would need 5 to 6 breaks for arriving the 97 
port…now is a bit better, its ok to walk for long..walk…means now I can continuously 98 
for around an hour= 99 
100 
SL  =You think it is related to the exercises and deep-breathing that’s you have 101 
done?= 102 
103 
14  =Yes Yes…related…or take good care of own self during bad weather, something 104 
like health care by own self. 105 
106 
SL  Some precaution..er..some method for self-health-care during worsening of the 107 
disease…..orr, it’s quite good, learnt quite a lot. 108 
109 
14  Yes, really could learn a lot, it’s all because of Nurse MN..haha. 110 
111 
SL  Um…that’s great that’s great! Then what about Nick? 112 
113 
8 We know what is COPD through the workshop, in the past it’s not clear what 114 
kind of disease we are suffering from. 115 
116 
SL O…really? 117 
118 
8 In the past what I know is coughing, lots of mucous..something like in thebody is 119 
in the  situation of heatiness, then now after attending the workshop know this is 120 
COPD..ha…So, in terms of learning, we have Nurse MN for explaining the disease to 121 
us patiently, in addition to the therapy from the doctors..although my disease is 122 
comparatively severe, because I have this disease for 20 years already, when I 123 
counted, it does have 20 year, but I have not been aware in the past, and think that 124 
keep taking fresh air and traditional Chinese Medicine sometimes would fix the 125 
problem. Then eventually became serious…I was working and comparably busy that 126 
time, went usually for injection, injection is for emergency case, means an one-off 127 
medication, intravenous injection, then became receiving the intravenous injection 128 
every 2 days, worsening the situation…made me can’t work anymore and I am 129 
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suffering from it, I had a job before. 130 
131 
SL  Then what about now? [8  now…]How do you feel after joining the workshop 132 
[8 after the workshop I learnt a lot, meanwhile my situation became more serious, 133 
then after joining the workshop…it reminded us the things that should take 134 
precaution, mostly importantly is not to caught a flu.] 135 
136 
SL I see, most importantly not to catch a flu= 137 
138 
8 =Ar..most importantly not to caught a flu, because once the trachea was 139 
irritated.. .I am weak and there is nothing I can do….once caught a cold, I couldn’t 140 
stand for that…ar, once couldn’t stand for that, then have to go for injection, then 141 
then then everything, then hospitalized. Last year, I was hospitalized for 3 times. 142 
143 
SL   O..so you learnt more about the disease through the workshop, like what is 144 
COPD and how to take care of yourself..I mean, self protection, and try not to worsen 145 
the situation= 146 
147 
8 =Um..Um, yes, yes….in this case, yes… 148 
149 
SL  What else have you learnt? 150 
151 
8 What I have learnt is how to take care of myself with COPD, when my situation 152 
became serious, the most serious was I couldn’t get out of bed, couldn’t go shitting, 153 
couldn’t eat, walking is no way. I’ve tried using wheelchair to go to the Port with the 154 
help of my wife. Ha, the above was my condition last year. But now, different aspects, 155 
for example, medical support…..as I am now following up at the government hospital, 156 
as well as hospital in Zhuhai. I have also been to Lee Ka Shing Hospital in ZanTao, my 157 
home town, and was hospitalized there. Then I consulted the experts, but I’m told 158 
that my disease is already in a comparatively severe stage. 159 
160 
SL  I means you know that your situation became more serious= 161 
162 
8 =Tried lung function assessment, reported that I am with severe pulmonary 163 
emphysema, the respiratory system is at level 2, level 2 in lung failure ((Type II 164 
respiratory failure)), also(  ) it is difficult for curing this disease; now I am using 165 
antihypertensive drug, it is usually doing fine, but if I was having a flu, my blood 166 
pressure and heart rate would increase= 167 
168 
SL (3.1 – 11:38) =So you learnt from the workshop that you have to be aware of 169 
controlling the situation of your flu..[8  Um, um, um] O, right..ar…you have tired the 170 
workshop last year, ar, what do you think about the time arrangement of the 171 
workshop?= 172 
173 
8 =Its quite good! Because, after the learning…you...you.. I mean work on nothing 174 
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now, I can’t work on anything anyway..ar..so now..usually in the morning…I…I go for a 175 
walk in the park cause I am living in the area of NAPE. 176 
177 
SL  Then how do you feel about the workshop? Maybe Ivan, what do you think 178 
about the time arrangement of the workshop? Maybe divded into 2 parts? Since 179 
some learners can acquire the skills in 2 parts. But some of learners may need 3 parts 180 
for the learning, is dividing the workshop into parts helpful for you to pick up the 181 
management skills for self-caring? Is it too frequent? Or is it not enough? 182 
183 
8 Its quite good, through the learning, I know what is going on, on top of that, 184 
there are guidance provided by expertise like Nurse MN, then I know what is going 185 
on..I..I…understand the illness condition is like this, what I should do. Ar, now is using 186 
pharmaceutical therapy, now Iam..I have bought a machine…those machine for 187 
delivering oxygen, I means it is always needed, I was told by the doctor to keep under 188 
oxygen therapy all the time or at least 15 hours. But I was not able to sit there for 189 
such a long time, so I just used the oxygen when I felt difficulty in breathing, I didn’t 190 
use it when I didn’t feel short of breath. However, I have no choice now, I have to use 191 
oxygen even when I am sleeping. 192 
193 
SL  Um, what about Wilson, what do you think about the learning time for the 194 
workshop? How many lessons have you taken? 195 
196 
14 I…I’ve forgotten how many[8  Many lessons…I remember almost 4, to5] 197 
lesson I’ve taken. 198 
199 
SL I see, taken as many as 4 to5 lessons. What about Amy? 200 
201 
10  The timing..… 202 
203 
SL  Ivan, how many lessons have you taken? 204 
205 
19 Seems like 3 lessons. 206 
207 
SL  I see, 3 lessons..do you think if 3 lessons are enough?Is it too frequent or not 208 
enough? 209 
210 
19  O, its enough. 211 
212 
SL  its enough..!? It’s enough..!? what about 2 lessons? Anyone has taken 2 lessons? 213 
214 
10  I have 2 lessons. 215 
216 
SL You have 2 lessons, were 2 lessons enough? 217 
218 
10  My problem is the time, so I could only attend 2 lessons 219 
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220 
SL I see, I see…then what do you think about the 2-lessons or the 3-lessons 221 
arrangement? I mean about the workshop? 222 
223 
8 In general, it is fine. It is indeed a matter of taking care of your own disease.....it 224 
is mainly teaching us people acknowledge the characteristics of the disease, and 225 
what do we have to pay attention, the most important thing is on us, that is all. 226 
227 
SL (3.2 – 14:10)  So you think both 2 or3 lessons should be enough, then what 228 
about the venue? Is it convenience to you with holding the workshop in the section 229 




14 I think the previous venue [19  No problem] is easier to be found [8 If you got 234 
the chance of (  )] and more spacious, that’s my opinion. 235 
236 
SL  I see..Isee…think that the First Out-patient department is easier to be found, but 237 
the present venue is more spacious? 238 
239 
14 No.. 240 
241 
SL  I see, that place, where the previous..er..seminar was held? 242 
243 
14  Yes, where the seminar hold….haha…haha 244 
245 
SL  I see…good good…what about Amy? 246 
247 
OB She was specially arranged, she was at the outpatients, taken the workshop in a 248 
clinic. 249 
250 
SL  I see…it means she took the workshop separately. So, in general the venue is 251 
fine, right, right!? It’s ok…haha! 252 
253 
19  it’s ok. 254 
255 
SL (2.1 – 15:45)  Alright…so, you guys have just shared quite a lot of content that 256 
taught by Nurse MN, they are more or less emphasized on deep breathing, some of 257 
them about exercises, some of them about self-recuperation and knowledge of the 258 
disease, right? If there are any parts in the workshop which are most impressive to 259 
you? 260 
261 
10  You mean which parts? 262 
263 
SL  The content of the lesson, since there are so many… 264 
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265 
10  I see, the teaching content….since we don’t know nothing in the beginning, then 266 
of course, we will have more understanding about the disease only after being taught, 267 
something like that. 268 
269 
SL  In which way you mean? 270 
271 
10  Its like in the beginning don’t know anything about that disease, ha..like this.. 272 
273 
SL I see….understanding of the disease… 274 
275 
10  Ar, don’t know it is like this not until it became like this, so got to start 276 
protecting myself now. 277 
278 
SL  Um..um..then, it means the understanding of disease impress you most. Well, 279 
maybe Old Wong, which part of the course is most impressive to you, amongst the 280 
teaching content. 281 
282 
14  It means…taught me those, I am impressed by the breathing [ 8 Breathing… 283 
really…] 284 
285 
SL  Um..breathing, about how to breath? 286 
287 
14  It is (participant demonstrats) the breathing that involves breathing in and 288 
breathing out. Arh..then to the lung it is….[19  It means good to the lung function] 289 
more comfortable  [ 19  For lung inflation] For those moments I was able to 290 
learn, I followed the instruction, for those I couldn’t remember, I did it in free style 291 
with my own movements.  292 
293 
SL  In what way do you mean? 294 
295 
14  Hahaha…it means those…movements that freely done by myself. 296 
297 
SL  Which particular style do you mean? Cause Nurse MN has taught you guys 298 
several movements… 299 
300 
14  Ha, I’ve forgotten most of those movements…hahaha (everyone laughs). 301 
302 
SL  Mostly forgotten..haha! 303 
304 
19  Not good at memory…hahaha.. 305 
306 
SL  Because apart from those health exercise, breathing exercise, there are some 307 
others about energy saving, those movement that help saving energy= 308 
309 
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8 =Yes, those technique, breathing technique, energy saving technique 310 
311 
SL  Those techniques, yes, those techniques, which particular you could 312 
remember? 313 
314 
14  Haha…some of them can be remembered, but not much memory about them 315 
now, mostly do it myself in free-style…. 316 
317 
(Every one laughed) 318 
319 
8  Free-style 320 
321 
14  Move freely 322 
323 
SL  Arh..but you think it is still useful?= 324 
325 
14  =Useful! When you worked on whatever movements..[ 19  Its useful!...Those 326 
techniques, it means understand more about the disease] If they… are teaching 327 
sincerely, of course you would be taught something beneficial and useful, it is 328 
definitely great if you can do it yourself, but there so many to remember, how to 329 
remember.. hahaha 330 
331 
SL  I see..then, then, it means it’s a bit pity that something learnt from the 332 
workshop has forgotten, right? 333 
334 
14  That’s right. 335 
336 
SL  O right, what about Ivan? Which part of the content impressed you most? 337 
Amongst all those content that taught in the workshop? 338 
339 
19  I am most impressed by breathing in and breathing out, it’s good for lung 340 
function. 341 
342 
SL  I see, breathing, those involve breathing out, that’s true, it’s good to the 343 
lung…O…what made you having such a feeling? 344 
345 
19  It means the feeling of..you are long-term, it’s better now for lung inflation when 346 
taking deep breathing; In the past when I was smoking, my lung could not be 347 
expanded even I took a deep breath, now is really better, my chest expanded when I 348 
was deep breathing, I could feel it. 349 
350 
SL  I see, you could feel it yourself, that lung inflation was really taking place, after 351 
controlled breathing, it is helpful to your lung function, you felt it, it’s really good that 352 
you have the feeling as such= 353 
354 
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19  =Nonetheless, it’s yourself who don’t smoke, its real… 355 
356 
SL  Haha.. 357 
358 
19  Haha.. 359 
360 
SL  It’s not bad, this workshop taught you how to taking care of yourself in daily 361 
habit, right? 362 
363 
19  That’s right. 364 
365 
SL  Not bad, not bad. Then…Nick? What impressed you most? 366 
367 
8  It’s…it’s still those breathing technique, and also those breathing at night, the 368 
night exercises, need to do it before sleep, they are those involving breath out and 369 
breath in, I do it every night and do it before sleep. But my, my…lung function is 370 
really worse, I am already in…the doctor said in level 2 of failure in breathing function, 371 
I tried to understand, to see if the situation could be improved by surgery, but the 372 
advice is better not to do so, you can tried, not impossible, and said would be 373 
troublesome, and got to be assessed in advance, this operation can be done in 374 
Xiamen and Hong Kong, I have enquired, but still better not to do so.. 375 
376 
SL  So you think after the deep breathing before sleep is helpful to this.. 377 
378 
8  Yes….sometimes about how to cough up sputum.. 379 
380 
SL  Ar, expectorate, how to cough sputum up? Can you guys share a bit? How come 381 
this part is impressive as well…ha!? 382 
383 
8  Its always difficult for us to cough the sputum up, not enough strength to do so, 384 
if tried several times will become short of breath, sometimes..sometimes I drank 385 
some water, sometimes sat down and patted my back, then have got use my strength, 386 
the workshop taught us how to save the energy, how to use the strength…and how 387 
to save the energy together with deep breath to force it out. 388 
389 
SL  I see..mainly the coughing technique..right? 390 
391 
8  Yes..yes.. 392 
393 
SL  You’ve just mentioned energy saving, anything about energy saving technique 394 
impress you? 395 
396 
8  It does, it does, energy saving means in order to breath smoothly, you have to 397 
breath in and breath out, usually, when I inhaled oxygen, I would exhaled more 398 
oxygen out, but all this technique …have been taught when I was hospitalized in KWH 399 
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during 2005. 400 
401 
SL  Then it means you keep using this method..I see, that’s not 402 
bad..then..er..Right..let me make a brief conclusion first.…just before everyone of you 403 
mentioned the key points from your learning , for example, breathing, how to control 404 
the breath, a breath focusing on breathing out, right? A breath that breathing out 405 
deeply, right? [8  Yes] Another thing is exercises, you guys have mentioned…you 406 
know the breathing exercise, it means you guy worked on those movements for 407 
breathing as well, right? And that its impressive, right? Also, something about 408 
precaution of preventing worsening the condition of the disease.  How to protect 409 
yourself from being attacked by the flu easily, right? Then…er..er..there is something 410 
like, as you guys just mentioned, the energy saving methods and techniques.. er.. 411 
er…or something about the skills of coughing and expectoration ..er..er..actually in 412 
the workshop there are contents other then these, such as something about the skills 413 
for using inhalation drugs, do you remember anything about that? 414 
415 
8  (.2) I have to do the inhalation all the time…..now the doctor teaches us this 416 
knowledge, as well as the workshop here, have to teach according to the instruction, 417 
otherwise you practice incorrectly. 418 
419 
SL  You have followed the instruction for drug inhalation…Ha, is everyone here 420 
also…right Wilson have not used this drug inhalation, Amy, you used it, have you 421 
followed the instruction? 422 
423 
10  Yes, I take it in the morning and in the night. 424 
425 
SL In the morning and the night…umum, what about the technique of inhalation? 426 
For example, have you followed the instruction of how to breath in and breath out 427 
during inhalation? 428 
429 
10  Before inhalation got to breath out, then breath out slowly after inhalation. 430 
431 
SL  Umum…. 432 
433 
10  Most importantly is mouth rinsing after inhalation. 434 
435 
SL  Mouth rinsing after inhalation, that’s correct that’s correct…you still 436 
remembered, still remembered. 437 
438 
10 Um. 439 
440 
Then…Ivan? Can you remember? 441 
442 
19  Remember! (coughed…) Breath in from the nose and breath out through the 443 
mouth. 444 
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445 
SL  Umumum…still remember. Nick, you have done this too. 446 
447 
8  I remember…I need to take it every day. The one called Seretide has to be 448 
inhaled every morning after waking up and every night before going to bed, so two 449 
times in total. Then, for the one which normally is taken at 3pm in the afternoon, we 450 
called it ShuLok Wa in the mainland and it is called Spiriva here, it is round in shape 451 
and is covered by pushing the lid, I'm also using it now, thus I'm using these two 452 
medication at the moment. 453 
454 
SL Great, then if there is any, any short-of-breath management, would you guys 455 
also remember? Short-of-breath management means do you know what to do when 456 
encountering difficulty in breathing. 457 
458 
10  (.2) Nurse taught me to use that pipe ((metered-dose inhaler, MDI)). 459 
460 
SL  You even have the pipe ((MDI))? 461 
462 
10  I have, for the precaution of short of breath. 463 
464 
SL  Good, good good. This one is also related to short-of-breath management, any 465 
other things you have learnt concerning the short of breath situation? 466 
467 
8 (Short-acting agonist) O this one, this one…[10   I seldom use this one, 468 
seldomly us, use it only for a precaution purpose, do this in the morning] In the past, 469 
I used it only in emergency situation, but now I keep it with me wherever I go 470 
sometimes, use it when having difficulty in breathing. I used once just before I came 471 
here, before I used even for 4 times per day. 472 
473 
SL  Umum…Ivan? Ivan can you remember anything about the short-of-breath 474 
management? 475 
476 
19  Short-of-breath management? Means the time of the walking motion? 477 
478 
SL  It means, what would you do when you encounter difficulty in breathing during 479 
any of your activities? 480 
481 
10  Then I myself…if this situation happened when I am walking up stairs, I will 482 
stop walking, take a little break, wait till the situation is relieved and 483 
become…not…not so serious…then I start climbing up the stairs again. 484 
485 
SL  Um, I see I see. It means stop and take a rest= 486 
487 
10  =If keep walking steadily on blading surface. Distance is not a problem. So, it 488 
happen usually when I was climbing up stairs, it was like after climbing up for around 489 
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3 steps, I encountered a little bit of difficulty in breathing, mainly because of myself…I 490 
felt I have to stop, then I stop. 491 
492 
SL  Umum, I see I see, then Old Wong? Anything else about short-of-breath 493 
management? 494 
495 
14  Well, no big problem so far, I keep climbing up stairs every day. 496 
497 
SL  So this short of breath situation is not frequently happened, right? Good good 498 
good. Then what about dietary, you guys have not mentioned dietary much, do you 499 
still remember this content that taught in the workshop?= 500 
501 
8  =Yes yes yes…got to take some non-greasy food, like those prepared from 502 
steaming or stewing..also with some vegetables, it means, don’t take too much food 503 
with high CO2 content, something like this. 504 
505 
SL  Ar…you can well remember the CO2 concept, quite good. Then what kind of 506 
food contains more CO2, should be avoided? And which type better take more? Do 507 
you guys...remember? 508 
509 
8  Rice is one of those, rice contains lots of CO2, those related to starch. 510 
511 
SL  Starch, rice…yes yes…good good good, anything else? 512 
513 
8  Those vegetables and fruits are better. 514 
515 
SL  Take more vegetables, fruits, not so greasy; anything else? 516 
517 
14  Um…not much, avoiding something like those with high cholesterol content. 518 
Only take a tiny amount and not so frequently…don’t take it too often…ha…usually 519 
we take vegetables and fishes and not that much for those with high cholesterol. We 520 
also take less meat, maybe sometimes will have some, should not totally stop eating 521 
meat, and got have some from time to time…..hahaha! 522 
523 
SL  Ha..then Amy, anything else? 524 
525 
10  I am the same, more or less like that. 526 
527 
SL  How similar? 528 
529 
10  Means less meat but more fishes. 530 
531 
SL Umumum….Ivan? 532 
533 
19 (.2) The same…having more like vegetables and fruits. 534 
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535 
SL  More vegetables and fruits, quite good, you guys actually have learnt something, 536 
right?! 537 
538 
8  I’ve quitted alcohol and smoking, just sometimes having a bit of tea, nothing 539 
more, not much digestion now. 540 
541 
SL (2.2 – 29:40)  That’s good, that’s good..ok, another question..which part of the 542 
course is the most important in your daily life? It means, most helpful and and 543 
related?...So, you guys have just revised the different contents and parts that you 544 
learnt from the workshop, right!? Then which part of those knowledge is the 545 




SL  Maybe different person will have different answer, no need to be the same, it 550 
means, which parts that you learnt from the workshop most related to your own 551 




14  Those involving learning..? 556 
557 
SL  Yes..there are so many things that you’ve learnt. 558 
559 
10  Most important is those about short of breath. 560 
561 
SL  Most important is stop the condition of short of breath..I see..how to stop it? 562 
563 
10 For me, when I was working…I found it difficult to breath when I became 564 
nervous..[8  yes] So weird. Once relaxed, I became totally fine and seems like 565 
nothing happened, also when walking up a slope, I’ll have become short of breath 566 
again if I walked for too long, then I have to walked slower, dare not to increase the 567 
speed. 568 
569 
SL  Then do you think it is a kind of skills for saving your energy? 570 
571 
10 This seems not related to energy saving or not, sometimes the most important 572 
factor is yourself, just like what I just said, when you found it difficult to breath in a 573 
fast walk, then you have to stop, put it this way…stopped for awhile, then walked 574 
again slowly, its quite good, nothing serious happened afterward; sometimes when 575 
hurrying for doing something or going somewhere and became nervous (  ), then 576 
short of breath again, so shitty! It’s totally fine when I was slow down and relax, 577 
would not have problem in breathing all day long. 578 
579 
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SL  Then it means you have learnt the skills to stop yourself of having short of 580 
breath, it is always the most impressive if what you’ve learnt can be applied to the 581 
daily life..its good, this example is special, very special…helpful! 582 
583 
10  Yes, its right, a bit special.  584 
585 
SL If there is anything else in what you have learnt is related to your daily life? 586 
Which parts? 587 
588 
8  The most important to me is don’t get nervous…yes…like keeping a relaxed mind, 589 
and work slowly, then everything will be fine. If I have an appointment with the 590 
others…I’m not like this before, now when I have an appointment with the others, I 591 
will become…..nervous, when I become nervous...when you...I used to have this 592 
characteristic of getting nervous easily, when I am nervous, I will walk faster, 593 
sometimes will not think of slowing down, want to walk faster and faster, 594 
eventually..eventually eventuallly eventually..[10  short of breath] short of breath. 595 
596 
(All nod their heads) 597 
598 
SL  Ooo…you guys have the similar feeling [8  that’s serious] [19  I am not scared 599 
of walking on blading surface, but once on the stairs, I am scared.] 600 
601 
SL  I see= 602 
603 
8  =I can’t walk on stairs, it happened years ago, fortunately there are lift at mine, 604 
If  I have to walk through stairs for doing something, I would just give up. 605 
606 
SL  But still you learnt from the workshop that to slow down, and stop making 607 
yourself easily become short of breath= 608 
609 
19  =Yes, got to be slow in making a movement. 610 
611 
SL  Slower in making a movement, now you can applied what you’ve learnt from 612 
the workshop into daily life [8  This is the most important point, can’t hurry, once 613 
hurry, everything is gone] Is it correct, Wilson? 614 
615 
14  I am already old, then of course everything is slowed down…haha..haha..JUST 616 
TAKE IT EASY=. 617 
618 
SL  =I see I see…that’s good, that’s good. Apart from slowing down during walking 619 
that stop the condition of short of breath, anything else from the workshop could be 620 
applied to daily life?= 621 
622 
10 =Maybe I am sensitive to something…when I smelled something strange, those 623 
symptoms like coughing would be triggered..then I would get sick. I am very sensitive, 624 
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once I smell something, my situation will get worse. 625 
626 
SL  It means sensitivity…to sense any changes to your body and what triggers short 627 
of breath?= 628 
629 
10  =Its fast, once I smelled something, I will get worse immediately, anyway, if I 630 
smelled something wrong, I will , anyway its very fast, it’s not ok like this. 631 
632 
SL  Umum..then will you consider this is a kind of surveillance of symptoms...your 633 
sensitivity is higher? 634 
635 
10 (.2) Yes, not so fast in the past, since...now went I smelled it, when smelled it I 636 
started feeling sick..it is like this. 637 
638 
SL  Yes…actually you have learnt from the workshop that you should play attention 639 
to this issue,to avoid, to take precaution. 640 
641 
10  Yes 642 
643 
SL (2.3 – 34:15)  I see I see..its good. If that’s all for this issue, I would like to ask, 644 
there is an item called the Action Plan in the content of the workshop, it means if the 645 
symptoms can’t be relieved during exacerbation, you guys were taught to use the 646 
anti-wheeze drug, for 4 dosages, then take an 1-hour self-observation before the use 647 
of a further 4 dosages, still remember?= 648 
649 
8, 10   =Yes..Yes..it was mentioned. 650 
651 
SL  It was mentioned…what about the 2 gentlemen here? Wilson? Ivan? 652 
653 
14  I have not tried that, so can’t remember..haha. 654 
655 
19  I have tried. 656 
657 
SL  Anything remember about the content? 658 
659 
19  Yes. 660 
661 
SL  Can remember…have not tried. Ar, someone have tried, someone have not tried. 662 
Ok, then could each one of you share something about this topic. Ar, Nick, why you 663 
tried this method? 664 
665 
8  I frequently try this. 666 
667 
SL  Frequently try…using particularly this one? 4 dosages, 1-hour self-observation, if 668 
not working, then 4 more dosages afterward!? 669 
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670 
8  For me, I have tried this method in the past sometimes…I tried when I was 671 
wheezing, very efficient…Um…this is my experience when I initially used this, then 672 
before…,few years ago I used the舒樂靈((ventolin))…err…used it during wheezing 673 
only…[SL  you only use it during wheezing]  Err…then in the class we were also 674 
taught to use it during short of breath…can use 4 dosages. 675 
676 
SL  Have you tried? 677 
678 
8  Yes yes yes, I have, I didn’t use if it is not serious sometimes, I am not using this 679 
that often now, I will not used those unless I’m required to use much force. 680 
681 
SL  How do you feel about the effect? 682 
683 
8  It was better in the beginning, now seems like becoming becoming...becoming 684 
feel that now, seems like, maybe my condition became more serious, seems like not 685 
so useful, but it’s still good to surpress the symptoms for a bit, sometimes it 686 
happened when I was walking on the road, I also stood for a while and stopped for a 687 
while, so, I seldom go to places which is far away now. 688 
689 
SL  Umum, then do you think this method of using 4 dosages during wheezing, then 690 
1-hour self-observation, then 4 more dosages afterward is helpful..er er..when 691 
responding to the exacerbation? 692 
693 
8  (.2) Still fine…after I sprayed for 2 times I sat still, lie down, sat still, once 694 
recovered, then..then..then..no need to use it again. 695 
696 
SL  Any difficulties when doing this? 697 
698 
8  I take with me wherever I go. 699 
700 
SL  You keep it with you all of the time. 701 
702 
8  I have I have I have…I keep it with me even when I was going out. 703 
704 
SL I see, then, what about Amy? Have you tired by following the instruction of this 705 
Action Plan.. 706 
707 
10  I have not inhaled so many times [SL  You have not inhaled so many times] I 708 
mean I am using it ((Seretide,舒悅泰)) in the morning and at night, so now for the 709 
one ((MDI)), I use one more time in the morning. 710 
711 
SL This Action Plan aimed at using the drugs during exacerbation only. 712 
713 
10 I take it as a precaution before exacerbation. 714 
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715 
SL I see, precaution before exacerbation, followed the doctor’s guidance, and you 716 
followed your habit with a designated time frame. 717 
718 
10 Well..it’s mostly used just once, in the morning= 719 
720 
SL =Then, have you ever tried the 4 dosages method when you found difficult in 721 
breathing? 722 
723 
10 No. 724 
725 
SL  I see...never tried, why? Ar, what’s the problem in doing this? 726 
727 
10 No..not because of having problem, it’s just I felt that there was no 728 
exacerbation. 729 
730 
SL O, during exacerbation! I mean the reason of not trying this method during 731 
exacerbation, what is it...? 732 
733 
10 Anyway, I didn’t find difficulty in breathing when I was walking, something like 734 
this; If I became a bit nervous, it exacerbated for a bit, once I sat down, it stopped, 735 
then the problem is gone, it is like this.. 736 
737 
SL  I see, the symptoms relieved by taking a break…I see I see…so you [10  Um, 738 
anyway the most important point is, don’t get myself nervous, personally I’m solving 739 
the problem in this way.]  So you have never followed the drugs-controlling 740 
method? 741 
742 
10 Um..um…I have not tried so many dosage, so I used one more in the morning. 743 
744 
SL Um, got it, got it. What about Ivan? Have you tried this… 745 
746 
19 I..I seldomly wheezed, I’m like..like going up slopes..like going up stairs. Once 747 
wheezed, I stopped for a while then the symptoms were gone, no problem= 748 
749 
8 =Not that serious= 750 
751 
SL =Ar…just like Amy, stopped when wheezed… 752 
753 
19 I have not tried inhaling those gases, but those with the shape as an UFO, I 754 
approximately take once every 2 days. 755 
756 
SL I see, once every 2 days [10  You take once every 2 days, for me it is twice per 757 
day] Um, um, um. 758 
759 
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8 (.3) The instruction is twice per day= 760 
761 
19 =I really seldomly wheezed, only a little bit when I was going up stairs fast, not 762 
that serious. 763 
764 
10 (low voice) It varies between people. 765 
766 
SL (2.4 – 39:27) Um, got it, both of you could relieve the symptoms by asking a 767 
break, so have never followed the guidelines of the Action Plan. Um, understand. 768 
Then maybe we can talk about some of the teaching methods in the workshop. 769 
Er…Do you guys still remember how Nurse MN taught you guys the various skills? 770 
Still remember? How Nurse MN taught you guys, what kind of methods? 771 
772 
8 Like taught…like the drug using skills? 773 
774 
SL Anything, teaching you how to use the drug is one of them. 775 
776 
8 There are some, like those concerning the dosage for using the drugs, how to 777 
use them, and got to clean up after medication, all these..all these..all these were 778 
taught. 779 
780 
SL  O, how did Nurse MN tell you all these? 781 
782 
8 By using the samples, there are so many samples by that time.. 783 
784 
SL Ar, samples, she did it by showing you the samples= 785 
786 
8  =Showed the samples, gave them to us…demonstrate to us…then we followed 787 
what she did. People like myself, never followed the instructions. In the past decade, I 788 
used the same drugs, the UFO ((Seretide)) one I’ve been using for 10 years= 789 
790 
SL =Ar…I found that there are so many things on your desk…haha..What are they? 791 
The book in blue, what’s that? 792 
793 
8 This one ? [SL  Is it given by Nurse MN?] Well,in the past, I have to fill it in. 794 
795 
SL  I see..I see, you do fill in this, You have done the record [ 8  Yes, yes, yes, here..] 796 
Then it was the leaflet that given to you by Nurse MN, right? 797 
798 
8 Here(open the leaflet) taught us how to fill it in. 799 
800 
SL I see, you have done the homework, right, right! 801 
802 
8 Cause I’m comparatively serious, so I know more about those things. 803 
804 
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Sl Um, I see I see. Ar, so you remember Nurse MN has showed you some samples, 805 
right? 806 
807 
8 Yes, yes. 808 
809 
SL Then has told you, demonstrated to you, right? 810 
811 
8 Um. 812 
813 
SL Then have you practice together with Nurse MN in the workshop?= 814 
815 
8 =Taught us to do the exercises. 816 
817 
SL Taught you guys exercises…alright… Showed you guys and then you guys 818 
repeat..?= 819 
820 
8 =Yes yes yes…there was a TV showing all those. 821 
822 
SL There was a TV, showing you guys the video. 823 
824 
8 Yes yes yes…there is also an instruction sheet which I’ve forgotten to bring it, 825 
with quite a lot of styles, seems to be 8 of them [19 haha…] 826 
827 
SL Those with 8 styles, those breathing exercises…your information is quite 828 
complete. Right…so Nurse MN has used so many methods to teach you, could you 829 
learn anything, was it helpful to you?= 830 
831 
8 =Yes, a little bit [ (  ) a bit] It’s not possible to be ((learn)) 100%. 832 
833 
10, 8  couldn’t learn them all. 834 
835 
8 Well, sometimes I tried that energy saving skills, work on a little bit of those 836 
exercises, also tried the night exercises, although I cannot perform all steps, I still had 837 
exercise….I also play those ((gymnastic instruments in the park)), these are all I do, no 838 
others. 839 
840 
 (All giggle) 841 
842 
SL Ivan, anything else? 843 
844 
19 Quite the same…haha! Can’t remember those Tai Chi styles…really can’t 845 
remember, not good at memorizing things…hahaha 846 
847 
10 Quite the same. 848 
849 
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SL Hahaha…so its quite the same for everyone. 850 
851 
8 I am not a patient person, one day my wife did the Tai Chi, I just don’t know how 852 
to do it [19  Those those those…5 style…hahaha]= 853 
854 
SL =Those 5 styles…haha…then there seems to be one follow-up telephone 855 
interview, called and updated your condition= 856 
857 
8 =Yes yes yes, Nurse MN is really good in this [10  she did, um um] Sometimes 858 
called and asked for my situation. 859 
860 
SL How do you feel?= 861 
862 
8 =It’s quite good, very caring for us. We...patients don't really know those 863 
knowledge, it is due to my personality. Rare.....I rarely participate in complicated 864 
activities now. In the past, we work all the time in the Mainland since I had business 865 
there and I needed to travel a lot by that time, alternatively I cannot participate in 866 
any activities already. 867 
868 
SL Then what about Wilson? How do you feel about the follow-up telephone 869 
interview from Nurse MN [ 14  She she she] How was it? 870 
871 
14 She sometimes called me from time to time and updated my situation, we do 872 
appreciate her consideration to us. 873 
874 
SL Ar…is it helpful to your learning? I mean, would it strengthen or help remind you 875 
the knowledge that you have learnt? Any effects that help your learning? 876 
877 
14 Yes yes, there were of course some effects, I mean followed her instruction and 878 
worked on it…to help keep my body well…more scientific.  879 
880 
SL Ar…it means followed her instruction, what you mean is she could remind you? 881 
Right? 882 
883 
14 Yes yes.. 884 
885 
SL It’s not bad. What about Ivan? About this follow-up telephone interview… 886 
887 
19 Follow-up telephone interview is quite food. 888 
889 
SL also good..? 890 
891 
19 I mean she cares for us. 892 
893 
SL Then what about your learning, anything helpful to that? 894 
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895 
19 Yes, it’s helpful. 896 
897 
SL How did it help you? How did it help your learning? 898 
899 
19 It is..err…making the lung function better.  900 
901 
SL I see, I see, Isee…then…then…umum, then you guys respond to the workshop 902 
are quite..quite the same. Actually do you think the self-management workshop for 903 
COPD…er…should it be or put it this way…which organization to conduct or which 904 
location to held this kind of workshop, that you think would be helpful to you illness 905 
control? 906 
907 
8 It would be the best if the government could organize more of these functions, 908 
There are so many COPD patients nowadays..so many, when I was in the park I saw 909 
every of the elderly there were having this disease, some of them didn’t know their 910 
trachea is not alright, the lung is not alright, that’s the situation. In fact, nowadays 911 
there are so many diseases, as well as COPD are are are…are quite a lot…now I 912 
think… 913 
914 
SL I see..feel that it will be better if it can be arranged by the government. 915 
916 
8 Yes…more promotion from the government. 917 
918 
SL Increasing government’s promotion. 919 
920 
8 In the past we smoke, nowadays people seldomly smoke already, but still there 921 
are people who smoke 922 
923 
SL I see…it means the government’s promotion to the community should be done, 924 
then do you mean there is a need for the workshop or management classes that held 925 
by the hospital, health center or Health Bureau is needed? 926 
927 
8 Also needed..also needed [SL  also needed] These are also good…if people are 928 
taught about precaution as such, number of patients will be reduced in the future. 929 
This is, this is a kind of environmental problem, related to pollution, some related to 930 
job duty, some related to smoking  931 
932 
SL Um, them apart from what Nick just said something about the community, or if 933 
there is anything else or will that be better if these functions is targeted to certain 934 
specific category of people? Or where to do it? How to do it? Targeted to which kind 935 
of people? Anything like this…we can talk about it, it means is this kind of workshop 936 
useful in Macau? 937 
938 
(.4) 939 
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940 
SL We have just mentioned that the government can do something for it, to 941 
promote to the community more about…the associated knowledge 942 
943 
8 Yes…knowledge…especially those professional kind..those kinds..something, 944 
maybe those constantly ((staying in)) polluted ((environment))..those…those workers 945 
946 
SL Those high-risk people, is that what you mean? 947 
948 
8 Umumum, these things are good….reduced the number of patients, is good to 949 
the country, good to the patient himself/herself. Now, may I tell you that having this 950 
kind of diseases really is suffering, first, is the loss of income resources, you…you 951 
can’t work when you are having this kind of disease, even if you want to go for work! 952 
You just can’t make any money, even though there are chances for you to make a big 953 
fortune, there is nothing you can do it! Sometimes, when I am wheezing….I would 954 
wheeze when I squat down. My disease is so severe that I sometimes really cannot 955 
reach things put high up [19  Can’t use any force] Can’t use any force, I have never 956 
been able to carry anything. Sometimes when I went shopping in the supermarket, 957 
very close to my home, I got some tissue paper there, I got difficulty in breathing 958 
when carried those stuffs and force myself into the lift.  959 
960 
SL I see, I see, then about that… 961 
962 
8 Sometimes, it didn’t work even I forced myself to do so! 963 
964 
SL Yes yes yes…then about the workshop, which location do you think this kind of 965 
workshops should be necessarily be held?= 966 
967 
8 =General it is available in hospitals…if the authority can promote a bit more will 968 
be perfect.  969 
970 
SL Health authority?= 971 
972 
8 =Yes, health authority, health centre, also the government should provide more 973 
resources to the organizations. 974 
975 
SL What kind of organization? 976 
977 
8 Like…to the society organization….ar..more..more promotion, more learning 978 
opportunities related to the disease as such.  979 
980 
SL I see…means the different organizations in the society, especially those medical 981 
organizations are needed. 982 
983 
8 These issues are related to the environment. 984 
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985 
SL I see, I see. Ok, we have talked for quite a while already..means about the 986 
contents of the workshop. So now would like to know how you guys control the 987 




SL Means how did you control the condition of your lung disease? 992 
993 
8 (.2) About self-control…nowadays, this is different for different families [19  It 994 
means…take a normal life, take good rests…do more exercises, this is my opinion] 995 
996 
SL Umumum…if there is anything else?= 997 
998 
8 =It is needed….because it is always better to manage this kind of things by 999 
yourself, during exacerbation, you really can’t do much. Like generally at the 1000 
beginning we didn’t play much attention to it neither, I myself did mine, sometimes 1001 
you are not ok. You will not be ok once this kind of disease became serious, you 1002 
totally couldn’t stand for that when you found difficulty in breathing, how can you 1003 
ask go for work in this case, just can’t work. 1004 
1005 
SL Um..anything else Wilson, how did you usually manage your lung disease. 1006 
1007 
14 I myself…in terms of dietary…I myself..ar..be more careful. 1008 
1009 
SL For example? 1010 
1011 
14 It means…means the others….those..have…means should reduce those harmful 1012 
food in the diet, don’t take it. Ar..in this way will be better to the body. 1013 
1014 
SL It means play attention to the dietary [8  In term of dietary, nutrition is also 1015 
important]  Um, nutrition is important…umum., what about Amy?= 1016 
1017 
10 =I am the same, dietary is important. 1018 
1019 
SL Anything else guys? Apart from dietary..and taking more rest? 1020 
1021 
8 Dietary…weather is cold, most important is to keep yourself warm when the 1022 
weather is cold, don’t caught a cold, it’s not ok once caught a cold. 1023 
1024 
SL I see..this is important as well, the method of self protection. 1025 
1026 
8 Cause coughing…once you cough, you are infected, the solution to infection 1027 
nowadays is taking antibiotics, in addition we are now at ‘high risk’ weather, will be 1028 
very dangerous once got sick. 1029 
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1030 
SL Got it, got it…well…then usually what are the most effective methods for you 1031 
guys to control the lung disease in daily life? Actually, we can discuss separately, it 1032 
means any differences regarding this issue before and after attending the workshop? 1033 
[8  Yes, there is] It means, any differences in the skills for controlling the ill lung 1034 
before and after attending the workshop? 1035 
1036 
19 There is. Like comparing…like after the workshop…know more about the 1037 
condition that I didn’t know before attending the workshop, once attended, then you 1038 
know more.  1039 
1040 
SL Which condition? 1041 
1042 
19 It means something like….how to…to maintain the lung function, etc. those 1043 
involve breathing out and breathing in. 1044 
1045 
SL I see..breathing out and breathing in…to the maintenance of lung function, then 1046 
it means, there are differences before and after the workshop …I see, it’s like this. 1047 
Err…anything else…er…it means err…what about your feeling? 1048 
1049 
8 It means I understand what kind of disease we are having through the workshop, 1050 
the main problems of it, so, we learnt all these through the workshop, although it is 1051 
dreadful, still if you play enough attention to all these, the lifespan are still able to be 1052 
extended, can be treated well in time.. 1053 
1054 
SL Quite positive towards the concept of self-management of the disease, right? 1055 
Good good. 1056 
1057 
8 Umum…if not that I didn’t pay much attention to this disease before, and I also 1058 
didn't know the severity of it.......I feel that ......The living standard of nowadays is 1059 
much better, even people with this disease can be prolonged life. Otherwise, it really 1060 
could not be treated in 20 years ago... we would have no way to be treated before 1061 
[14  incurable /((untreatable))…haha]  1062 
1063 
SL Haha, what about Wilson? Any differences in your daily control of the lung 1064 
disease before and after the workshop? 1065 
1066 
14 If you had not attended the workshop, you did not know ….how to control your 1067 
body. For now, the workshop teaches you how and how…..Well, although you 1068 
don’t …don’t get all, to some extent, you know what it is about. Well, you execute in 1069 
accord to it, then you become better in health. [SL  Um, understood] If you don’t 1070 
know, you are so ignorant that you don’t know what to do and which is good. Since 1071 
there is workshop, you can learn what is good and then follow it…..haha! 1072 
1073 
SL Got it…It means you know the skills through the workshop, maybe couldn’t 1074 
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learn them all, but learnt as much as possible, right? 1075 
1076 
14 Exactly.. 1077 
1078 
SL I see, that’s good that’s good…means it’s helpful. What about Amy??= 1079 
1080 
10 =I am the same. Having no knowledge before the workshop, went to the 1081 
emergency when it happened, got to went to the emergency immediately when it 1082 
happened. 1083 
1084 
SL Went to the emergency immediately when it happened. What about now? 1085 
1086 
10 I don’t scare now…he.. 1087 
1088 
SL Don’t scare now means..? 1089 
1090 
10 Cause no need to go frequently to the emergency now, it the past, it’s almost 1091 
like around a week, really= 1092 
1093 
SL =What are the reasons? 1094 
1095 
10 It means maybe I am now taking medicine, and doing those breathing exercises, 1096 
those, I changed a bit of others. It’s not easy to get cough or short of breath once 1097 
changed..  1098 
1099 
SL Reducing the exacerbation rate, Ar..its nice. It means the number of times for 1100 
going to the emergency is also reduced.. I see, very good. So, the methods that you 1101 
guys just mentioned are all helpful to you, right? You guys pointed out that these 1102 
methods are positive to lung function, to deep breathing and to the disease, right? 1103 
Also the frequency of going to the emergency were reduced because you guys 1104 
followed the instruction that guiding your dietary habit and self-management skills 1105 
[ 10  Yes] right? Then it’s very good, they are all helpful, right!? Er..er..again talk 1106 
about exacerbation..er…er… are there any differences in managing the situation 1107 
before and after the workshop? I mean, towards exacerbation, short of breath, cough, 1108 
any differences in managing these situations before and after the workshop? 1109 
1110 
8 (.3) Yes, yes…  1111 
1112 
SL How? 1113 
1114 
8 It’s like, now I understand what to do during exacerbation, or know which drugs 1115 
to use I was having difficulty in breathing, sit down and take a break, anyway wait till 1116 
the situation became stable, no need to take the ambulance immediately, no such a 1117 
situation. 1118 
1119 
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SL Umum..I see, it means similar to the situation as Amy=  1120 
1121 
8 =Cause I will sweat once nervous, I am strange in this, once sweated will want to 1122 
go piss, I ‘ve got this situation quite often. I’m very serious now, so can’t…can’t get 1123 
nervous, nowadays my…so nowadays my wife are working no more and takes care of 1124 
me  1125 
1126 
SL I see, it is like this. Ar, Ivan? Do you have any……any idea to share with us? Any 1127 
differences between the way that you manage during exacerbation before and after 1128 
the workshop? 1129 
1130 
19 (.4) For me……..exacerbation doesn’t happen that often..not too frequent, rare. 1131 
Never happen really. 1132 
1133 
SL Ar…it is like this. So just like what you’ve just said, the symptoms can be relieved 1134 
by taking a rest. [19  That’s it] I see, so the differences is not so obvious. I see, got it, 1135 
what about Wilson?  1136 
1137 
14 Me…before the workshop, I didn’t know how to relieve the symptoms by myself 1138 
when I was suffering from walking.  1139 
1140 
SL O, didn’t know how to relieve=  1141 
1142 
14 =Right, now with the skills that taught by Nurse MN…it is like, if suffering from 1143 
walking…ar…control the breathing [8 (Murmur) The breathing skills] take a rest, 1144 
then physically comparatively better, then not..not…not so, you know.  1145 
1146 
SL So, you have learnt some breathing and resting skills = 1147 
1148 
14 =Hehe…yes…if there is no one to teach you, you will not know how to relieve 1149 
the symptoms, after the workshop then you know how to relieve, like controlling the 1150 
breath, and taking a rest, then it becomes fine afterward   1151 
1152 
SL Um….ok, a brief conclusion, so, every one of you learnt from the workshop the 1153 
skills for managing the short of breath situation, relieving the situation and even 1154 
reduced the frequency for going into the emergency, right? It’s quite good. Then, 1155 
would like to have the last opinion from you guys, as a COPD patient, what kind of 1156 
nursing service do you think would be helpful to you? Nursing service means, means 1157 





SL Or some suggestions will also be ok! Give us, the nurse some suggestions, how 1163 
could our nursing service be improved to provide a better service to the COPD 1164 





14 Actually….the nurses to us, the patient really...ar…for us..ar…those ar…as such as 1169 
such what kind of diet, instructing us in different aspects, it is very helpful indeed. 1170 
Working on some other things, like the instruction in exercises are very helpful as 1171 
well. 1172 
1173 
SL Dietary, exercises, the nurses can do something more in these aspects.  1174 
1175 
14 Very helpful…hehe. 1176 
1177 
SL Good good, anything else? According to the point of view of COPD patient, any 1178 




8 Nowadays….different patients are having different situations, very hard to say! 1183 
1184 
SL I understand, just talk about it based on you, yourself= 1185 
1186 
8 =Meanwhile I’m comparatively more serious, different from those general cases, 1187 
So, in the level 2 like us is preparing to go into level 3, I am the type which is 1188 
comparatively serious, cause if the symptoms appeared, common family like us is 1189 
taking care of us  like this, sometime, when the symptoms appeared, there is really 1190 
nothing more you can do, got to go to the hospital.  1191 
1192 
SL Umum…then how can the nurses be improved for those patients in a serious 1193 
case?= 1194 
1195 
8 =The best would be…let those who are comparatively serious know more about 1196 
the illness condition, we also know it. ..ar…on top of that, the nutrition, this is for 1197 
sure, nutrition, doing exercises by myself, these things do….((for)) relieve our 1198 
disease…ar, ar…and those aspect in terms of the hospital....it means, for example 1199 
patient with the same situation said, meanwhile it seems like the the number of 1200 
COPD patients is increased, Is the hospital enough? Is the hospital bed enough? 1201 
1202 
SL O, not enough hospital bed. I see I see, then what’s your need personally? You 1203 
have just emphasis that your situation is comparatively serious, how actually could 1204 
the nursing service back up yourself, support you in terms of disease management? 1205 
Any suggestions for us?= 1206 
1207 
8 =I am not quite sure about some medical physic ((physiology)), anyway the 1208 
doctor advise us to take drugs, but now is not that often, since nowadays it is using 1209 
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the more like using the spray, these are just help curing, spray directly into the lung 1210 
and no need to pass through the stomach, there are quite a lot of drugs now, 4 of 1211 
them, I have taken quite a lot, taken 4 different types=  1212 
1213 
SL =Then you have one opinion in terms of drugs…there are aspiration drugs which 1214 
you don’t have to take them orally, then apart from drug usage in the control of your 1215 
condition, what could the nurses do in this aspect…  1216 
1217 
8 The most important to me now is the cough, I couldn’t cough the phlegm up. 1218 
1219 
SL I see…the cough…the skills of coughing= 1220 
1221 
8 =The cough…sometimes sometimes got stuck in the chest, it seems like I 1222 
couldn’t cough the phlegm up, we can’t really use the phlegm suctioning machine, 1223 
sometimes my chest has such a situation, but not often, sometimes having a 1224 
condition as such is a bit annoying, then I took some mucolytics, some doctors gave 1225 
me some mucolytics, then I took the mucolytics under such a condition. 1226 
1227 
SL Then what about Ivan? Under the considerations of a COPD patient, what could 1228 
be done by the nurses to respond to your need? 1229 
1230 
19 I think its sufficient now [ SL  It’s sufficient already…I see] seems like I can feel it, 1231 
maybe I have recovered a little bit better, not as serious as him (8), so I think it should 1232 
be sufficient.  1233 
1234 
SL Sufficient in terms of which aspect? 1235 
1236 
19 (.2) I mean usually….I go to the hospital once every 2 months….for that, how do 1237 
you call it….that [SL  follow-up consultation?] follow-up consultation every 2 months, 1238 
apart from that, I take care of myself usually. 1239 
1240 
SL I see…follow-up consultation every 2 months is sufficient, then mostly managing 1241 
the condition in a self-care basis. What about the nurses? What about our nursing 1242 
service? 1243 
1244 
19 Its quite good…like Nurse MN is quite considerate to us. 1245 
1246 
Q So the definition of good is having the considerations from the 1247 




19 I think is quite good, take care of us well. 1252 
1253 
SL I see, like this, like this, it’s because you have joined this workshop, right..is it 1254 
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like this? Do you have this feeling? 1255 
1256 
19 Of course it is. 1257 
1258 
SL Then does this workshop is really what you guys needed?=  1259 
1260 
8 =It is needed, needed, at least, there is quite a lot of knowledge that we need to 1261 
know, not everyone understands this disease [19  Yes, yes] at least some one should 1262 
understand, meanwhile there are some skills, how to control the nutrition, how to 1263 
manage during exacerbation and emergency situation, have some knowledge about 1264 
this. [19  It means…it means the nurses.…it means there is someone there introduce 1265 
us of how to understand the illness condition, and how to adapt myself to the 1266 
disease, it’s quite good] At least I know what’s going on, you know we know nothing 1267 
about medicine. 1268 
1269 
SL Then you think this is what the nurses should do? 1270 
1271 
19 (.2) Not a must………………   1272 
1273 
(8 : hahaha) 1274 
1275 
SL Not a must!?..Why? 1276 
1277 
19 Errrr……..if you dont…if you don’t take care of yourself, it’s useless no matter 1278 
how good the nurses teach you. 1279 
1280 
SL I see…so you think that it is more like your own responsibility for taking care of 1281 
your condition [19 Yes, myself] [8  hahaha] If there are any other suggestions, or 1282 
Amy? 1283 
1284 
10 I think the same, just like, even if Nurse MN taught you, but you don’t manage 1285 
yourself, then it means nothing no matter how you are taught. 1286 
1287 
SL But do you think it is needed for Nurse MN to teach you?= 1288 
1289 
10 =Yes, the reason for need to be taught is to understand how…like we don’t know 1290 
what to do…how to, how to better help myself [8  that’s more communication from 1291 
the nurses, more communication] Thus, the nurse needs to.. 1292 
1293 
SL I see…all of you think that the workshop is needed, it means what you want 1294 
from the nurses is, to assist you guys to understand more about the disease, or skills 1295 
for self-management for the disease, only work in the way would benefit to the 1296 
management for the disease, right? Ok, I think it’s quite complete for the content of 1297 
our discussion, any more other opinions and suggestions regarding the 1298 
self-management of COPD?= 1299 
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1300 
19 =The origin of COPD…I think the main cause is smoking, right..right? It should be 1301 
[8 Smoking is one of the reasons]  For the situation as such, the government 1302 
should do more promotion about quit smoking! 1303 
1304 
SL Tell smoker to quit smoking, tell them don’t start smoking. It’s good.. I see, right 1305 
right. From the opinion of patient like you= 1306 
1307 
19 =Yes, now that after we got this condition…really…feel that smoking..really is 1308 
something really bad really bad! 1309 
1310 
SL Really bad, really bad.. 1311 
1312 
14 Smoking and taking alcohol is the worse, those who have this disease are mostly 1313 
smokers [19 Feel that he (8) became so serious, can’t even carry something, really 1314 
is suffering] 1315 
1316 
SL  Yes, yes. 1317 
1318 
8 Ya….I’m younger than he (19) [14  Smoking really (  )] I am not that old, he (19) 1319 
is 10 years older than me, older than me for 10 years, the condition is still very good 1320 
even older than me for 10 years, can tell by how he talks, his complexion [14  haha] 1321 
my complexion is not good, showing…a bit not enough oxygen. In the past, I always 1322 
think that my complexion is resulted from lack of oxygen= 1323 
1324 
SL =Just heard of what you guys said……like Ivan and Nick both mentioned the 1325 
need for education from the government, about quit smoking, towards the 1326 
community= 1327 
1328 
8 =It should, it should. 1329 
1330 
SL Its good, also should strengthen the consciousness of the high risk patients 1331 
towards the disease, right… um, good good good. Anything else?  1332 
1333 
10 (.2) Should be quite complete. 1334 
1335 
SL  quite complete. 1336 
1337 
8 Um…..more exchanging ideas, communicate more! 1338 
1339 
SL Right, then thank you everyone. 1340 
Supplementary notes:1341 
Energy saving – forgot 1342 
Patting the neck with cold water – (8) tried for few times 1343 
It’s not a problem of having much content, more content more knowledge. 1344 
